Drug: Linaclotide|Drug: Placebo
Drug: Voxelotor
Drug: revefenacin|Drug: Placebo|Drug: Formoterol
Drug: Cariprazine|Drug: Placebo
Drug: ganaxolone|Drug: Placebo
Drug: Ibuprofen|Drug: Lidocaine Patch 4%
Drug: DEFINITY
Drug: Teduglutide|Other: Standard Medical Therapy|Device: Syringe|Device: Needle
Drug: deutetrabenazine Low|Drug: deutetrabenazine High|Drug: Placebo
Drug: Olanzapine|Drug: Placebos
Drug: Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy|Drug: Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and HSCT
Drug: Levomilnacipran ER|Drug: Fluoxetine|Drug: Placebo
Drug: Upadacitinib|Drug: Placebo for Upadacitinib
Drug: Larazotide Acetate|Drug: Matching Placebo
Drug: Transdermal Estrogen
Drug: Delamanid (DLM)|Drug: Isoniazid (INH)|Dietary Supplement: Pyridoxine (vitamin B6)
Drug: Tradipitant|Drug: Placebo
Drug: Upadacitinib|Drug: Placebo for Upadacitinib|Drug: Topical corticosteroids (TCS)
Drug: Daromun|Procedure: Surgery alone|Procedure: Surgery
Drug: Oral dexamethasone|Drug: Nebulized Epinephrine|Drug: Oral placebo|Drug: Nebulized normal saline
Drug: TEV-50717|Drug: Placebo
Drug: ADS-5102
Drug: Test naproxen sodium tablet|Drug: Commercial naproxen sodium tablet|Drug: Commercial naproxen sodium liquid gels capsule|Drug: Placebo tablet
Drug: A4250|Drug: Placebo
Drug: RVL-1201|Other: Vehicle ophthalmic solution
Drug: iron isomaltoside(Monofer®)
Drug: Tranexamic Acid
Drug: Progesterone vaginal ring (PVR)
Drug: S5G4T-1
Drug: S5G4T-1|Drug: S5G4T-2
Drug: Rilpivirine 25 mg|Drug: Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC)
Drug: Test Product|Drug: Reference Product|Drug: Placebo
Drug: BLI800|Drug: Fortrans
Drug: Mepolizumab 100 milligrams|Drug: Placebo|Drug: Salbutamol
Drug: Ixazomib, thalidomide, & dexamethasone (ITD) re-induction|Drug: Conventional autologous stem cell transplant (ASCT-con)|Drug: Augmented autologous stem cell transplant (ASCT-aug)|Drug: ITD consolidation and ixazomib maintenance vs. No further therapy
Drug: VT-1161|Drug: Placebo
Drug: IW-3718|Drug: placebo
Drug: YYD302 2ml|Drug: Active comparator: Synovian Inj.
Drug: capecitabine
Drug: Neridronic acid|Drug: Placebo
Drug: Rapastinel|Drug: Placebo
Drug: Dupilumab (SAR231893/REGN668)|Drug: Asthma controller therapies (incl. prednisone/prednisolone)|Drug: Asthma reliever therapies
Drug: AG-348
Drug: Baricitinib
Drug: Galcanezumab|Drug: Placebo
Drug: Dalteparin|Drug: Saline
Drug: TEZ/IVA|Drug: IVA|Drug: Placebo
Drug: Norgestrel 0.075 mg tablets
Drug: D-PLEX
Drug: Magnesium group|Drug: Normal saline group
Drug: Photodynamic Therapy with indocyanine green and diode laser|Procedure: Mechanical debridement alone
Drug: Melatonin 5 mg|Drug: Vitamin C 1 GM Oral Tablet|Drug: Vitamin E 400 UNT|Drug: N-acetylcysteine
Drug: Atezolizumab|Drug: Bevacizumab|Drug: Cisplatin|Drug: Paclitaxel
Drug: Mirikizumab
Drug: Dexamethasone|Drug: Normal saline
Drug: BOTOX®, Allergan|Drug: Placebo
Drug: 18F-choline PET
Drug: Selinexor|Drug: Placebo
Drug: Ondansetron
Drug: Simdax
Drug: Somatropin
Drug: Recombinant Human Growth Hormone (rhGH) Injection
Drug: Acetaminophen|Drug: Ibuprofen 600 mg|Behavioral: Educational intervention|Drug: Placebo oral capsule
Drug: Memantine Hydrochloride|Drug: Placebo
Drug: Entresto|Drug: Valsartan
Drug: D961H capsule 10mg|Drug: D961H sachet 10mg
Drug: Decitabine|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone
Drug: Acetaminophen|Drug: Placebo|Drug: IV Hydromorphone
Drug: Corticoids|Other: Placebo
Drug: Tranexamic Acid 100 MG/ML|Drug: Placebo
Drug: Semaglutide 1.0 mg|Drug: Semaglutide 2.4 mg|Drug: Placebo I (Semaglutide)|Drug: Placebo II (Semaglutide)
Drug: sacubitril/valsartan|Drug: Valsartan
Drug: Dabrafenib|Drug: Trametinib
Drug: Spironolactone 25mg|Drug: Placebo oral capsule
Drug: Administration of DAA-based treatment
Drug: Bardoxolone methyl|Drug: Placebo
Drug: Memantine|Radiation: Whole Brain Radiotherapy (WBRT)|Procedure: Stereotactic Radiosurgery (SRS)
Drug: Placebo|Drug: 90 mcg Reference Product|Drug: 180 mcg Reference Product|Drug: 90 mcg Test Product
Drug: Fitusiran (ALN-AT3SC)
Drug: Cannabidiol (CBD) Oil Capsules|Drug: Sunflower Lecithin Oil in Capsule
Drug: Sulfur hexafluoride lipid-type A microspheres
Drug: Semaglutide|Drug: Placebo
Drug: Semaglutide|Drug: Placebo (semaglutide)
Drug: Brexpiprazole|Other: Placebo
Drug: methylcobalamin|Drug: saline solution
Drug: AG-348|Drug: Placebo
Drug: B/F/TAF|Drug: Placebo to match DTG|Drug: Placebo to match F/TDF|Drug: DTG|Drug: F/TDF|Drug: Placebo to match B/F/TAF
Drug: Indomethacin SR|Drug: Placebos
Drug: RPh201|Other: Placebo
Drug: 5mg Serlopitant Tablets|Drug: Placebo Tablets
Drug: Preventive Gel|Drug: Marketed Control
Drug: Placebos|Drug: Cattle Encephalon Glycoside and Ignotin
Drug: Montelukast 10mg|Drug: Placebo
Drug: Placebo Oral Tablet|Drug: Cortancyl Oral Tablet|Drug: Levocetirizine Oral Tablet
Drug: Azithromycin|Drug: Amoxicillin
Drug: ACT-541468|Other: Placebo
Drug: TJP-008-1|Drug: TJP-008-2|Drug: Coolprep powder
Drug: 18F-FES PET
Drug: isosorbide mononitrate|Drug: Placebos
Drug: Saline Solution for Injection|Drug: Leuprolide Acetate
Drug: Molidustat (BAY85-3934)|Drug: Darbepoetin alfa|Drug: Placebo of Molidustat (BAY85-3934)|Drug: Placebo of Darbepoetin alfa
Drug: Temocillin|Drug: meropenem or imipenem
Drug: amyloid PET
Drug: Magnesium Sulfate|Drug: Nifedipine
Drug: Nivolumab 10 MG/ML Intravenous Solution|Other: Best Supportive Care
Drug: Lipiodol|Device: Mock catheter
Drug: Carvedilol
Drug: Recombinant Human Prourokinase|Drug: Alteplase
Drug: Aprocitentan 12.5 mg|Drug: Aprocitentan 25 mg|Drug: Placebo
Drug: Polypill|Drug: Aspirin|Drug: Atorvastatin|Drug: Metoprolol|Drug: Valsartan
Drug: Hydroxychloroquine|Drug: Placebo
Drug: Cipros 20 association|Drug: Crestor 20 mg
Drug: Progesterone
Drug: 5 mg Serlopitant Tablets
Drug: TETA 4HCL|Drug: Penicillamine
Drug: Intranasal ketamine|Drug: Placebo
Drug: Pomalidomide|Drug: Dexamethasone|Drug: Venetoclax
Drug: Prazosin|Drug: Placebo
Drug: Butylphthalide|Drug: Butylphthalide Placebo
Drug: Brexpiprazole|Drug: Placebo|Drug: Citalopram Hydrobromide|Drug: Escitalopram|Drug: Fluoxetine|Drug: Paroxetine|Drug: Sertraline|Drug: Duloxetine|Drug: Venlafaxine Extended Release Oral Capsule
Drug: Entinostat|Drug: Placebo|Drug: Exemestane
Drug: Lactated Ringer's|Drug: Normosol
Drug: TEZ|Drug: IVA
Drug: Clonidine|Other: Morphine
Drug: Lidocaine Jet Injector|Drug: Placebos
Drug: Indomethacin|Drug: Acetaminophen
Drug: Bimekizumab|Drug: Secukinumab|Other: Placebo
Drug: Vitamin D 3
Drug: D-cycloserine|Drug: Placebo
Drug: Muscadine Plus|Drug: Placebos
Drug: Recombinant Human Growth Hormone Injection (rhGH)
Drug: Sarilumab
Drug: Bismuth subsalicylate|Drug: Placebo Oral Tablet
Drug: Mirikizumab|Drug: Placebo|Drug: Secukinumab
Drug: Carboplatin|Drug: Paclitaxel|Drug: Cisplatin|Radiation: Radiotherapy
Drug: Olaparib 300mg tablets
Drug: Indomethacin 100Mg Suppository|Procedure: IVF/ICSI
Drug: DEP-Ru
Drug: LY01008|Drug: Bevacizumab
Drug: JZP-258|Drug: Placebo Oral Tablet
Drug: Podofilox Gel 0.5%|Drug: Condylox Topical Gel 0.5%|Drug: Placebo Gel
Drug: Casimersen|Drug: Golodirsen
Drug: Fermented Soy|Other: Placebo
Drug: Chronocort®|Drug: Standard Care
Drug: AJM300|Drug: Placebo
Drug: APL-2
Drug: Dexmedetomidine Hydrochloride
Drug: FX006 32 mg
Drug: Methylprednisolone
Drug: CNG Chemotherapy|Drug: NCCN Chemotherapy|Radiation: CNG Radiation|Radiation: NCCN Radiation
Drug: INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)|Drug: INSULIN GLARGINE (HOE901)|Drug: Metformin|Drug: Insulin Glulisine (HMR1964)
Drug: Trastuzumab deruxtecan (DS-8201a)|Drug: Ado-trastuzumab emtansine (T-DM1)
Drug: Sodium Zirconium Cyclosilicate 5g|Drug: Sodium Zirconium Cyclosilicate 10g|Drug: Placebo
Drug: Zero-dose|Drug: 90 mcg of PROAIR® HFA|Drug: 180 mcg of 90 mcg of PROAIR® HFA|Drug: 90 mcg of albuterol sulfate inhalation aerosol
Drug: Turoctocog alfa pegol
Drug: SJP-0035 0.001%|Drug: Placebo
Drug: Cipros 10 association|Drug: Crestor 10 mg
Drug: Lidocaine 4% Topical Application Cream [LMX 4]|Drug: Lidocaine Hydrochloride 2 mg/mL Injectable Solution|Drug: Normal Saline
Drug: Tralokinumab|Drug: Placebos
Drug: Ketamine Hydrochloride
Drug: APL-2|Other: Sham Procedure
Drug: VX-445|Drug: TEZ|Drug: IVA
Drug: VX-445|Drug: TEZ|Drug: IVA|Drug: TEZ/IVA
Drug: VX-445|Drug: TEZ|Drug: IVA|Drug: Matched Placebos
Drug: Dexmedetomidine
Drug: Mirikizumab|Drug: Placebo
Drug: 3M DuraPrep|Drug: ChloraPrep
Drug: Ocrelizumab
Drug: Venglustat GZ/SAR402671|Drug: Placebo
Drug: Trastuzumab deruxtecan|Drug: Capecitabine|Drug: Lapatinib|Drug: Trastuzumab
Drug: Apalutamide|Drug: ADT (Standard of Care)
Drug: Ferric carboxymaltose|Drug: Ferrous Sulfate
Drug: Napabucasin|Drug: Fluorouracil|Drug: Leucovorin|Drug: Irinotecan
Drug: Clindamycin 1% Gel|Drug: Placebo
Drug: HLX01|Drug: Methotrexate(MTX)
Drug: Rucaparib|Drug: Nivolumab|Drug: Placebo Oral Tablet|Drug: Placebo IV Infusion
Drug: Sotagliflozin (SAR439954)|Drug: Placebo
Drug: EPORON|Drug: EPREX
Drug: Osimertinib 80mg/40mg|Drug: Placebo Osimertinib 80mg/40mg
Drug: SHR3680|Drug: Bicalutamide
Drug: Oseltamivir|Drug: Placebo
Drug: Durvalumab|Other: Placebo|Drug: Cisplatin/ Etoposide|Drug: Carboplatin/ Paclitaxel|Drug: Pemetrexed/ Cisplatin|Drug: Pemetrexed/ Carboplatin|Radiation: Radiation
Drug: BGB-290 capsule|Drug: Placebo capsule
Drug: risankizumab|Drug: placebo for rizankizumab
Drug: Naloxone, intranasal|Drug: placebo, intranasal|Drug: Naloxone, intramuscular|Drug: placebo, intramuscular
Drug: Placebo|Drug: Ustekinumab (approximately 6 mg/kg)|Drug: Ustekinumab 90 mg
Drug: ART-123|Drug: Placebo Comparator - Placebo
Drug: Pembrolizumab|Drug: Lenvatinib|Drug: Paclitaxel|Drug: Doxorubicin
Drug: Monthly bolus of cholecalciferol per os|Drug: Daily dose of cholecalciferol per os|Other: Control
Drug: Gan Fu Le Tablets|Drug: Tyroserleutide for injection|Drug: Placebo
Drug: ZL-2306(nirapairb)|Drug: Placebo
Drug: REGN2810/ipi|Drug: REGN2810/chemo/ipi|Drug: Pembrolizumab
Drug: 0.3% sodium hyaluronate ophthalmic solution|Drug: 0.1% sodium bromide solution|Other: Meibomian gland massage|Other: Placebo
Drug: Eltrombopag|Drug: rhTPO
Drug: hydroxyurea|Drug: Imatinib
Drug: Ketamine 10 MG/ML|Drug: Placebos|Drug: Midazolam 1 MG/ML
Drug: Morphine|Drug: Epinephrine|Drug: naropin
Drug: Sugammadex|Drug: Neostigmine|Drug: Glycopyrrolate
Drug: Tadekinig alfa
Drug: Abaloparatide|Drug: Placebo
Drug: Midostaurin|Drug: Midostaurin Placebo|Drug: Chemotherapy
Drug: Dextroamphetamine|Drug: Placebo|Diagnostic Test: [18F]Fallypride|Diagnostic Test: [18F]-FE-PE2I
Drug: HLX04 100 mg in 4 ml Injection|Drug: Avastin 100 mg in 4 ml Injection
Drug: Morphine|Drug: Ketamine
Drug: 177Lu-PSMA-617|Other: Best supportive/best standard of care
Drug: Acthar Injectable Product|Drug: Depo medrol
Drug: QPI-1002|Drug: Placebo
Drug: Alirocumab SAR236553 (REGN727)|Drug: Rosuvastatin|Drug: Atorvastatin|Drug: Simvastatin|Drug: Pravastatin|Drug: Lovastatin|Drug: Fluvastatin|Drug: Ezetimibe|Drug: Cholestyramine|Drug: Nicotinic acid|Drug: Fenofibrate|Drug: Omega-3 fatty acids|Drug: Placebo
Drug: Alirocumab SAR236553 (REGN727)|Drug: Rosuvastatin|Drug: Ezetimibe|Drug: Cholestyramine|Drug: Nicotinic acid|Drug: Fenofibrate|Drug: Omega-3 fatty acids|Drug: Atorvastatin|Drug: Simvastatin|Drug: Fluvastatin|Drug: Pravastatin|Drug: Lovastatin
Drug: Vitamin C|Drug: Thiamine|Drug: Hydrocortisone|Drug: Vitamin C Placebo|Drug: Thiamine Placebo|Drug: Hydrocortisone Placebo
Drug: PBK-1701TC|Drug: Standard oral preparation
Drug: Liposomal Bupivacaine|Drug: Standard Bupivacaine
Drug: Sacubitril/Valsartan 200mg (blinded)|Drug: Valsartan 160mg (blinded)
Drug: TNX-102 SL 5.6 mg
Drug: High dose Cytarabine|Drug: Cytarabine|Drug: Hign dose Daunorubicin
Drug: Rivaroxaban 10 MG
Drug: Tranexamic Acid|Drug: Placebo (Saline)|Other: Perioperative hypotension-avoidance strategy|Other: Perioperative hypertension-avoidance strategy
Drug: Levosimendan|Drug: Placebo for levosimendan
Drug: Balovaptan|Drug: Placebo
Drug: secukinumab 150 mg
Drug: CPI 613, mFolfirinox|Drug: Folfirinox
Drug: CPI-613 + HD Cytarabine and Mitoxantrone|Drug: HD Cytarabine and Mitoxantrone
Drug: IMAB362|Drug: placebo|Drug: oxaliplatin|Drug: leucovorin|Drug: fluorouracil
Drug: TV-46000 - A|Drug: TV-46000 - B|Drug: Placebo
Drug: docetaxel, nedaplatin, and capecitabine|Drug: nedaplatin|Drug: docetaxel, cisplatin, and fluorouracil|Drug: cisplatin|Drug: docetaxel, cisplatin, and capecitabine|Drug: docetaxel, nedaplatin, and fluorouracil
Drug: Nitrous Oxide|Other: Placebo
Drug: Tofacitinib
Drug: Ketamine
Drug: Acetazolamide|Procedure: Optic Nerve Sheath Fenestration|Procedure: Ventriculoperitoneal CSF Shunting
Drug: Rituximab
Drug: FUDR|Drug: Oxaliplatin|Drug: Leucovorin|Drug: 5FU
Drug: APL-2|Drug: Soliris
Drug: migalastat HCl 150 mg
Drug: Nepafenac 0.3% Oph Susp|Drug: Placebos|Drug: Nepafenac 0.3% Oph Susp (reference)
Drug: Atezolizumab|Drug: Paclitaxel|Drug: Dose-dense Doxorubicin or dose-dense Epirubicin|Drug: Cyclophosphamide
Drug: Tegoprazan/Amoxicillin/Clarithromycin|Drug: Lansoprazole/Amoxicillin/Clarithromycin
Drug: Inhaled treprostinil solution|Drug: Placebo solution
Drug: Efpeglenatide (SAR439977)|Drug: Placebo
Drug: Elbasvir 50 MG / Grazoprevir 100 MG Oral Tablet [Zepatier]
Drug: Dulaglutide
Drug: Reproxalap Ophthalmic Solution (0.25%)|Drug: Reproxalap Ophthalmic Solution (0.5%)|Drug: Vehicle Ophthalmic Solution
Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Docetaxel|Drug: Paclitaxel|Drug: Pertuzumab IV|Drug: FDC of Pertuzumab and Trastuzumab SC|Drug: Trastuzumab IV|Drug: Trastuzumab SC|Procedure: Surgery|Radiation: Post-operative Radiotherapy|Drug: Hormone Therapy
Drug: sparsentan|Drug: irbesartan
Drug: Genvoya 150Mg-150Mg-200Mg-10Mg Tablet|Drug: Dolutegravir 50 mg plus one RTI
Drug: Obinutuzumab|Drug: Bendamustine
Drug: recombinant human thrombopoietin|Drug: Platelet Concentrate
Drug: vibegron|Drug: Placebos|Drug: Tolterodine Tartrate ER
Drug: Quadruple therapy|Drug: Classic treatment
Drug: Fasinumab AI|Drug: Fasinumab PFS
Drug: Sennosides colonic preparation|Drug: Oral Gentamycin|Drug: Oral Ornidazole|Drug: Oral Placebo Gentamycin|Drug: Oral Placebo Ornidazole
Drug: Arimoclomol|Drug: Placebo oral capsule
Drug: Crenezumab (RO5490245)
Drug: Levotuss
Drug: Tenofovir Alafenamide
Drug: Aripiprazole Oral Solution|Drug: Placebo Oral Solution
Drug: Duloxetine|Drug: Escitalopram
Drug: Brexpiprazole|Drug: Placebo
Drug: SOF|Drug: DAG181
Drug: Placebo Oral Tablet|Drug: AGB101 220 mg tablet
Drug: Tofacitinib|Other: Placebo
Drug: BCX7353 capsules|Drug: Placebo oral capsule
Drug: Eliglustat GZ385660|Drug: Imiglucerase GZ437843
Drug: Lidocaine|Drug: Ketorolac|Drug: paracetamol
Drug: Lidocaine Hydrochloride|Other: Placebo
Drug: Granisetron|Drug: Midazolam
Drug: Fecal Microbiota Transplantation (FMT)|Drug: Sham-transplantation Placebo
Drug: Misoprostol|Drug: Placebos
Drug: Bupivacaine Group|Other: Placebo
Drug: Molgramostim
Drug: Doxycycline and tauroursodeoxycholic acid|Drug: Standard of care
Drug: Methylphenidate|Other: Matching Placebo
Drug: Brolucizumab|Drug: Aflibercept
Drug: Alirocumab 150 MG/ML [Praluent]
Drug: Cyclophosphamide|Drug: Fludarabine|Radiation: Total Body Irradiation|Drug: Tacrolimus|Drug: cellcept|Drug: g-csf|Procedure: Peripheral Blood Transplant
Drug: Liraglutide Pen Injector [Saxenda]|Drug: Placebo Liraglutide Pen Injector
Drug: Dextromethorphan Hydrobromide|Drug: Avicel PH101 (Microcrystalline Cellulose NF) for Compounding|Drug: Oxycodone
Drug: R-DA-EPOCH-21|Drug: R-BL-M-04|Drug: R-DA-EPOCH-21 + auto-SCT|Drug: R-BL-M-04 + auto-SCT
Drug: Bilastine Ophthalmic Solution 0.6%|Drug: Ketotifen Ophthalmic Solution 0.025% (Zaditen)|Drug: Vehicle of Bilastine Ophthalmic Solution
Drug: Topiramate|Drug: Naltrexone
Drug: Omalizumab|Drug: Placebo
Drug: risankizumab|Drug: secukinumab
Drug: KN035 plus Gemcitabine & oxaliplatin|Drug: Gemcitabine & oxaliplatin
Drug: Melatonin 4 mg Tablet
Drug: CMAB008|Drug: MTX|Drug: Remicade
Drug: Cyclophosphamide and ATG|Drug: Alemtuzumab
Drug: Dexmedetomidine|Drug: Sodium chloride 0.9%
Drug: Mosapride|Drug: Placebo Oral Tablet
Drug: Vilaprisan (BAY1002670)
Drug: Blinatumomab
Drug: Z-100|Drug: Placebos
Drug: Restrictive fluid therapy|Drug: Liberal fluid therapy
Drug: Sennosides colonic preparation|Drug: Oral Gentamycin|Drug: Oral Ornidazole|Drug: Oral placebo Gentamycin|Drug: Oral placebo Ornidazole
Drug: Oxaliplatin|Drug: Paclitaxel|Drug: S-1 (Tegafur, Gimeracil and Oteracil Porassium Capsules)
Drug: Tranexamic Acid|Other: Placebo
Drug: Cholecalciferol|Drug: Placebo Oral
Drug: Celestamine®
Drug: Ibrutinib
Drug: Azythromycin|Dietary Supplement: Inuline and fructo-oligosaccharides|Drug: Albendazole|Dietary Supplement: Fortified blend flour
Drug: enfortumab vedotin|Drug: docetaxel|Drug: vinflunine|Drug: paclitaxel
Drug: Racecadotril plus ORS|Drug: ORS
Drug: Ketoconazole|Drug: Terconazole
Drug: High-dose|Drug: Standard dose
Drug: Botulinum toxin type A|Other: Upper extremity orthoses|Other: Home exercise program
Drug: gel loaded with steroids (momentasone)|Drug: gel loaded with antibiotic (Levofloxacin)|Drug: gel loaded with both steroids and antibiotic
Drug: AK1820|Drug: Voriconazole
Drug: Avatrombopag|Drug: Placebo Oral Tablet
Drug: mavacamten|Drug: Placebo
Drug: Dysport Injectable Product
Drug: Ipilimumab|Drug: Nivolumab
Drug: FOLFOX|Procedure: Hepatic resection
Drug: Actovegin|Drug: Placebo
Drug: CMAB007|Drug: Symbicort|Drug: Seretide|Drug: Ventolin|Drug: placebo
Drug: Irinotecan Liposomal Injection [Onivyde]
Drug: Sorafenib|Drug: HAIC of FOLFOX|Drug: HAIC of OXA
Drug: Ozanimod
Drug: Propofol|Drug: Dexmedetomidine
Drug: Lurasidone HCL 160 mg|Drug: Quetiapine XR 600 mg
Drug: avapritinib|Drug: regorafenib
Drug: HS-25 10mg|Drug: HS-25 10mg combination with Atorvastatin|Drug: HS-25 20mg combination with Atorvastatin|Drug: Atorvastatin|Drug: HS-25 20mg|Drug: Placebe of HS-25 and Atorvastatin
Drug: acetylsalicylic acid|Drug: Placebo
Drug: Ozanimod|Other: Placebo
Drug: Etripamil|Drug: Placebo|Device: Aptar Pharma Nasal Spray
Drug: Tranexamic Acid|Drug: Oxytocin
Drug: Gabapentin Oral Capsule [Neurontin]|Drug: Placebo Oral Capsule [CEBOCAP]
Drug: BP101|Drug: Placebo
Drug: rectal misoprostol 600mg
Drug: GSP 301 NS|Drug: GSP 301 Placebo NS
Drug: Ibrutinib|Drug: Venetoclax|Drug: Chlorambucil|Drug: Obinutuzumab
Drug: Rimegepant|Drug: Placebo
Drug: Salmeterol Xinafoate and Fluticasone Propinate Powder|Drug: Seretide
Drug: HU007|Drug: Restasis|Drug: Moisview
Drug: MT-6548
Drug: VX-659|Drug: TEZ|Drug: IVA|Drug: TEZ/IVA
Drug: Colistimethate sodium|Drug: Saline Solution
Drug: KP415 oral capsule
Drug: Sildenafil|Drug: Placebo oral capsule
Drug: PolyPill
Drug: Radotinib
Drug: Botulinum toxin type A|Procedure: Strabismus surgery
Drug: Radium-223 chloride|Drug: Rhenium-188-HEDP
Drug: Itraconazole
Drug: G.S.P. Oral Solution 400 mg/ml
Drug: ALLN-177|Drug: Placebo
Drug: Alectnib|Drug: Cisplatin|Drug: Vinorelbine|Drug: Gemcitabine|Drug: Pemetrexed|Drug: Carboplatin
Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody|Drug: Placebo Comparator|Drug: Nab-paclitaxel|Drug: Pemetrexed|Drug: Carboplatin|Drug: Cisplatin
Drug: Vibramycin|Device: Phototherapy
Drug: Foster 100/6mg NEXThaler|Drug: Foster 100/6mg pMDI
Drug: Esomeprazole|Drug: Placebo
Drug: Ranibizumab|Procedure: No drug
Drug: Arterolane-piperaquine|Drug: Arterolane-piperaquine+mefloquine|Drug: Artemether-lumefantrine
Drug: Meditoxin|Drug: Placebo
Drug: Atezolizumab|Drug: Placebo
Drug: PLX-PAD
Drug: Guselkumab|Drug: Placebo for guselkumab|Drug: Etanercept
Drug: Albutein 20% Injectable Solution|Other: Standard medical treatment
Drug: Creon® 25000|Drug: Creon® 10000
Drug: Brimonidine Tartrate Ophthalmic Suspension|Drug: Brimonidine Tartrate Ophthalmic Solution
Drug: Gefapixant 45 mg BID|Drug: Gefapixant 15 mg BID|Drug: Placebo
Drug: salbutamol
Drug: Oxaliplatin|Drug: Tegafur,gimeracil and oteracil potassium|Drug: Xeloda
Drug: Empagliflozin|Drug: Placebo
Drug: Canakinumab|Drug: Placebo
Drug: BCD-085|Other: placebo
Drug: VX-659|Drug: TEZ|Drug: IVA
Drug: VX-659|Drug: TEZ|Drug: IVA|Drug: Matched Placebos
Drug: Fulvestrant 500mg|Drug: Palbociclib 125mg|Drug: Goserelin 3.6 MG|Drug: Placebos
Drug: Resveratrol|Drug: Placebo
Drug: DTG + 3TC|Drug: TAF based regimen (TBR)
Drug: ADX-102 1% Topical Dermal Cream|Drug: Vehicle of ADX-102 Topical Dermal Cream
Drug: Ipilimumab|Drug: IMO-2125
Drug: Ilaprazole
Drug: Gantenerumab|Drug: Placebo
Drug: Sofosbuvir and Daklatasuvir
Drug: Letermovir|Drug: Valganciclovir|Drug: Acyclovir (ACV)|Drug: Placebo to ACV|Drug: Placebo to LET|Drug: Placebo to VGCV
Drug: Rituximab|Drug: Bortezomib
Drug: Bufei Huatan granule|Drug: Yifei Qinghua granule|Drug: Placebo Bufei Huatan granule|Drug: Placebo Yifei Qinghua granule
Drug: Vitamin E|Drug: Standard dressing
Drug: Paracel 1|Drug: Paracel Placebo|Drug: Paracel 2 R0185|Device: KXL High Power System (2 J)|Device: KXL High Power System (10 J)
Drug: Chlorhexidine gluconate at 2%|Drug: Chlorhexidine gluconate at 0.12%
Drug: DCCR|Drug: Placebo for DCCR
Drug: Pomalidomide|Drug: Cyclophosphamide|Drug: Dexamethasone
Drug: ARRY-371797|Other: Placebo
Drug: Obeticholic acid (10 mg)|Drug: Obeticholic acid (10 mg to 25 mg)|Drug: Placebo
Drug: MT-6548|Drug: Darbepoetin alfa|Drug: MT-6548-matching placebo|Drug: Darbepoetin alfa-matching placebo
Drug: Ceftobiprole medocaril|Drug: Ceftazidime|Drug: Ceftriaxone
Drug: Ribociclib|Drug: Letrozole
Drug: Levosimendan 2.5 MG/ML|Drug: Placebos
Drug: Canagliflozin|Drug: Placebo
Drug: Autologous Serum 20%|Drug: Autologous Serum 50%
Drug: ADS-5102, 137 mg|Drug: ADS-5102, 274 mg|Other: Placebo
Drug: Simvastatin 20 mg|Other: Placebo Oral Tablet
Drug: Temozolomide Plus Cisplatin|Drug: High-Dose IFN-a2b
Drug: Baricitinib|Drug: Placebo
Drug: Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml|Drug: Propofol+ Rocuronium+ Fentanyl + Inhalational|Procedure: Open Pancreaticoduodenectomy
Drug: Atezolizumab|Drug: Bevacizumab|Drug: Sorafenib
Drug: N1539|Drug: Placebo
Drug: Esflurbiprofen|Drug: Diclofenac diethylamine
Drug: INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)|Drug: Insulin glargine (HOE901)
Drug: Esketamine 56 mg|Drug: Esketamine 84 mg|Drug: Placebo|Drug: Duloxetine (Oral Antidepressant)|Drug: Escitalopram (Oral Antidepressant)|Drug: Sertraline (Oral Antidepressant)|Drug: Venlafaxine Extended Release (XR) (Oral Antidepressant)
Drug: Early Vasopressors|Drug: Early Fluids
Drug: OnabotulinumtoxinA|Other: Topical Aluminium Chloride (cosmetic product)
Drug: Evolocumab 140 mg SC Q2W|Drug: Evolocumab 420 mg SC QM|Other: Placebo SC Q2W|Other: Placebo SC QM
Drug: LY900014|Drug: Insulin lispro
Drug: EG12014|Drug: Herceptin
Drug: HS-25 and Atorvastatin|Drug: Atorvastatin
Drug: 17-Hydroxyprogesterone Capronate
Drug: Bupivacaine + dexamethasone|Device: Ultrasound
Drug: HCP administration with PFS|Device: Subject self-administration with AI/Pen
Drug: Tranexamic Acid Injectable Solution|Drug: Sodium Chloride 0.9%
Drug: BGB-A317|Drug: Paclitaxel, or Docetaxel, or Irinotecan
Drug: Simethicone 80 MG
Drug: Linagliptin|Drug: Empagliflozin|Drug: Placebo
Drug: Morphine Sulfate
Drug: CNTX-4975-05 (trans-capsaicin)|Drug: Placebo
Drug: Icosapent Ethyl|Other: Placebo
Drug: TCM and conventional drug|Drug: TCM placebo and conventional drug
Drug: Diazepam Buccal Soluble Film 5, 7.5,10, 12.5, and 15 mg
Drug: Baricitinib|Drug: Placebo|Drug: Topical corticosteroid
Drug: Apatinib(Tab. 500mg/d) combined with EGFR-TKI(as previously)
Drug: PD-1 antibody
Drug: BGB-290|Drug: Placebo
Drug: IPP-201101
Drug: Tenapanor|Drug: Placebo|Drug: Sevelamer Carbonate
Drug: Neoadjuvant FOLFOX|Drug: Conventional adjuvant FOLFOX
Drug: L-carnitine|Drug: Placebo
Drug: KL-140|Drug: Placebo
Drug: Relamorelin|Drug: Placebo
Drug: SDN-037|Drug: Placebo
Drug: CDK 4/6 inhibitor|Drug: Non-Steroidal Aromatase Inhibitor|Drug: Fulvestrant
Drug: Sodium Chloride 0.9% Inj|Drug: Tranexamic Acid
Drug: Trastuzumab plus docetaxel (for 4 21-day cycles) after four 14-day cycles of Doxorubicin plus cyclophosphamide
Drug: Lucerastat|Drug: Placebo
Drug: BMN 111
Drug: 25% AgNO3 solution followed by 5% NaF|Drug: 25% AgNO3 solution followed by 5% NaF with fTCP
Drug: Abilify 2, 5, 10, 15mg (Tablet)|Drug: Placebo of Abilify 2, 5, 10, 15mg (Tablet)
Drug: hCG|Drug: Placebo
Drug: Palbociclib|Drug: Placebo|Drug: Tamoxifen|Drug: Goserelin
Drug: PF-04965842 100 mg|Drug: PF-04965842 200 mg|Drug: Placebo
Drug: CR845 0.5 mcg/kg|Drug: Placebo
Drug: Heparin|Device: TIPS
Drug: macitentan
Drug: Cannabidiol Oral Solution|Drug: Placebo|Drug: Vigabatrin
Drug: Glucagon Nasal Powder|Drug: Glucagon Hydrochloride Solution
Drug: Liraglutide 6 MG/ML Pen Injector|Drug: Metformin|Drug: Sulfonylurea/non-sulfonylurea insulin secretagogues
Drug: TJO-002|Drug: Latanoprost
Drug: Dapagliflozin 10mg|Drug: Exenatide 2 mg [Bydureon]|Drug: Placebo Oral Tablet|Drug: Placebo injection|Drug: Insulin|Drug: Metformin, if taken before
Drug: Steroid eye drop|Drug: Ophthalmic steroid ointment|Radiation: Radiation|Drug: Temozolomide|Drug: depatuxizumab mafodotin|Other: cold compress|Drug: Vasoconstrictor eye drop
Drug: Carvedilol|Other: Laboratory Biomarker Analysis|Other: Patient Observation
Drug: Remaxol (succinate + methionine + inosine + nicotinamide)|Drug: Ringer's Solution
Drug: Molidustat (BAY85-3934)
Drug: Treatment of TongBi Capsule|Drug: Treatment of TongBi placebo
Drug: 129Xe MRI|Drug: 133XE scintigraphy
Drug: 129Xe MRI|Drug: 133 Xe scintigraphy
Drug: HEXI-PREP By Clinell Wipes|Drug: Chloraprep|Drug: Placebos
Drug: fitusiran|Drug: factor VIII or factor IX
Drug: fitusiran|Drug: recombinant Factor VIIa and FEIBA
Drug: glasdegib|Drug: daunorubicin + cytarabine|Drug: azacitidine|Drug: Placebo|Drug: cytarabine|Procedure: HSCT
Drug: Remaxol®|Drug: Ringer's Solution
Drug: Capecitabine|Drug: mFOLFOX6 or CAPOX
Drug: Medox® Anthocyanin capsules
Drug: Alirocumab SAR236553|Device: Current auto-injector device (AI)|Device: New auto-injector device (SYDNEY)
Drug: Methotrexate
Drug: Ketum|Drug: Placebo
Drug: HS-25|Drug: Placebo of HS-25
Drug: Eltrombopag|Drug: IST (ATG + CsA)
Drug: Relugolix|Drug: Low-Dose Hormonal Add-Back
Drug: BGB-A317|Drug: Sorafenib
Drug: Bimekizumab|Drug: Adalimumab|Other: Placebo
Drug: FE 999315 (6 mg)|Drug: FE 999315 (9 mg)|Drug: Mesalazine (3,600 mg)
Drug: Bimekizumab|Other: Placebo
Drug: Simethicone Solution|Drug: Water
Drug: evinacumab
Drug: Murepavadin|Drug: Two anti-pseudomonal antibiotics
Drug: REGN2810|Drug: REGN2810/chemo/ipi|Other: Chemotherapy
Drug: Daprodustat (GSK1278863)|Drug: Placebo|Drug: Iron therapy
Drug: denosumab
Drug: Botulinum toxin type A
Drug: BHV-4157
Drug: Sildenafil 25 MG Oral Tablet|Drug: Pentoxifylline|Other: Placebo
Drug: Obinutuzumab|Drug: Bendamustine|Drug: Venetoclax
Drug: Aspirin|Drug: Placebo
Drug: B/F/TAF
Drug: Commercial Hepatitis B vaccine|Other: Standard Treatment
Drug: Oral Levonadiflixacin/Linezolid Tablet|Drug: Intravenous Levonadiflixacin/Linezolid Infusion
Drug: Peg-Filgrastim
Drug: C-11 choline PET tracer|Drug: Gadobutrol|Device: PET/MR scanner
Drug: Norco|Drug: Ibuprofen
Drug: BLI4700|Drug: FDA Approved Bowel Preparation
Drug: Gemcitabine|Radiation: standard chemoradiotherapy
Drug: fosnetupitant/ palonosetron|Drug: netupitant/palonosetron|Drug: dexamethasone
Drug: Triptolide Wilfordii|Drug: Placebo Oral Tablet
Drug: WTX101|Drug: SOC Therapy
Drug: Etanercept
Drug: Olaparib
Drug: 4th dose of hexavalent vaccine 1 month after the 3rd dose
Drug: Carboplatin|Drug: Gemcitabine|Drug: Pemetrexed|Drug: Docetaxel|Drug: Vinorelbine
Drug: Hydrocortisone, sodium succinate|Drug: Normal saline
Drug: Denosumab|Drug: Placebo
Drug: Vilaprisan (BAY1002670)|Drug: Placebo
Drug: Inclisiran Sodium|Drug: Placebo
Drug: Daprodustat tablets|Drug: Matching placebo tablets|Drug: Epoetin alfa vials|Drug: Saline vials or bags
Drug: evinacumab|Drug: Placebo
Drug: LIQ861 Inhaled Treprostinil
Drug: Oxaliplatin|Drug: Capecitabine
Drug: Lenabasum 5 mg|Drug: Lenabasum 20 mg|Other: Placebo oral capsule
Drug: VB-111 + Paclitaxel|Drug: Paclitaxel
Drug: risankizumab|Drug: placebo for risankizumab
Drug: Magnesium Oxide|Drug: Placebo Oral Tablet
Drug: CaPre|Drug: Placebo
Drug: MIN-101 32 mg|Drug: Placebo Oral Tablet|Drug: MIN-101 64 mg
Drug: Inclisiran|Drug: Placebo
Drug: Ketamine Hydrochloride|Drug: Placebo
Drug: Clonidine|Drug: Morphine
Drug: Vitamin D with calcium and clomiphene citrate|Drug: Placebo Oral Tablet with calcium and clomiphene citrate
Drug: Dexamethasone|Drug: Placebo
Drug: Tramadol
Drug: Edoxaban|Drug: Standard of Care (SOC)
Drug: Duloxetine Hydrochloride
Drug: Talazoparib with enzalutamide|Drug: Placebo with enzalutamide
Drug: Fucicort® Lipid cream|Drug: Fucidin® cream|Drug: Fucicort® Lipid cream vehicle|Drug: betamethasone (Lianbang Beisong®) cream
Drug: Fluticasone propionate/salmeterol 100/50 µg|Other: Placebo|Drug: Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT
Drug: Placebo|Drug: AVP-786
Drug: Adapalene and Benzoyl Peroxide Topical Gel|Drug: Epiduo Topical Product|Drug: Placebo
Drug: Trans Sodium Crocetinate plus SOC|Other: Standard of Care (SOC)
Drug: GSK2696274
Drug: Cetuximab + FOLFIRI
Drug: APL-130277|Drug: APO-go®
Drug: Ipilimumab|Drug: Nivolumab|Procedure: Local Consolidative Therapy (LCT)
Drug: Axicabtagene Ciloleucel|Drug: Platinum-containing salvage chemotherapy (eg, R-ICE) followed by high dose therapy (eg, BEAM) and autologous stem cell transplant in responders.
Drug: levothyroxin|Drug: Placebo Oral Tablet
Drug: TRC101|Drug: Placebo
Drug: Bevacizumab|Drug: HD204|Drug: Carboplatin|Drug: Paclitaxel
Drug: Erdafitinib|Drug: Vinflunine|Drug: Docetaxel|Drug: Pembrolizumab|Device: Fibroblast Growth Factor Receptor inhibitor Clinical Trial Assay (FGFRi CTA)
Drug: BCD-085 Q2W|Drug: BCD-085 Q4W|Drug: Placebo
Drug: Cingal|Device: Monovisc|Drug: Triamcinolone Hexacetonide
Drug: Capoten®
Drug: vitamin D3|Drug: Placebo
Drug: rhNRG-1|Drug: Placebo
Drug: Midazolam|Drug: Propofol
Drug: Injection Sclerotherapy|Drug: N-butyl-2-cyanoacrylate
Drug: Cisplatin|Radiation: Intensity Modulated Radiation Therapy|Drug: Ulinastatin
Drug: Simvastatin|Drug: Placebo
Drug: Lipid Emulsions, Intravenous|Drug: Intralipid, 20% Intravenous Emulsion
Drug: Fluticasone/ Formoterol|Drug: fluticasone/ salmeterol
Drug: Amchafibrin|Other: Saline Solution
Drug: Everolimus|Drug: Tacrolimus|Drug: Mycophenolate Mofetil
Drug: Brolucizumab 6 mg|Drug: Aflibercept 2 mg
Drug: Bosinji|Drug: Loxonine tab.|Procedure: Acupuncture
Drug: Investigational OTC Cream|Drug: 0.05% Desonide|Other: Placebo Cream
Drug: SonoVue
Drug: Steroid|Drug: Rituximab|Drug: Cyclophosphamide
Drug: Cladribine|Drug: Fludarabine|Drug: Busulfan|Drug: Cytarabine
Drug: 0 ppm F (placebo, negative control)|Drug: 250 ppm F as NaF (dose-response control)|Drug: 500 ppm F as NaF (dose-response control)|Drug: 1100 ppm F as NaF (positive control)
Drug: Reducing Antibiotics treatment duration|Drug: Standard Antibiotics treatment duration
Drug: Pimodivir 600 mg|Drug: Placebo|Other: SOC Treatment
Drug: gefitinib, pemetrexed,cisplatin|Drug: Vinorelbine, cisplatin
Drug: Injection, botulinum toxin + corticoid|Drug: Injection, placebo of toxin + corticoid|Drug: Injection, botulinum toxin + placebo corticoid
Drug: Acarbose|Drug: Prandial insulin
Drug: Midostaurin
Drug: GROUP 1: Long testosterone|Drug: GROUP 2: Short testosterone|Drug: GROUP 3: Control
Drug: Octenidinedihydrochlorid|Other: Placebo
Drug: VP-102|Drug: Placebo|Device: Applicator
Drug: Decitabine|Drug: Arsenic Trioxide
Drug: Insulin degludec|Drug: Insulin Aspart|Drug: Insulin detemir
Drug: FF/UMEC/VI|Drug: FP/SAL|Drug: Tiotropium|Drug: Albuterol/salbutamol|Device: ELLIPTA DPI|Device: DISKUS DPI|Device: RESPIMAT inhaler|Device: Metered Dose Inhaler|Device: Connected Inhaler System
Drug: MYL-1501D
Drug: Wilate
Drug: Crocin|Drug: Placebo Oral Tablet
Drug: Hydromorphone|Device: PCA pump
Drug: Cabozantinib S-malate|Other: Laboratory Biomarker Analysis|Other: Placebo|Other: Quality-of-Life Assessment
Drug: Phentermine-Topiramate|Drug: Liraglutide|Drug: Naltrexone/bupropion|Drug: Phentermine
Drug: Placebo (0.9% saline)|Drug: Pantoprazole
Drug: Dexamethasone|Drug: Sterile isotonic saline solution
Drug: Pembrolizumab|Drug: Epacadostat|Drug: Placebo
Drug: Surgiguard
Drug: FYU-981|Drug: Febuxostat
Drug: SP-102|Drug: Placebo
Drug: Methotrexate|Drug: Placebo
Drug: Methylprednisolone|Drug: Methylprednisolone placebo
Drug: Ferric maltol 30 mg (Feraccru®)
Drug: Infliximab|Drug: Cyclophosphamide
Drug: Atezolizumab|Drug: Placebo|Drug: Gemcitabine|Drug: Capecitabine|Drug: Carboplatin
Drug: Sulodexide|Drug: Statin|Drug: Antiplatelet Agents|Drug: ACE inhibitor
Drug: Bimekizumab|Drug: Ustekinumab|Other: Placebo
Drug: sofosbuvir and daclatasvir
Drug: red blood cell transfusion trigger
Drug: Oxygen gas|Other: Ambient air
Drug: Alemtuzumab GZ402673|Drug: Glatiramer acetate|Drug: Beta-Interferon|Drug: Methylprednisolone|Drug: Ranitidine|Drug: Ceterizine|Drug: Dexchlorpheniramine|Drug: Paracetamol|Drug: Acyclovir|Drug: Prednisolone
Drug: Dornase Alfa Inhalant Solution [Pulmozyme]|Drug: Placebos
Drug: Cosyntropin
Drug: Dexamethasone|Other: Laboratory Biomarker Analysis|Drug: Netupitant/Palonosetron Hydrochloride|Drug: Olanzapine|Other: Placebo|Drug: Prochlorperazine|Other: Quality-of-Life Assessment
Drug: Omeprazole|Drug: DLBS2411|Drug: Placebo capsule of Omeprazole|Drug: Placebo caplet of DLBS2411
Drug: Dexamethasone|Other: Placebo|Behavioral: Questionnaires
Drug: gemcitabine and cisplatin (Induction and adjuvant chemotherapy)|Radiation: IMRT|Drug: gemcitabine and cisplatin (Induction chemotherapy)|Radiation: IMRT and concurrent cisplatin
Drug: Apatinib|Drug: Oxaliplatin|Drug: 5-fluorouracil
Drug: Tranexamic Acid|Drug: Placebo
Drug: Ixekizumab|Drug: Placebo
Drug: MDR-101
Drug: Tralokinumab|Drug: Placebo
Drug: SCY-078
Drug: Ad5.hAC6|Drug: Placebo
Drug: Local Anesthetic Solution|Drug: Bupivacaine HCl|Drug: Liposomal Bupivacaine
Drug: DT group|Drug: ET group|Drug: NX group
Drug: BGB-A317|Drug: Docetaxel
Drug: Ertapenem|Drug: Sulopenem-Etzadroxil/Probenecid|Drug: Ciprofloxacin|Drug: Metronidazole|Drug: Amoxicillin-Clavulanate|Drug: Sulopenem
Drug: Pembrolizumab|Drug: Epacadostat|Drug: Cetuximab|Drug: Cisplatin|Drug: Carboplatin|Drug: 5-Fluorouracil
Drug: Clopidogrel|Drug: Ticagrelor
Drug: Losartan group|Drug: Placebo group
Drug: Sulopenem|Drug: Sulopenem-Etzadroxil/Probenecid|Drug: Ertapenem|Drug: Ciprofloxacin|Drug: Amoxicillin-clavulanate
Drug: e-Device
Drug: Sildenafil Citrate
Drug: Romidepsin|Drug: Pralatrexate
Drug: ACT|Drug: TACT
Drug: Apatinib|Drug: XELOX
Drug: ZX008 02 and 0.8 mg/kg/day|Other: Placebo
Drug: Sulopenem-Etzadroxil/Probenecid|Drug: Ciprofloxacin
Drug: Ticagrelor|Drug: Placebo
Drug: PET MPI|Drug: SPECT MPI|Drug: Pharmacological stress agents
Drug: Tamoxifen|Drug: Matching placebo
Drug: Bevacizumab|Drug: Atezolizumab|Drug: Chemotherapy|Drug: Placebos
Drug: DCC-2618|Drug: Placebo Oral Tablet
Drug: Ga-68 labeled PSMA-11 PET
Drug: Maralixibat|Drug: Placebo
Drug: efpeglenatide (SAR439977)|Drug: placebo
Drug: Intravenous immunoglobulin
Drug: Sotagliflozin (SAR439954)|Drug: Empagliflozin|Drug: Placebo
Drug: Nivolumab + Ipilimumab|Drug: Chemotherapy
Drug: Bupivacaine|Behavioral: patient-reported pain scores|Other: saline
Drug: Tamoxifen|Drug: Toremifene
Drug: n3-PUFA|Drug: Placebo
Drug: NVK-002 Concentration 1|Drug: NVK-002 Concentration 2|Drug: Placebo
Drug: Molidustat (BAY85-3934)|Drug: Darbepoetin alfa
Drug: Acarbose|Drug: Metformin|Drug: Placebo
Drug: pralatrexate|Dietary Supplement: Vitamin B12 and folic acid
Drug: Mitomycin c
Drug: Nivolumab|Drug: Epacadostat|Drug: Placebo|Drug: Carboplatin|Drug: Cisplatin|Drug: Gemcitabine|Drug: Paclitaxel|Drug: Pemetrexed
Drug: Etoposide Capsule + Methotrexate Tablet + Topotecan Capsule|Drug: Etoposide Capsule + Methotrexate Tablet + Everolimus Tablet
Drug: Cosyntropin Injectable Suspension, 1 mg/mL|Drug: Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin|Drug: Vigabatrin
Drug: BIVV009|Drug: Placebo
Drug: BIVV009
Drug: Riluzole|Drug: Placebo
Drug: Lanthanum Carbonate
Drug: Clarithromycin|Drug: Water for injection
Drug: Dupilumab|Drug: Matching Placebo|Other: Background Treatment: Topical Corticosteroids|Other: Background Treatment: Moisturizers
Drug: Pemafibrate|Drug: Placebo
Drug: PP6M 700 mg eq.|Drug: PP6M 1000 mg eq.|Drug: PP3M 350 mg eq.|Drug: PP3M 525 mg eq.|Drug: PP1M|Other: Placebo
Drug: FFI-1010
Drug: Bortezomib
Drug: CI-581-a|Drug: CI-581-b
Drug: Marizomib|Drug: Temozolomide|Radiation: radiotherapy
Drug: Alirocumab|Other: Placebo
Drug: TransCon hGH
Drug: CI-581a|Drug: CI-581b|Behavioral: Motivational Enhancement Therapy (MET)|Behavioral: Mindfulness Based Relapse Prevention
Drug: Idarucizumab
Drug: 12 weeks (Sofosbuvir 400mg/Ledipasvir 90mg)|Drug: 8 weeks (Sofosbuvir 400mg/Ledipasvir 90mg)
Drug: Anti-HBV antiviral prophylaxis
Drug: Elagolix|Drug: Estradiol/Norethindrone acetate (E2/NETA)
Drug: Cyclophosphamide|Drug: Mesna|Drug: rATG|Drug: Methylprednisolone|Drug: G-CSF|Biological: IVIg|Biological: Autologous Stem Cells
Drug: Bupropion|Behavioral: Positively smoke free|Other: Brief advice to quit smoking
Drug: Kcentra|Drug: Frozen Plasma Product, Human
Drug: Docetaxel|Drug: Cisplatin|Drug: Fluorouracil|Radiation: radiotherapy
Drug: Norepinephrine
Drug: Caffeine Citrate|Drug: Placebo
Drug: Levetiracetam
Drug: intranasal oxytocin spray|Other: intranasal spray without oxytocin
Drug: sumatriptan nasal powder|Drug: Placebo
Drug: Givosiran|Drug: Placebo
Drug: SM-1|Drug: Placebo
Drug: DEB|Radiation: SBRT
Drug: Fimasartan 120mg|Drug: Atorvastatin 40mg|Drug: Placebo for Fimasartan 120mg|Drug: Placebo for Atorvastatin 40mg
Drug: LY2963016|Drug: Lantus®|Drug: Insulin Lispro
Drug: LY2963016|Drug: Lantus®
Drug: SHP615
Drug: Nitazoxanide|Drug: Placebo
Drug: SHP615|Drug: MHOS/SHP615
Drug: BGB-3111|Drug: Bendamustine|Drug: Rituximab
Drug: tissue plasminogen activator|Other: Saline
Drug: spironolactone|Drug: Doxycycline
Drug: Dexamethasone|Drug: Rovalpituzumab tesirine
Drug: Atropine|Other: Placebo Eyedrops
Drug: Raltegravir|Drug: Lamivudine
Drug: sotagliflozin (SAR439954)|Drug: glimepiride|Drug: metformin|Drug: placebo
Drug: Botulinum Toxin type A (intradermal / submucosal injection at pain area)|Drug: Botulinum Toxin type A (intra-masseter injection on the ipsilateral of pain involved)
Drug: PGA mesh reinforcement
Drug: STR001-IT and STR001-ER
Drug: Calcipotriene/Betamethasone Dipropionate|Drug: Taclonex®|Drug: Placebo
Drug: Ticagrelor|Drug: Rivaroxaban
Drug: Saline|Drug: Sodium Nitrite
Drug: Alternate Management|Drug: Control
Drug: EU Avastin®|Drug: BAT1706|Drug: Paclitaxel|Drug: carboplatin
Drug: BMS-986205|Biological: Nivolumab|Drug: Placebo
Drug: P2B001|Drug: Rasagiline|Drug: Pramipexole|Drug: Pramipexole ER
Drug: MT-6548|Drug: Darbepoetin alfa
Drug: ATM-AVI|Drug: MTZ|Drug: MER|Drug: COL
Drug: Benralizumab
Drug: Methylprednisolone|Drug: Saline
Drug: Tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC)
Drug: Treatment of Panlongqi Tablet|Drug: Treatment of Panlongqi placebo
Drug: Avatrombopag 60 mg
Drug: Tesetaxel and Capecitabine|Drug: Capecitabine
Drug: Liposomal bupivacaine|Drug: Bupivacaine hydrochloride
Drug: SHP465
Drug: Placebo|Drug: Pimavanserin 34 mg|Drug: Pimavanserin 20 mg
Drug: Denosumab Injection
Drug: Afrezza Inhalant Product
Drug: Low molecular weight heparin|Drug: Placebos
Drug: Amitriptyline|Drug: Placebo oral capsule|Drug: Tramadol
Drug: Budesonide 0.5 MG/ML|Drug: Mometasone nasal spray
Drug: CCRT+GP|Drug: CCRT+PF
Drug: intravitreous aflibercept|Drug: Bevacizumab + Deferred Aflibercept Group
Drug: Dapaconazole|Drug: Ketoconazole
Drug: NOVOCART® Inject plus
Drug: Arbaclofen
Drug: Isatuximab SAR650984|Drug: Bortezomib|Drug: Lenalidomide|Drug: Dexamethasone|Drug: Acetaminophen (paracetamol) or equivalent|Drug: Ranitidine or equivalent|Drug: Diphenhydramine or equivalent
Drug: Thalidomide combined with R-CHOP|Drug: R-CHOP
Drug: SID142|Drug: Rinexin® Tab
Drug: botulinum toxin type A
Drug: HL151|Drug: Talion Tab
Drug: CJ-12420/Clarithromycin/Amoxicillin
Drug: Dexmedetomidine|Other: Placebo
Drug: HLX03|Drug: adalimumab
Drug: Dexmedetomidine|Drug: Remifentanil
Drug: Polyethylene Glycol
Drug: Duloxetine Hydrochloride|Drug: Placebo
Drug: Emicizumab
Drug: Dapagliflozin 10Mg Tab|Other: Placebo
Drug: Cabergoline|Drug: Gliclazide
Drug: ADV-Tk|Procedure: LT
Drug: Nintedanib
Drug: Belimumab|Drug: Rituximab|Drug: Rituximab-placebo|Drug: Standard therapy (Including Immunosuppressants)|Drug: Standard therapy (Excluding Immunosuppressants)|Drug: Steriod Taper
Drug: Emapalumab
Drug: Palovarotene
Drug: adalimumab
Drug: Methylprednisolone|Drug: Dexamethasone
Drug: Colchicine|Drug: Placebo
Drug: subcutaneous progesterone
Drug: Tong-Luo-Qu-Tong Plaster|Drug: Qi-Zheng-Xiao-Tong Plaster
Drug: Metformin|Drug: Placebo Oral Tablet
Drug: Fremanezumab|Drug: Placebo
Drug: MC2-01 cream|Drug: Cal/BDP combination|Drug: Cream vehicle
Drug: NACT|Procedure: RT+PLND|Drug: Adjuvant chemotherapy
Drug: Recombinant human erythropoietin
Drug: Trifluridine/Tipiracil hydrochloride (S95005)
Drug: ASTX727|Drug: Dacogen
Drug: TPF+CCRT|Drug: CCRT+ PF
Drug: Mepolizumab
Drug: Etoposide Injection plus Methotrexate Injection|Drug: Etoposide Capsule plus Methotrexate Tablet
Drug: Hydroxychloroquine|Drug: Hydroxychloroquine placebo
Drug: Retapamulin|Drug: Placebo Ointment
Drug: Bupivacaine|Drug: liposomal bupivacaine
Drug: Fasinumab|Other: Diclofenac|Other: Celecoxib|Drug: Matching placebo
Drug: Amifampridine Phosphate|Drug: Placebo Oral Tablet
Drug: Exparel|Drug: 0.25% bupivacaine
Drug: Placebo|Drug: Sodium Zirconium Cyclosilicate (ZS)
Drug: TEV-48125
Drug: Cholestyramine Powder 4g|Drug: Prednisolone|Drug: Standard treatment
Drug: Botulinum toxin type A|Device: transcranial direct current stimulation|Other: hybrid training model of CIMT and BIT|Other: usual care
Drug: Angiotensin II|Drug: Normal saline|Drug: Norepinephrine
Drug: Ivermectin Lotion 0.5%|Drug: Placebo/Vehicle Lotion
Drug: Daratumumab SC: daratumumab + rHuPH20
Drug: Provera 10 mg.|Drug: Ganirelix (GnRH antagonist)
Drug: ZX008 (Fenfluramine Hydrochloride)
Drug: Rivaroxaban 10 Milligrams|Drug: Enoxaparin 40 Milligrams/0.4 Milliliters Prefilled Syringe
Drug: Etelcalcetide|Drug: Cinacalcet
Drug: Cabotegravir Tablets|Drug: Rilpivirine Tablets|Drug: Cabotegravir Injectable Suspension|Drug: Rilpivirine Injectable Suspension
Drug: Rapamycin|Drug: Placebo Oral Tablet
Drug: Hydrochlorothiazide 50mg Tablet|Drug: Placebo Tablet
Drug: Rituximab|Drug: Prednisone
Drug: Durvalumab|Drug: Tremelimumab (Regimen 1)|Drug: Tremelimumab (Regimen 2)|Drug: Sorafenib|Drug: Durvalumab (Regimen 1)|Drug: Durvalumab (Regimen 2)
Drug: Mepolizumab|Drug: Prednisolone
Drug: 17P|Other: Placebo
Drug: Torsemide|Drug: Furosemide
Drug: Follitropin alfa|Drug: FE 999049
Drug: Treatment duration of cisplatin based chemotherapy
Drug: MB02 (Bevacizumab Biosimilar Drug)|Drug: EU-approved Avastin®|Drug: Carboplatin|Drug: Paclitaxel
Drug: Zoledronic Acid
Drug: Rituximab 1g IV|Drug: Cyclophosphamide 50Mg Oral Tablet|Drug: Placebo of Rituximab|Drug: Placebo Oral Tablet
Drug: Acetaminophen
Drug: Ertapenem 1000 MG|Drug: Fosfomycin Oral Suspension|Drug: Gentamicin Sulfate, Injectable|Drug: Ceftriaxone
Drug: Botulinum toxin type A|Drug: Placebo
Drug: IC-Green KIT
Drug: Imipenem+Cilastatin/Relebactam
Drug: Denosumab|Dietary Supplement: calcium|Dietary Supplement: vitamin D
Drug: Fluorescéine Sodique Faure|Procedure: White-light surgery
Drug: SHP647|Other: Placebo
Drug: Tramadol|Other: Placebo
Drug: Arbaclofen|Drug: Placebo
Drug: CORETOX®|Drug: BOTOX®
Drug: Tacrolimus|Drug: Tacrolimus Extended Release Oral Tablet [Envarsus]
Drug: Imiquimod 5% cream|Drug: Placebo cream|Procedure: Fulguration
Drug: Bevacizumab + FOLFIRI-3
Drug: Durvalumab|Drug: Tremelimumab
Drug: setmelanotide|Drug: Placebo
Drug: Brexpiprazole
Drug: Evolocumab 140 mg/mL|Drug: Placebo
Drug: Placebo Vaginal Insert|Drug: Prasterone 6.5 mg (0.50%) Vaginal Insert
Drug: Peppermint Oil
Drug: Fasinumab|Drug: Placebo
Drug: sotagliflozin (SAR439954)|Drug: insulin glargine (HOE901)|Drug: Placebo
Drug: KX2-391 Ointment 1%|Drug: Placebo
Drug: Reduced dose of DOAC|Drug: Full dose of DOAC
Drug: Netarsudil/Latanoprost 0.02%/0.005%|Drug: GANFORT®
Drug: Cholecalciferol|Drug: Placebo
Drug: Mirtazapine|Drug: Megestrol
Drug: EK-12|Drug: INF beta-1a
Drug: 25 mg SHP647|Drug: 75 mg SHP647
Drug: Octohydroaminoacridine Succinate|Drug: Aricept|Drug: Placebos
Drug: Nintedanib|Drug: Placebo
Drug: Timolol|Drug: Non biologically active gel
Drug: M207 Microneedle System
Drug: Lysobact Complete Sprey|Drug: Tantum Verde® Spray|Drug: Pharyngal® Oromucosal Spray|Drug: Placebo
Drug: Placebo|Drug: Atezolizumab
Drug: CR845
Drug: CP-690,500 5 mg|Drug: CP-690,550 10 mg
Drug: Nasotestt 5 mg|Drug: Androgel 50 mg|Other: Nasotestt Placebo|Other: Androgel Placebo
Drug: KHK7580
Drug: Tranexamic Acid 500 MG
Drug: 7-day course of antibiotics|Drug: 14-day course of antibiotics
Drug: Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml|Drug: Placebo
Drug: Cx601|Other: Placebo
Drug: Olaparib|Drug: Cediranib
Drug: Levoketoconazole|Drug: Placebo
Drug: Normal saline|Drug: Ringer's Acetate
Drug: Probio'Stick|Drug: Placebo
Drug: Ivacaftor
Drug: Dara SC|Drug: Dara IV
Drug: FMX103 1.5%
Drug: Placebo ZNS|Drug: ZNS
Drug: isatuximab SAR650984|Drug: carfilzomib|Drug: dexamethasone
Drug: PHMB 0.08%|Drug: Propamidine 0.1%|Drug: placebo|Drug: PHMB 0.02%
Drug: Polatuzumab Vedotin|Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Vincristine Placebo|Drug: Prednisone|Drug: Polatuzumab vedotin Placebo
Drug: Cobimetinib|Drug: Atezolizumab|Drug: Pembrolizumab
Drug: Very Low Nicotine Content Cigarettes|Drug: Normal Nicotine Content Cigarettes
Drug: Avelumab|Other: Laboratory Biomarker Analysis|Other: Placebo
Drug: FMX101|Drug: Vehicle Foam
Drug: Exparel Injectable Product|Drug: Bupivacaine Hydrochloride
Drug: Golimumab
Drug: Cefoxitin|Drug: Piperacillin-tazobactam
Drug: Gabapentin|Drug: Placebo Oral Capsule
Drug: Mifepristone|Drug: Misoprostol
Drug: Jinfukang Koufuye|Drug: Docetaxel|Drug: Pemetrexed|Drug: Cisplatin
Drug: Azacitidine|Drug: Pevonedistat
Drug: Teduglutide
Drug: Beclometasone dipropionate/Formoterol Fumarate/Glycopyrronium
Drug: Faster-acting insulin aspart|Drug: Insulin aspart|Drug: Insulin degludec|Drug: Metformin
Drug: Probiotic
Drug: Enalapril
Drug: Pertuzumab|Drug: Trastuzumab|Drug: Docetaxel|Drug: Paclitaxel|Drug: Eribulin
Drug: NPO-11|Drug: Placebo
Drug: Tocilizumab Prefilled Syringe [Actemra]|Drug: Placebos|Drug: Glucocorticoids
Drug: FG-4592|Drug: Placebo
Drug: Enzastaurin Hydrochloride|Other: R-CHOP + placebo
Drug: nab-paclitaxel|Drug: Paclitaxel|Drug: Carboplatin
Drug: (vic-)trastuzumab duocarmazine|Drug: Physician's choice
Drug: Varenicline|Behavioral: Brief smoking cessation counseling
Drug: BGF MDI (PT010)|Drug: GFF MDI (PT003)|Drug: BFF MDI (PT009)|Drug: Symbicort® Turbohaler® Inhalation Powder
Drug: Leuprolide Mesylate
Drug: ITM + Sham QLB|Drug: ITM + Bupivacaine QLB
Drug: Botulinum toxin A (GSK1358820)|Drug: Placebo
Drug: Chloroprocaine Hcl 2% Inj|Drug: Normal saline
Drug: Pembrolizumab|Drug: Epacadostat|Drug: Sunitinib|Drug: Pazopanib
Drug: Oligopin|Drug: Placebo
Drug: Inhaled Nitric Oxide|Drug: Placebo
Drug: Placebo|Drug: SPD489 (Lisdexamfetamine dimesylate)|Drug: SPD489
Drug: Bexagliflozin tablets, 20 mg|Drug: Bexagliflozin tablets, placebo
Drug: CLS006|Drug: CLS006 Vehicle
Drug: SHP647|Drug: Placebo
Drug: Denosumab
Drug: Crenolanib|Drug: Midostaurin|Drug: Cytarabine|Drug: Duanorubicin
Drug: inhaled titration of morphine chlorhydrate|Drug: IV placebo|Device: Inhaled placebo|Drug: IV titration of morphine chlorhydrate
Drug: REGN2810|Drug: Investigator Choice (IC) Chemotherapy
Drug: A arm (DA-90)|Drug: B arm (DAC)|Drug: A arm (CLAG-M)|Drug: B arm (FLAG-IDA)
Drug: Nelfinavir|Drug: Cisplatin|Radiation: Pelvic EBRT and Brachytherapy
Drug: Methoxyflurane|Drug: Standard of care
Drug: Treatment discontinuation
Drug: Fumaderm|Drug: risankizumab
Drug: Gabapentin|Drug: Metamizol|Drug: Tramadol
Drug: Tolvaptan
Drug: TRC150094|Drug: Placebo
Drug: Ethanol-lock
Drug: N-Acetylcysteine|Drug: Placebo Oral Tablet
Drug: Decitabine|Drug: Dexamethasone
Drug: F-627|Drug: Neulasta
Drug: octreotide capsules|Drug: Matching placebo
Drug: Apatinib
Drug: Brivaracetam
Drug: Crenolanib|Drug: Cytarabine|Drug: Mitoxantrone|Drug: Placebo Oral Tablet|Drug: Fludarabine|Drug: Idarubicin|Drug: G-CSF
Drug: Methylprednisolone + prednisolone
Drug: Lumateperone|Other: Placebo
Drug: Peri|Drug: HCTZ
Drug: Choline alfoscerate|Drug: Placebo
Drug: IL-1Ra|Drug: IL-1Ra Placebo
Drug: Dolutegravir|Drug: Standard of Care (EFV + 2 NRTI backbone)
Drug: Duloxetine 60mg|Drug: Placebo
Drug: SUN-131 1.5% TDS|Drug: Placebo TDS
Drug: FF/VI via ELLIPTA DPI|Drug: FF via ELLIPTA DPI
Drug: Netarsudil|Drug: Placebo
Drug: Placebo|Drug: SPN-812 ER High Dose A|Drug: SPN-812 ER High Dose B
Drug: Placebo|Drug: SPN-812 ER Low Dose A|Drug: SPN-812 ER Low Dose B
Drug: Fimasartan or Fimasartan/Hydrochlorothiazide|Drug: Perindopril or Perindopril/Indapamide
Drug: BL-8040 1.25mg/kg + G-CSF|Drug: Placebo +G-CSF
Drug: Budesonide oral suspension
Drug: Recombinant Human Growth Hormone Injection
Drug: RBX2660|Drug: Placebo
Drug: Edoxaban|Drug: Warfarin|Drug: parenteral anti-coagulant (UFH)
Drug: Temozolomide + Valproic Acid|Drug: Temozolomide + Chloroquine
Drug: AMPHORA
Drug: Apixaban 5 MG|Device: left atrial appendage closure
Drug: Placebo|Drug: Sotagliflozin (SAR439954)
Drug: Treatment 2 weeks Envarsus followed by 2 weeks Advagraf|Drug: Treatment 2 weeks Advagraf followed by 2 weeks Envarsus
Drug: Vilaprisan (BAY1002670)|Other: Matching placebo to ulipristal|Other: Matching placebo to vilaprisan|Drug: Ulipristal (Esmya)
Drug: Degarelix
Drug: Dabigatran etexilate|Drug: Tinzaparin
Drug: Iron isomaltoside (Monofer)|Drug: Ferric carboxymaltose
Drug: Testosterone|Drug: Estradiol
Drug: Sulfate, Magnesium|Drug: Placebo - Concentrate
Drug: oral propranolol|Drug: oral atenolol
Drug: SGX942|Drug: Placebo
Drug: Iron Isomaltoside (Monofer)|Drug: Ferric carboxymaltose
Drug: Clarithromycin 1000 MG|Drug: Azithromycin 250 mg|Drug: Rifampicin|Drug: Ethambutol
Drug: Ketamine|Drug: Morphine
Drug: Icaritin|Drug: Sorafenib Tosylate Tablets
Drug: Icaritin|Drug: HUACHANSU PIAN
Drug: tenofovir monotherapy|Drug: tenofovir plus entecavir combination
Drug: lamivudine plus adefovir combination|Drug: Tenofovir Disoproxil Fumarate
Drug: ABT-493/ABT-530
Drug: BREMEN eye drops|Drug: Combigan® and Azopt® concomitantly
Drug: Daratumumab|Drug: Velcade|Drug: Dexamethasone
Drug: Vedolizumab IV|Drug: Placebo
Drug: KRN23
Drug: Apixaban Oral Tablet [Eliquis]|Drug: Warfarin
Drug: Vivitrol|Drug: Buprenorphine
Drug: Triptorelin Pamoate PR 3-month|Drug: Triptorelin Acetate PR 1-month
Drug: Ponesimod
Drug: dasotraline|Drug: Placebo
Drug: Panitumumab|Drug: Irinotecan|Drug: Oxaliplatin|Drug: l-leucovorin|Drug: 5-fluorouracil
Drug: Sildenafil|Drug: low molecular weight heparin
Drug: Methylprednisolone|Drug: Isotonic saline
Drug: OCP + Metformin|Drug: OCP + Placebo|Drug: Metformin + Placebo
Drug: ES135
Drug: FE 999049|Drug: Follistim
Drug: DRV 800 mg + COBI 150 mg + FTC 200 mg + TAF 10 mg FDC
Drug: RisperiDONE 0.5 MG
Drug: concomitant chemotherapy plus an aromatase inhibitor (AI)|Drug: chemotherapy followed by an aromatase inhibitor (AI)
Drug: Bevacizumab|Drug: sodium chloride 0.9%
Drug: QAW039|Drug: Placebo
Drug: Qapzola|Drug: Placebo
Drug: EPREX
Drug: Conbercept Ophthalmic Injection|Drug: sham injection
Drug: Botulinum toxin type A|Drug: 0.9% Sodium Chloride Injection
Drug: Hetrombopag Olamine|Drug: matching placebo
Drug: Placebo|Drug: ABT-493/ABT-530
Drug: Paracetamol|Drug: NSAID|Drug: Placebo Oral Tablet
Drug: Elbasvir/ Grazoprevir 50/100 mg fixed dose combination
Drug: GLA5PR GLARS-NF1|Drug: GLA5PR GLARS-NF1 placebo|Drug: Pregabalin|Drug: Pregabalin placebo
Drug: C1-esterase inhibitor|Drug: Placebo
Drug: Thalidomide|Drug: Infliximab
Drug: Metoclopramide|Drug: Diphenhydramine|Drug: Normal saline
Drug: Ondansetron|Drug: Dexamethasone|Drug: Aprepitant|Drug: Olanzapine
Drug: 5-Fluorouracil|Drug: Normal Saline Flush, 0.9% Injectable Solution
Drug: risankizumab|Drug: methotrexate
Drug: Glecaprevir/Pibrentasvir
Drug: AZLI|Drug: Placebo
Drug: Pro-Thrombin Concentrate Complex|Drug: NaCl 0.9%
Drug: Dexamethasone|Drug: Placebos
Drug: Methylphenidate|Drug: Placebo
Drug: Velcade|Drug: Melphalan|Drug: Prednisone|Drug: Daratumumab
Drug: Dabigatran etexilate|Drug: Warfarin
Drug: TONKA|Drug: LEGALON
Drug: Calcitriol
Drug: Alvimopan|Drug: Placebo
Drug: Pregabalin|Drug: Placebos
Drug: Tranexamic Acid Injectable Solution|Other: Placebo
Drug: Empagliflozin 10 MG|Drug: Placebo oral capsule
Drug: Methoxyflurane|Drug: Normal saline
Drug: Bupivacaine|Drug: Liposomal Bupivacaine|Drug: Hydromorphone|Behavioral: Questionnaires
Drug: LY900014|Drug: Insulin Lispro|Drug: Insulin Glargine|Drug: Insulin Degludec
Drug: R-DA-EPOCH|Drug: R-DA-EPOCH + auto-HSCT|Drug: R-CEOP90|Drug: R-CEOP90 + auto-HSCT
Drug: Estradiol/Norethindrone Acetate|Other: Placebo for Elagolix|Drug: Elagolix|Other: Placebo for E2/NETA
Drug: Dexmedetomidine|Drug: Normal Saline Flush, 0.9% Injectable Solution_#1
Drug: SAR341402|Drug: insulin aspart|Drug: insulin glargine (HOE901)
Drug: Lidocaine|Drug: isotonic saline
Drug: Humira®|Drug: BI 695501
Drug: Interferon Alfa-2A|Drug: Cyclosporine Pill
Drug: Use Phase (Ulipristal Acetate, 30 mg)
Drug: Pirfenidone
Drug: CQ coadministered with PQ|Drug: DHA-PQP coadministered with PQ|Drug: CQ and PQ starting on Day 42|Drug: DHA-PQP and PQ starting on Day 42
Drug: Antithrombin supplementation|Drug: No antithrombin supplementation
Drug: dihydroartemisinin-piperaquine|Drug: sulphadoxine-pyrimethamine|Drug: dihydroartemisinin-piperaquine plus azithromycin
Drug: Corticosteroid
Drug: Rituximab window|Drug: Additional doses of Rituximab|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Doxorubicin hydrochloride|Drug: Vindesine Sulfate|Drug: Etoposide|Drug: Ifosfamide|Drug: Methotrexate|Drug: Prednisolone|Drug: Vincristine
Drug: Spironolactone 25 mg|Drug: Placebo oral capsule
Drug: CMAB009|Drug: Irinotecan|Drug: Folinic acid|Drug: 5-fluorouracil
Drug: Omeprazole|Behavioral: psychoeducation|Drug: Flupentixol +Melitracen
Drug: Relugolix|Drug: Relugolix Placebo|Drug: Low-dose Hormonal Add-back|Drug: Low-dose Hormonal Add-back Placebo
Drug: Oral Navelbine + Carboplatin|Drug: Gefitinib
Drug: suprachoroidal CLS-TA + IVT anti-VEGF agent|Drug: suprachoroidal sham + IVT anti-VEGF agent
Drug: Metamizol iv|Procedure: TAP block
Drug: Calcium acetate and sevelamer hydrochloride
Drug: Tocilizumab
Drug: Progesterone oral capsule|Drug: Placebo oral capsule
Drug: Cyclophosphamide|Drug: Bortezomib|Drug: Dexamethasone, 40 mg|Drug: Daratumumab
Drug: E2007
Drug: Paclitaxel, Cisplatin|Drug: EC to docetaxel or paclitaxel
Drug: ALKS 3831
Drug: Prednisolone|Biological: immunoglobulin
Drug: CapeOX(Capecitabine+Oxaliplatin)|Other: Observation
Drug: 4-OH tamoxifen|Drug: Placebo gel
Drug: Azithromycin|Drug: Placebo Oral Tablet
Drug: Dapagliflozin|Drug: Saxagliptin|Drug: Placebo
Drug: Afinitor (everolimus)
Drug: SOV2012-F1|Drug: AndroGel
Drug: Botulinum toxin type A injection|Other: Sham
Drug: RHB-105|Drug: Active Comparator
Drug: Brexpiprazole (OPC-34712)|Drug: Aripiprazole|Drug: Placebo
Drug: Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody|Drug: Placebo|Drug: Nab-paclitaxel|Drug: Doxorubicin|Drug: Cyclophosphamide|Drug: Filgrastim|Drug: Pegfilgrastim
Drug: CHF 5993 100/6/12.5 µg|Drug: 160 µg budesonide + 4.5 µg formoterol fumarate
Drug: BMN 111|Drug: Placebo
Drug: Donepezil patch|Drug: aricept Tab
Drug: Alteplase|Drug: acetylsalicylic acid|Drug: Placebo Oral Tablet|Drug: placebo IV
Drug: MIL60|Drug: Bevacizumab
Drug: DF289 plus DF277|Drug: DF289|Drug: DF277
Drug: Warfarin|Drug: Apixaban 2.5 MG|Drug: Rivaroxaban 20 MG
Drug: Alectinib|Drug: Crizotinib
Drug: Vilaprisan (BAY1002670)|Other: Standard of care
Drug: pemetrexed|Drug: Folic Acid|Drug: Vitamin B12 Injection|Drug: Dexamethasone
Drug: Amiodarone Hydrochloride|Drug: Placebo Oral Tablet
Drug: rivaroxaban
Drug: PRO-122|Drug: Timolol eye drops|Drug: Dorzolamide-Timolol Ophthalmic|Drug: Brimonidine Ophthalmic Solution|Other: Placebo1|Other: Placebo 2|Drug: Krytantek
Drug: Tylenol
Drug: Apixaban|Drug: Aspirin
Drug: ISV-305|Other: Vehicle
Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody|Drug: Vinorelbine|Drug: Gemcitabine
Drug: Apremilast
Drug: KW-0761 0.3 mg/kg IV|Drug: Placebo (saline)
Drug: Semaglutide|Drug: Liraglutide
Drug: Hylan G-F 20 (GZ/SAR402662)|Drug: Placebo
Drug: corticotherapy|Drug: Renin Angiotensin system (RAS) blockade
Drug: ALKS 5461|Drug: ALKS 5461 Placebo
Drug: Riboflavin
Drug: ALKS 3831|Drug: Olanzapine
Drug: EVD + IVF with Alteplase
Drug: Lidocaine Injectable Product|Drug: Lidocaine Topical Cream [LMX]
Drug: Pregabalin|Drug: Gabapentin
Drug: Zepatier Oral Product
Drug: Nano silver fluoride solution|Drug: Cavity Cleanser
Drug: TCM plus conventional drug|Drug: TCM placebo plus conventional drug
Drug: Rifaximin
Drug: Rifaximin|Drug: Azathioprine
Drug: Amantadine|Drug: Modafinil|Drug: Methylphenidate|Drug: Placebos
Drug: FF/UMEC/VI 100/62.5/25 mcg|Drug: FF/UMEC/VI 200/62.5/25 mcg|Drug: Salbutamol|Other: ACQ-7
Drug: Celebrex plus Metformin|Drug: Celebrex|Drug: Metformin
Drug: DWC20155|Drug: DWC20156|Drug: placebo of DWC20155|Drug: placebo of DWC20156
Drug: DWJ1252|Drug: Gasmotin|Drug: Placebo of Gasmotin|Drug: Placebo of DWJ1252
Drug: Clostridium Botulinum A Toxin
Drug: Fibrinogen Concentrate Human|Drug: Normal saline
Drug: SER-109
Drug: SER-109|Drug: Placebo
Drug: Ivabradine|Drug: Placebo
Drug: gilteritinib|Drug: LoDAC (Low Dose Cytarabine)|Drug: MEC (Mitoxantrone, Etoposide, Cytarabine)|Drug: FLAG (Granulocyte colony-stimulating factor (G-CSF), Fludarabine, Cytarabine)
Drug: Vancomycin inhalation powder|Drug: Placebo inhalation powder
Drug: citicoline
Drug: Tenecteplase|Other: Control
Drug: Daratumumab|Drug: Pomalidomide|Drug: Dexamethasone
Drug: Rituximab|Drug: Cyclosporin
Drug: OTL38|Device: near infrared imaging
Drug: Ataluren|Drug: PLACEBO
Drug: Ultravist 370Mg I/Ml Solution for Injection
Drug: Oxycodone Naloxone Combination
Drug: 2% ketoconazole cream|Drug: Hydrophilic Cream
Drug: Permethrin|Drug: Elimite 5% Cream
Drug: Sildenafil Citrate 25Mg Tab|Drug: Placebo Oral Tablet
Drug: treatment : H. pylori eradication
Drug: 5% fluoride varnish|Drug: 8% arginine containing paste|Drug: Self-adhesive resin
Drug: Phenoxybenzamine|Drug: Doxazosin
Drug: everolimus|Drug: exemestane
Drug: MK-1986|Drug: Comparator
Drug: Insulin degludec/liraglutide|Drug: Insulin degludec
Drug: Rexmyelocel-T|Drug: Placebo
Drug: Ceftriaxone|Drug: Benzyl penicillin plus gentamicin|Drug: Metronidazole|Other: Placebo
Drug: Empagliflozin|Other: Placebo
Drug: HMS5552|Drug: Placebos
Drug: AG-120 (ivosidenib) with Azacitidine|Drug: Placebo with Azacitidine
Drug: Aripiprazole IM Depot|Drug: Aripiprazole tablet
Drug: Diclofenac sodium gel 1%|Drug: Voltaren® Gel (Diclofenac Sodium Topical Gel) 1%|Drug: Placebo gel
Drug: Zirconium Cyclosilicate
Drug: Insulin degludec/liraglutide|Drug: Insulin degludec|Drug: Liraglutide
Drug: PRC-063 oral capsules|Drug: Placebo oral capsules
Drug: Aflibercept Injection|Drug: False injection
Drug: Dexmedetomidine|Drug: Midazolam oral solution|Drug: Oral saline|Drug: Nasal saline
Drug: Terbinafine
Drug: Canagliflozin 100 mg|Drug: Canagliflozin 300 mg|Drug: Placebo
Drug: Benralizumab (Medi-563)|Drug: Placebo
Drug: Darbepoetin|Drug: Placebo
Drug: QL1101|Drug: Avastin®|Drug: Paclitaxel|Drug: Carboplatin
Drug: Paclitaxel + Carboplatin|Drug: Paclitaxel only
Drug: Efinaconazole Topical
Drug: IDP-123 Lotion|Drug: IDP-123 Vehicle Lotion
Drug: CF101 2mg|Drug: CF101 3mg|Drug: Apremilast 30mg|Drug: Placebo Oral Tablet
Drug: Omega 3 fatty acid|Drug: Placebo oil
Drug: Immune Globulin 10% Intravenous Solution
Drug: lidocaine gel|Drug: placebo gel
Drug: Denosumab|Other: Placebo
Drug: Durvalumab|Drug: Tremelimumab|Drug: Abraxane + carboplatin|Drug: Gemcitabine + cisplatin|Drug: Gemcitabine + carboplatin|Drug: Pemetrexed + carboplatin|Drug: Pemetrexed + cisplatin
Drug: Oral CAB|Drug: Oral TDF/FTC|Drug: Placebo for oral CAB|Drug: Placebo for oral TDF/FTC|Drug: CAB LA|Drug: Placebo for CAB LA
Drug: FOLFOX regimen|Drug: Sorafenib 200Mg Tab
Drug: Sofosbuvir , daclatasvir|Drug: Placebos
Drug: Erythropoietin|Drug: normal saline
Drug: Guselkumab|Drug: Placebo
Drug: Allopurinol|Drug: Mannitol
Drug: Vitamin D3
Drug: Fasinumab|Drug: Naproxen|Drug: Fasinumab-matching placebo|Drug: Naproxen-matching placebo
Drug: Risperidone ISM 75 mg|Drug: Risperidone ISM 100 mg|Drug: Placebo of Risperidone ISM
Drug: Doxorubicin|Drug: Bleomycin|Drug: Vinblastine|Drug: Dacarbazine
Drug: Tenoten for children|Drug: Placebo
Drug: Polymyxin B
Drug: SHR3824|Drug: Placebo
Drug: Dexamethasone|Drug: Daratumumab|Drug: Carfilzomib
Drug: Nitroglycerin I|Drug: Placebo I|Drug: Nitroglycerin II|Drug: Placebo II
Drug: Gabapentin|Drug: Placebo
Drug: QVM149|Drug: Salmeterol/fluticasone plus tiotropium
Drug: Candida Antigen|Drug: Zinc Sulfate
Drug: Fimasartan/Amlodipine, Rosuvastatin|Drug: Fimasartan/Amlodipine|Drug: Fimasartan, Rosuvastatin
Drug: Alirocumab|Drug: Placebo
Drug: Mycophenolate Mofetil|Drug: Prednisolone
Drug: Abemaciclib|Drug: Standard Adjuvant Endocrine Therapy
Drug: Tocilizumab|Drug: MTX|Drug: Placebo Matched to MTX|Drug: Placebo Matched to Tocilizumab
Drug: Sayana® Press
Drug: capsaicin 8% patches (Qutenza)|Other: Placebo patches
Drug: Apixaban|Drug: Rivaroxaban|Drug: Edoxaban|Drug: Dabigatran|Drug: Acenocoumarol|Drug: Phenindione|Drug: Warfarin
Drug: Macitentan 10 mg|Drug: Placebo
Drug: Paravertebral Block|Drug: Pectoral Nerve Block
Drug: Recombinant staphylokinase|Drug: Alteplase
Drug: Opioids|Drug: Dexmedetomidine|Drug: Placebo
Drug: Melflufen|Drug: Pomalidomide|Drug: Dexamethasone
Drug: Pracinostat|Drug: Placebos|Drug: Azacitidine
Drug: Empagliflozin|Drug: Placebo Oral Tablet
Drug: High-dose Epirubicin Combined with CVP ± Rituximab|Drug: Standard-dose Epirubicin Combined with CVP ± Rituximab
Drug: Sirolimus
Drug: Allopurinol|Drug: Cytarabine|Drug: Daunorubicin Hydrochloride|Drug: Vincristine Sulfate|Drug: Dexamethasone|Drug: Pegylated Recombinant L-Asparaginase Erwinia Chrysanthemi|Drug: Methotrexate|Procedure: Bone Marrow Aspiration and Biopsy|Drug: Cyclophosphamide|Drug: Mercaptopurine|Biological: Rituximab|Drug: Doxorubicin|Drug: Thioguanine|Biological: Inotuzumab Ozogamicin|Other: Laboratory Biomarker Analysis
Drug: SB11 (Proposed ranibizumab biosimilar)|Drug: Lucentis (ranibizumab)
Drug: Sodium Thiosulfate|Drug: Placebo-Normal Saline
Drug: solifenacin|Behavioral: Pelvic floor muscle exercise-based behavioral therapy
Drug: Inhaled amikacin|Drug: Inhaled placebo
Drug: VAL-083, Dianhydrogalactitol|Drug: Physician's Choice of Salvage Therapy - temozolomide|Drug: Physician's Choice of Salvage Therapy - lomustine|Drug: Physician's Choice of Salvage Therapy - carboplatin
Drug: UB-421|Drug: current standard HAART treatment
Drug: N-Acetylcysteine|Drug: Placebo|Behavioral: IPPI (Integrated Preventive Psychological Intervention)|Behavioral: PSM (Psychological stress management)
Drug: Methotrexate|Drug: Ustekinumab|Other: Placebo
Drug: Misoprostol|Drug: Oxytocin
Drug: Atezolizumab
Drug: Levofloxacin based sequential therapy|Drug: bismuth quadruple therapy for 10 days (BQ)
Drug: Warfarin, NOAC
Drug: lidocaine-prilocaine cream|Drug: meloxicam rectal suppository
Drug: NaCl20% (Continuous hyperosmolar therapy)
Drug: PCD|Drug: PD
Drug: Esomeprazole|Drug: Amoxicillin-Potassium Clavulanate Combination|Drug: Clarithromycin|Drug: Vitamin D3
Drug: Metronidazole gel|Drug: Chlorhexidine Gluconate
Drug: FMX-103|Other: Vehicle Foam
Drug: Prednisolone
Drug: Atropine sulfate 0.01%|Drug: Placebo
Drug: Itacitinib|Drug: Placebo|Drug: Prednisone|Drug: Methylprednisolone
Drug: Tranexamic Acid 500 MG|Drug: Calcium Dobesilate
Drug: Ceftobiprole medocaril|Drug: Daptomycin
Drug: Metoprolol Tartrate|Drug: Placebo
Drug: Exemestane Tablets|Other: ovarian function suppression/ablation|Genetic: CYP2D6*10 gene test|Drug: Tamoxifen
Drug: Ceftobiprole medocaril|Drug: Vancomycin plus Aztreonam
Drug: Semaglutide|Drug: Canagliflozin|Drug: Placebo (canagliflozin)|Drug: Placebo (semaglutide)
Drug: Tranexamic acid (TXA).|Drug: Placebo
Drug: letrozole plus metformin|Drug: letrozole
Drug: oral drug and vaginal placebo|Drug: oral drug and oral placebo|Drug: Vaginal placebo+ oral placebo
Drug: Vitamin D3 (Treatment)|Other: Mixed diet of carbohydrate and protein (Control)
Drug: Dexamethasone|Drug: Prednisone
Drug: Companion Tablet
Drug: Teriparatide|Drug: Placebo|Dietary Supplement: Calcium supplement|Dietary Supplement: Vitamin D
Drug: gentamicin|Drug: placebo
Drug: Alcohol|Drug: No alcohol
Drug: Simvastatin 40mg|Drug: Diclofenac Potassium 50 MG
Drug: ADX-102 Ophthalmic Solution (0.5%)|Drug: Vehicle of ADX-102 Ophthalmic Solution
Drug: iGlarLixi|Drug: Insulin Glargine|Drug: Metformin|Behavioral: Lifestyle therapy
Drug: Azithromycin|Other: Placebo
Drug: Miltefosine|Drug: Paromomycin|Drug: Sodium stibogluconate
Drug: Colchicine opocalcium 1mg|Drug: Prednisone : Cortancyl 20mg
Drug: Hydroxyurea
Drug: Morphine sulphate
Drug: Fixed Dose Combination|Drug: Etodolac|Drug: Cyclobenzaprine
Drug: Masitinib Mesylate|Drug: Riluzole 50Mg Tablet|Drug: Placebo Oral Tablet
Drug: EndoTAG-1|Drug: Gemcitabine
Drug: capecitabine plus oxaliplatin before and after surgery|Drug: capecitabine plus oxaliplatin after surgery
Drug: Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody|Drug: Atezolizumab Placebo|Drug: Paclitaxel
Drug: Lumacaftor|Drug: Ivacaftor
Drug: HAI|Drug: chemotherapy ± target therapy
Drug: Mona Lisa® NT Cu380 Mini|Drug: ParaGard® CuT380A
Drug: Intrathecal methotrexate|Drug: High-dose intravenous methotrexate
Drug: New profilaxis|Drug: Profilaxis recommended
Drug: Apremilast|Other: Placebo
Drug: Topical application Tranexamic acid|Drug: Placebo (Normal saline)
Drug: Teriflunomide 14 MG Oral Tablet [Aubagio]|Drug: Placebo Oral Tablet
Drug: Dolutegravir|Drug: Tenofovir Alafenamide|Drug: Truvada|Drug: Atripla
Drug: Pimavanserin
Drug: Olokizumab 64 mg SC q4w|Drug: Olokizumab 64 mg SC q2w|Drug: Methotrexate
Drug: Antiandrogen|Drug: Antiandrogen+docetaxel
Drug: Plasmalyte|Drug: Ringer lactate
Drug: Empagliflozin 10Mg Tab
Drug: Ulipristal Acetate|Drug: Placebo oral capsule
Drug: glecaprevir (300mg)/pibrentasvir (120mg)
Drug: ONO-4538|Drug: Carboplatin|Drug: Paclitaxel|Drug: Bevacizumab|Drug: Placebo
Drug: dexmedetomidine
Drug: Neostigmine+glycopyrrolate|Drug: Sugammadex
Drug: Guanfacine|Drug: Placebo
Drug: Saxenda|Drug: Placebos|Procedure: RYGB
Drug: Bexagliflozin|Drug: Sitagliptin|Drug: Placebo for sitagliptin|Drug: Placebo for bexagliflozin
Drug: Dexmedetomidine Injection|Drug: Meperidine Injection
Drug: Crenezumab|Drug: Placebo
Drug: Tadekinig alfa|Drug: Placebo
Drug: 0.075% Capsaicin Lotion|Drug: placebo
Drug: Ashwagandha Root Extract Capsule|Drug: Placebo Capsule
Drug: Ruxolitinib|Drug: Extracorporeal photopheresis (ECP)|Drug: Low-dose methotrexate (MTX)|Drug: Mycophenolate mofetil (MMF)|Drug: mechanistic Target of Rapamycin (mTOR) inhibitors (everolimus or sirolimus)|Drug: Infliximab|Drug: Rituximab|Drug: Pentostatin|Drug: Imatinib|Drug: Ibrutinib
Drug: Ibrutinib|Drug: Venetoclax|Drug: Placebo Oral tablet to match Venetoclax
Drug: Iloprost|Drug: control
Drug: TNX-102 SL
Drug: Selinexor|Drug: Bortezomib|Drug: Dexamethasone
Drug: X0002|Drug: Placebo
Drug: B/F/TAF|Drug: F/TAF|Drug: DTG|Drug: DTG Placebo|Drug: F/TAF Placebo|Drug: B/F/TAF Placebo
Drug: Erythropoietin|Drug: Normal saline
Drug: 10 mg Bupivacaine|Drug: 5 mg Bupivacaine
Drug: Neupogen|Procedure: CD133 Cells Transplantation
Drug: Escitalopram|Drug: Placebo
Drug: SYL1001 ophthalmic solution|Drug: Vehicle opthalmic solution
Drug: Vortioxetine
Drug: Conbercept ophthalmic injection|Other: sham injection
Drug: Valganciclovir|Drug: Simple Syrup
Drug: Ustekinumab
Drug: Fremanezumab
Drug: Active Comparator: Olaparib tablets|Drug: Placebo
Drug: PMF104|Drug: Klean-prep
Drug: ABL001|Drug: Bosutinib
Drug: Ethinyl Estradiol, Norethindrone acetate, ferrous fumarate|Drug: Norethindrone
Drug: Ivabradine|Other: Sham Comparator
Drug: placebo for risankizumab|Drug: risankizumab IV|Drug: risankizumab SC
Drug: placebo for risankizumab SC|Drug: risankizumab IV|Drug: placebo for risankizumab IV|Drug: risankizumab SC
Drug: Aclidinium bromide/formoterol fumarate dihydrate|Drug: Placebo
Drug: placebo for risankizumab IV|Drug: risankizumab SC|Drug: risankizumab IV
Drug: Adalimumab|Drug: ABT-494|Drug: Placebo for ABT-494|Drug: Placebo for Adalimumab
Drug: Placebo|Drug: ABT-494
Drug: Ketamine|Drug: Thiopental
Drug: YHP1701|Drug: YHR1703|Drug: YHR1704
Drug: 1% Lidocaine|Drug: 0.25% Bupivacaine|Drug: Bupivacaine plus Lidocaine
Drug: Relugolix|Drug: Low-dose Hormonal Add-back|Drug: Relugolix Placebo|Drug: Low-dose Hormonal Add-back Placebo
Drug: Oxygen|Other: Placebo
Drug: Azathioprine and Allopurinol|Drug: Azathioprine
Drug: cisplatin, etoposide|Drug: cisplatin, etoposide, apatinib
Drug: QVM149
Drug: Dexamethasone|Other: Placebo
Drug: QMF149
Drug: FYU-981|Drug: Benzbromarone
Drug: lavender and chamomile essential oils
Drug: Esketamine|Drug: Placebo|Other: Standard of Care
Drug: ribociclib|Drug: letrozole|Drug: goserelin
Drug: Vitamin D3|Drug: Placebo
Drug: MMF|Drug: CYC|Drug: Glucocorticoids|Drug: MTX|Drug: AZA
Drug: Colistimethate Sodium|Drug: Saline Solution
Drug: Lavender Essential Oil
Drug: ALKS 8700|Drug: Dimethyl Fumarate
Drug: Paclitaxel|Drug: Carboplatin|Drug: Cisplatin|Drug: Vinblastine Sulfate|Radiation: three dimensional conformal radiotherapy
Drug: Glecaprevir/Pibrentasvir (G/P) 300mg/120mg|Drug: Ribavirin 200Mg Tablet
Drug: Nicotine|Behavioral: Moderate Intensity Exercise
Drug: Savolitinib|Drug: Sunitinib
Drug: Tinzaparin Sodium
Drug: Guselkumab|Drug: Placebo|Drug: Secukinumab
Drug: Sevoflurane|Drug: Remifentanil|Drug: Dexmedetomidine
Drug: Pemetrexed|Drug: Paclitaxel|Drug: Gemcitabine|Drug: Cisplatin|Drug: Carboplatin|Drug: REGN2810
Drug: amphetamine extended-release oral suspension, 2.5 mg/mL|Drug: Placebo extended-release oral suspension
Drug: Follitropin alfa (Gonal-f)|Drug: Follitropin alfa (Primapur)
Drug: Nicotine Bitartrate Lozenge 4mg|Drug: Nicotine Polacrilex 4Mg Lozenge
Drug: Empagliflozin 10 mg|Drug: Placebo Oral Tablet
Drug: nabiximols|Drug: placebo
Drug: Endostar|Drug: DDP
Drug: Pretomanid|Drug: Linezolid|Drug: Bedaquiline|Drug: Placebo Linezolid
Drug: Upadacitinib matching placebo|Drug: Abatacept matching placebo|Drug: Upadacitinib|Drug: Abatacept
Drug: Mepolizumab|Drug: Placebo|Drug: Mometasone furoate
Drug: tranexamic acid|Drug: Placebo
Drug: Relugolix|Drug: Leuprolide Acetate
Drug: Ethanol|Drug: Normal Saline|Drug: Paclitaxel/ Gemcitabine
Drug: Dexamethasone
Drug: Administration of Ropivacaïne|Drug: Administration of placebo
Drug: Placebo|Drug: Brivaracetam
Drug: Ojeok-San|Drug: Placebo
Drug: Ethanol|Drug: enoxaparin
Drug: Amlodipine|Drug: Losartan|Drug: Atenolol
Drug: Bundle|Procedure: Standard care
Drug: X0002
Drug: Nolasiban 900mg|Drug: Placebo
Drug: Evolocumab
Drug: Apixaban
Drug: Pyrotinib Plus Capecitabine|Drug: Lapatinib Plus Capecitabine
Drug: Ricrolin+|Drug: Epi-Off
Drug: Dasatinib 100 MG [Sprycel]|Drug: Nilotinib 150mg oral capsule [Tasigna]
Drug: Experimental drug: Aprepitant|Drug: Experimental drug: Ondansetron|Drug: Experimental drug: Dexamethasone|Drug: Experimental drug: Olanzapine|Drug: Standard: Aprepitant|Drug: Standard: Ondansetron|Drug: Standard: Dexamethasone
Drug: Epoetin Alfa|Drug: Normal saline
Drug: Palbociclib 125mg|Drug: Aromatase Inhibitors|Drug: Fulvestrant Injectable Product
Drug: Ribociclib|Drug: Placebo|Drug: Adjuvant endocrine therapy
Drug: Insulin degludec|Drug: Insulin glargine
Drug: Ticagrelor|Drug: Clopidogrel
Drug: Active Medication Combination (AMC)|Drug: Placebo (PLB)
Drug: Ipragliflozin|Drug: Sitagliptin
Drug: somapacitan|Drug: Norditropin
Drug: Zolpidem|Drug: Zoplicone|Drug: Placebo
Drug: Levonorgestrel (Kyleena, BAY86-5028)|Drug: Ethinyl estradiol and drospirenone (Yarina, BAY86-5131)
Drug: Ipatasertib|Drug: Abiraterone|Drug: Placebo
Drug: K-877|Drug: Placebo
Drug: Triptorelin for Injection|Drug: Recombinant Human Choriogonadotropin alfa Solution for Injection|Drug: Progesterone Soft Capsules
Drug: Placebo + Placebo Add-back|Drug: OBE2109 + Placebo Add-back|Drug: OBE2109 + Add-back
Drug: Prednisone|Drug: Placebos
Drug: CA|Drug: placebo group
Drug: BIIB074|Drug: Placebo
Drug: Placebo|Drug: Venetoclax|Drug: Cytarabine
Drug: N-acetyl cysteine (NAC)
Drug: Rifaximin|Other: Placebo
Drug: Oleogel-S10|Drug: Placebo
Drug: Ivacaftor|Drug: Placebo
Drug: Duloxetine|Drug: Placebo
Drug: Bardoxolone methyl
Drug: Bupivacaine|Drug: Dexmedetomidine|Drug: Magnesium Sulfate
Drug: Alirocumab 150 mg/mL|Drug: Placebo
Drug: Dinoprostone|Drug: Placebo
Drug: Temisartan+Amlodipine+Rosuvastatin (Combination drug)|Drug: Temisartan+Amlodipine|Drug: Temisartan+Rosuvastatin
Drug: bempedoic acid
Drug: Sotagliflozin (SAR439954)|Drug: placebo|Drug: Metformin|Drug: Sulfonylurea
Drug: sacubitril/valsartan|Drug: Enalapril|Drug: Valsartan|Drug: Placebo to match sacubitril/valsartan|Drug: Placebo to match enalapril|Drug: Placebo to match valsartan
Drug: Secukinumab 150 mg s.c.|Drug: Secukinumab 300 mg s.c.|Drug: Placebo
Drug: Atorvastatin|Drug: Methotrexate|Drug: Tacrolimus
Drug: Tobi Inhalant Product|Drug: Nebcin
Drug: Dronabinol|Dietary Supplement: Palmotoyletahnolamide
Drug: Antithyroid Drug|Procedure: Total thyroidectomy
Drug: Mifepristone, Oral, 200 Mg|Drug: Placebo Oral Tablet
Drug: IVIG|Drug: Infliximab
Drug: Phenazopyridine
Drug: Acetylsalicylic acid|Other: intensive blood pressure control
Drug: Nivolumab|Other: Placebo
Drug: intranasal fentanyl|Drug: Oral Morphine|Drug: oral placebo|Drug: intranasal placebo
Drug: Dexmedetomidine Injection [Precedex]|Drug: Bupivacaine
Drug: Melatonin 5 mg
Drug: MR308
Drug: TNX-102 SL|Drug: Placebo SL Tablet
Drug: Hydrocortisone
Drug: Rovalpituzumab tesirine|Drug: Topotecan
Drug: Semaglutide 0.5 mg|Drug: Semaglutide 1.0 mg|Drug: Sitagliptin placebo|Drug: Sitagliptin|Drug: Semaglutide placebo 0.5 mg|Drug: Semaglutide placebo 1.0 mg
Drug: Docetaxel|Drug: Oxaliplatin|Drug: Cisplatin|Drug: Irinotecan|Drug: Pemetrexed|Drug: S1
Drug: Sofosbuvir/Ledipasvir 12W|Drug: Sofosbuvir/Ledipasvir plus Ribavirin 12W|Drug: Sofosbuvir/Ledipasvir 24W|Drug: Sofosbuvir/Ledipasvir plus Ribavirin 24W
Drug: Azithromycin|Drug: Erythromycin|Drug: Ampicillin|Drug: Amoxicillin
Drug: Celecoxib 200mg oral capsule|Drug: parecoxib sodium|Drug: controlled-release oxycodone
Drug: IDP-124 Lotion|Drug: IDP-124 Vehicle Lotion
Drug: Aerosolized Calfactant|Device: Solarys
Drug: Pemetrexed|Drug: Cisplatin 75mg/m2|Drug: AC0010
Drug: Placebo oral capsule|Drug: 12.5 mg hydrochlorothiazide|Drug: 25.0 mg hydrochlorothiazide|Drug: 50.0 mg hydrochlorothiazide
Drug: Degarelix|Radiation: stereotactic body radiosurgery (SBRT)
Drug: Paracetamol
Drug: TPC|Drug: Bicalutamide 150 mg
Drug: Rivaroxaban|Drug: Placebo
Drug: Normal Saline|Drug: Lactated Ringer|Drug: Normosol-R Inj
Drug: Xe-133|Drug: Technegas
Drug: Metformin|Drug: Placebo
Drug: Dupilumab|Drug: Placebo
Drug: Sustanon 250|Drug: Zoladex|Other: Placebo
Drug: BGB-3111|Drug: Ibrutinib
Drug: Nitric Oxide|Other: Supportive treatment
Drug: SEL|Drug: Placebo
Drug: Lorlatinib|Drug: Crizotinib
Drug: QAW039 Dose 1|Drug: QAW039 Dose 2|Drug: Placebo
Drug: MSB11022|Drug: Humira®
Drug: Ketamine Hydrochloride|Other: Normal saline
Drug: Liprotamase|Drug: porcine PERT
Drug: Linagliptin and Basal Insulin|Drug: Basal Insulin and Bolus Insulin
Drug: Desmopressin ODT 25 µg|Drug: Desmopressin ODT 50 µg
Drug: Ribociclib|Drug: letrozole
Drug: TAK-438|Drug: Lansoprazole|Drug: TAK-438 Placebo|Drug: Lansoprazole Placebo|Drug: Bismuth-Containing Quadruple Therapy
Drug: Tadalafil 20 MG|Drug: Placebo 20 MG
Drug: 177Lu-edotreotide PRRT|Drug: Everolimus|Other: Amino-Acid Solution
Drug: Apatinib Oral Tablet|Drug: Placebo Oral Tablet
Drug: Colchicine|Drug: Spironolactone|Device: SYNERGY Bioabsorbable Polymer Drug-Eluting Stent|Drug: Colchicine-Placebo|Drug: Spironolactone-Placebo
Drug: Tolvaptan Oral Tablet
Drug: Dolutegravir|Drug: Emtricitabine/tenofovir alafenamide|Drug: Emtricitabine/tenofovir disoproxil fumarate|Drug: Efavirenz/emtricitabine/tenofovir disoproxil fumarate
Drug: Cefazolin
Drug: Dexmedetomidine|Drug: placebo
Drug: Apixaban|Drug: Dalteparin
Drug: mirabegron
Drug: Durvalumab|Drug: Tremelimumab|Drug: Carboplatin|Drug: Cisplatin|Drug: Etoposide
Drug: Raloxifene|Drug: Placebo
Drug: Oral Treprostinil
Drug: Plasmalyte A|Drug: Ringer Lactate
Drug: Memantine
Drug: Apatinib|Other: Placebo
Drug: 18F-DOPA
Drug: Preoperative Chemotherapy|Procedure: Surgery|Drug: Postoperative chemotherapy
Drug: fosmetpantotenate (RE-024)|Drug: Placebo
Drug: Pentoxifylline|Drug: Placebo|Drug: Tocopherol
Drug: Denosumab 60 MG/ML Prefilled Syringe|Drug: Zoledronic Acid 5Mg/Bag 100Ml Inj
Drug: Dextromethorphan|Drug: Memantine|Drug: dextromethorphan+memantine|Drug: placebo+valproate
Drug: Esketamine|Other: Placebo
Drug: Methylene Blue|Drug: Terlipressin
Drug: Capecitabine +/- Oxaliplatin|Procedure: local resection|Procedure: radical resection|Other: No adjuvant chemotherapy
Drug: Paclitaxel|Drug: Carboplatin|Drug: Atezolizumab|Drug: Bevacizumab|Drug: Atezolizumab Placebo
Drug: Ferric carboxymaltose|Drug: Placebos
Drug: Oral treprostinil|Drug: Placebo
Drug: Octafibrin|Drug: Cryoprecipitate
Drug: ART, Atorvastatin|Drug: ART, Rosuvastatin|Drug: ART, No statin|Drug: Healthy-HIV-negative
Drug: GBT440|Other: Placebo
Drug: Elenbecestat (E2609)|Drug: Placebo
Drug: Dapagliflozin|Drug: Placebo
Drug: Magnesium|Drug: Placebo Oral Tablet
Drug: Placebo for dexamethasone|Drug: Placebo for rovalpituzumab tesirine|Drug: Rovalpituzumab tesirine|Drug: Dexamethasone
Drug: Bu-Zhong-Yi-Qi-Tang|Drug: placebo
Drug: S-649266|Drug: Meropenem|Drug: Linezolid
Drug: Investigational medical product (IMP) administered in parent study
Drug: AIN457|Other: Matched placebo
Drug: Carbamazepine|Drug: Mirtazapine|Other: Placebo
Drug: JZP-258|Other: Placebo
Drug: Raltegravir|Drug: Placebo|Drug: Current ART
Drug: Dexamethasone|Drug: Carfilzomib
Drug: Daprodustat|Drug: Darbepoetin alfa|Drug: Iron therapy
Drug: Cenicriviroc|Drug: Placebo
Drug: Oxaliplatin: BSA-based HIPEC|Drug: Oxaliplatin: Concentration-based HIPEC
Drug: Cinacalcet 30 mg Tablet|Drug: Denosumab Inj 60 mg/ml|Other: Placebo tablets|Other: Saline Injection (Placebo)
Drug: Alitretinoin|Drug: cyclosporin A
Drug: Alitretinoin|Drug: Azathioprine
Drug: Fexinidazole
Drug: Gonyautoxins|Drug: Chirocaine ketorolac epinephrine
Drug: Filgotinib|Drug: Placebo to match filgotinib
Drug: ketoprofen and cyclobenzaprine association|Drug: Cyclobenzaprine
Drug: Atezolizumab|Other: Placebo
Drug: Acetaminophen|Drug: Dextrose 5
Drug: DWJ1252|Drug: Gasmotin
Drug: PXT3003
Drug: chidamide|Drug: cyclophosphamide|Drug: liposomal doxorubicin|Drug: vincristine|Drug: prednisone
Drug: Sbv|Drug: Miltefosine plus placebo|Drug: Miltefosine plus GM-CSF
Drug: Aclidinium bromide/formoterol Fixed-Dose Combination|Drug: Aclidinium bromide|Drug: Formoterol Fumarate|Drug: Placebo
Drug: risankizumab
Drug: Voclosporin|Drug: Placebo Oral Capsule
Drug: Daunomycin and Cytarabine (DA Regimen)|Drug: Daunomycin and Cytarabine (Intermediate Dose of DA Regimen)
Drug: semaglutide|Drug: placebo
Drug: Spironolactone 25Mg Tablet|Drug: Placebo Oral Tablet
Drug: Pegaspargase|Drug: Erwinia asparaginase|Drug: Cyclophosphamide|Drug: CYTARABINE|Drug: DASATINIB|Drug: DEXAMETHASONE|Drug: Dexrazoxane|Drug: Doxorubicin|Drug: ETOPOSIDE|Drug: HYDROCORTISONE|Drug: LEUCOVORIN CALCIUM|Drug: MERCAPTOPURINE|Drug: METHOTREXATE|Drug: NELARABINE|Drug: Vincristine
Drug: Corifollitropin alfa|Drug: hCG
Drug: Fentanyl Citrate|Drug: Placebo
Drug: Rituximab|Drug: Etoposide|Drug: Doxorubicin|Drug: Vincristine|Drug: Cyclophosphamide|Drug: Prednisone|Drug: Vindesine|Drug: Bleomycin
Drug: Rituximab|Drug: Methylprednisolone|Drug: Cyclophosphamide
Drug: Omacor|Drug: Placebo Oral Capsule
Drug: Semaglutide|Drug: Placebo|Drug: Liraglutide
Drug: Cisplatin|Drug: Doxorubicin|Drug: Carboplatin|Drug: 5Fluorouracil|Drug: Vincristine|Drug: Etoposide|Drug: Irinotecan|Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Sorafenib
Drug: AL 3818|Drug: Dacarbazine
Drug: Dolutegravir film-coated tablets|Drug: Dolutegravir film-coated dispersible tablets
Drug: Atezolizumab|Drug: Enzalutamide
Drug: Thalidomide|Other: Observation
Drug: Colchicine|Drug: Placebo Oral Tablet
Drug: Docetaxel|Drug: Cisplatin|Radiation: IMRT/TOMO|Drug: Chemotherapy
Drug: ascorbic acid|Drug: mFOLFOX6
Drug: commercially available lansoprazole|Drug: matched placebo
Drug: Budesonide/Formoterol fumarate dihydrate|Drug: Symbicort|Drug: Placebo
Drug: Semaglutide|Drug: Dulaglutide
Drug: Udenafil
Drug: Viaskin Peanut 250µg
Drug: HD201|Drug: Herceptin|Drug: Docetaxel|Drug: Epirubicin|Drug: Cyclophosphamide
Drug: Tegafur-Gimeracil-Oteracil Potassium|Radiation: Chemoradiotherapy|Procedure: Gastric resection|Drug: Oxaliplatin
Drug: Dexamethasone|Drug: NaCl (Control)|Drug: Paracetamol|Drug: EtoriCoxib|Drug: Oxycodone|Drug: Ropivacaine
Drug: Tamoxifen|Drug: Letrozole
Drug: K-877|Drug: Fenofibrate|Drug: Placebo (for K-877)
Drug: Dexamethasone|Drug: Rituximab
Drug: Apalutamide|Drug: Degarelix|Drug: Abiraterone Acetate|Drug: Prednisone
Drug: Letrozole|Procedure: ovarian drilling
Drug: Simethicone|Drug: Enema
Drug: Iron Sucrose Injection|Drug: Ferrous Bisglycinate
Drug: Sulfadoxine-pyrimethamine|Drug: dihydroartemisinin-piperaquine
Drug: Bupivacaine|Drug: Depo-Medrol Injectable Product|Other: Saline (Sodium Chloride) solution|Drug: Lidocaine
Drug: Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg|Drug: Olmesartan 40 mg, Rosuvastatin 20mg|Drug: Amlodipine/Olmesartan 10/40mg (Combination drug)
Drug: RHB-104
Drug: SCRT|Drug: Placebos
Drug: DFN-15|Other: DFN-15 Placebo
Drug: Eziclen®/Izinova®|Drug: Klean-Prep®
Drug: EGFR-TK Inhibitor
Drug: Occipital Nerve Block (ONB) using lidocaine and dexamethosone|Drug: Cervical Medial Branch Block (CMBB) using lidocaine and dexamethosone
Drug: Nivolumab|Drug: Tegafur-gimeracil-oteracil potassium|Drug: Oxaliplatin|Drug: Capecitabine|Drug: Placebo
Drug: Meropenem-Vaborbactam|Drug: Piperacillin/Tazobactam
Drug: NVB|Drug: EPI|Drug: DDP|Drug: CAP|Drug: GEM|Drug: H|Drug: CTX|Drug: T
Drug: FYU-981
Drug: Oxaliplatin|Drug: 5Fluorouracil bolus|Drug: 5Fluorouracil continu|Drug: Docetaxel|Drug: Folinic Acid
Drug: DFN-15 Active|Other: DFN-15 Placebo
Drug: ABT-494
Drug: SyB P-1501|Drug: SyB P-1501 placebo
Drug: SHP640|Drug: PVP-I 0.6%|Drug: Placebo
Drug: daclatasvir|Drug: asunaprevir|Drug: Ribavirin
Drug: Durvalumab (MEDI4736)|Drug: Paclitaxel + carboplatin|Drug: Gemcitabine + cisplatin|Drug: Gemcitabine + carboplatin|Drug: Pemetrexed + cisplatin|Drug: Pemetrexed + carboplatin
Drug: EndoTAG-1|Drug: Paclitaxel|Drug: Gemcitabine Hydrochloride
Drug: Rapastinel
Drug: Docetaxel|Drug: Fluorouracil|Drug: Cisplatin
Drug: Preloading before TAVI|Drug: Postloading after TAVI
Drug: 68Ga-HBED-CC-PSMA PET/CT
Drug: K-877|Drug: Fenofibrate|Drug: Placebo (for K-877)|Drug: Placebo (for Fenofibrate)
Drug: Placebo|Drug: Sevelamer Carbonate (GZ419831)
Drug: Somatostatin|Drug: Octreotide
Drug: 0.3% Sodium Hyaluronate Eye Drop
Drug: In open-label phase: treatment with tofacitinib|Drug: In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio
Drug: Nicotine Patch|Drug: Placebos
Drug: Gabapentin|Other: placebo
Drug: Cetuximab|Drug: avelumab|Drug: Cisplatin|Radiation: IMRT
Drug: Glutamin|Other: Maltodextrin
Drug: Bahman capsules|Drug: Placebo
Drug: SHP640|Drug: Placebo
Drug: Cisplatin|Radiation: radiotherapy
Drug: Genvoya
Drug: Indocyanine green|Drug: Technetium99|Device: Optonuclear probe
Drug: Doxorubicin|Drug: Trabectedin
Drug: Atezolizumab|Biological: Bevacizumab|Drug: Fluorouracil|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Oxaliplatin|Other: Quality-of-Life Assessment
Drug: gilteritinib|Drug: Placebo
Drug: Growth Factor, Platelet-Derived
Drug: Aromatase Inhibitors (Arimidex)|Drug: Tamoxifen|Procedure: SOB|Drug: FAC|Drug: Aromatase Inhibitors (Femara)|Drug: Aromatase Inhibitors (Aromasin)
Drug: CCX168|Drug: Prednisone|Drug: Cyclophosphamide|Biological: Rituximab|Drug: Azathioprine
Drug: Napabucasin|Drug: Nab-paclitaxel|Drug: Gemcitabine
Drug: Azacitidine|Drug: Venetoclax|Drug: Placebo
Drug: Bempedoic acid 180 mg tablet|Drug: Matching placebo tablet
Drug: Tranexamic Acid|Other: Saline Wash
Drug: Cellcept® in autoimmune bullous dermatoses
Drug: Growth Factors
Drug: Pembrolizumab|Drug: Gemcitabine|Drug: Vinorelbine
Drug: bempedoic acid|Drug: placebo
Drug: isatuximab SAR650984|Drug: pomalidomide|Drug: dexamethasone
Drug: Rituximab|Drug: Placebo of Rituximab|Drug: Mycophenolate Mofetil
Drug: AG-120|Drug: AG-120 matched placebo
Drug: Ticagrelor plus ASA|Drug: Clopidogrel plus ASA
Drug: 17 OHPC
Drug: roxadustat|Drug: DA
Drug: Budesonid 50mcg (Noex)|Drug: Budesonid 50mcg (Busonid)
Drug: bempedoic acid|Other: placebo
Drug: Acetaminophen, gabapentin|Drug: Acetaminophen|Drug: Ketamine , Lidocaine , Dexmedetomidine|Drug: Fentanyl, Dexmedetomidine|Drug: Dexamethasone , Ondansetron|Drug: Sevoflurane|Drug: Sevoflurane, Fentanyl
Drug: Dexamethasone|Drug: Normal Saline
Drug: olaparib|Drug: enzalutamide|Drug: abiraterone acetate
Drug: Dolutegravir|Drug: Darunavir-cobicistat|Drug: Emtricitabine-Tenofovir
Drug: cyclosporin A|Drug: Etanercept 50 MG Solution for Injection|Drug: Placebos
Drug: KHK4827|Drug: Placebo
Drug: Intranasal Oxytocin
Drug: orphenadrine, acetaminophen, caffeine and diclofenac sodium|Drug: Voltaren® (diclofenac sodium 50mg)
Drug: Levonorgestrel IUS (Mirena, BAY86-5028)
Drug: Decitabine|Drug: Cytarabine
Drug: YHD1119|Drug: Lyrica
Drug: Acetylsalicylic acid|Drug: Low Molecular Weight Heparin (LMWH)
Drug: Lidocaine Infusion
Drug: Apixaban 5 MG Oral Tablet [ELIQUIS]|Drug: Warfarin Sodium
Drug: Nanoxel®M|Drug: Mitomycin-C
Drug: Levofloxacin|Drug: Placebo Oral Tablet
Drug: DE-117|Drug: Latanoprost ophthalmic solution
Drug: suprachoroidal CLS-TA + IVT aflibercept|Drug: suprachoroidal sham + IVT aflibercept
Drug: Venetoclax
Drug: CTC|Drug: G-PERT
Drug: Metformin Hydrochloride|Other: Placebo
Drug: Fp MDPI|Drug: FS MDPI|Drug: Placebo
Drug: Ocrelizumab|Drug: Rituximab
Drug: rifapentine + isoniazid|Drug: Isoniazid
Drug: isotonic saline|Drug: i.v. sodium bicarbonate|Drug: oral sodium bicarbonate
Drug: TAF|Drug: TDF|Drug: TAF Placebo|Drug: TDF Placebo
Drug: Aprepitant|Drug: Ondansetron|Drug: Metoclopramide
Drug: Lactobacillus casei rhamnosus (Lcr 35 regenerans)|Other: NO Intervention
Drug: 4L PegLyte + 15 mg bisacodyl|Drug: 6L PegLyte + 15 mg bisacodyl
Drug: Dolutegravir
Drug: Rucaparib|Drug: Abiraterone acetate or Enzalutamide or Docetaxel
Drug: RGN-259|Drug: Placebo
Drug: NETILDEX ophthalmic gel|Drug: NETILDEX eye drops solution
Drug: pyrotinib|Drug: placebo|Drug: Capecitabine
Drug: Elbasvir/Grazoprevir Fixed Dose Combination
Drug: Hyperbaric bupivacaine|Drug: Hyperbaric prilocaine
Drug: Budesonide
Drug: Acalabrutinib in combination with bendamustine and rituximab|Drug: Placebo in combination with bendamustine and rituximab
Drug: Lanabecestat
Drug: Neridronic acid
Drug: AZD9291 80mg oral each day|Radiation: Radiation therapy
Drug: Iron Isomaltoside 1000|Drug: Tranexamic Acid|Drug: Placebos iron isomaltoside 1000|Drug: Placebos tranexamic acid
Drug: Tamsulosin 0.2mg + Solifenacin 5mg|Drug: Tamsulosin 0.2mg + Placebo(Solifenacin)
Drug: Furosemide Topical Gel|Drug: Vehicle Topical Gel
Drug: Abatacept subcutaneous|Drug: Placebo
Drug: Echinaforce
Drug: Acalabrutinib (ACP-196)|Drug: Rituximab|Drug: Idelalisib|Drug: Bendamustine
Drug: Pimavanserin|Drug: Placebo
Drug: Terlipressin administration|Procedure: bronchoscopy under local anesthesia|Procedure: Biopsy sampling
Drug: ascorbic acid|Drug: Chemotherapy
Drug: Daprodustat small|Drug: Daprodustat small placebo|Drug: Daprodustat large|Drug: Daprodustat large placebo|Drug: Darbepoetin alfa|Drug: Darbepoetin alfa placebo
Drug: Ferric maltol|Other: Placebo
Drug: MOD-4023|Drug: Somatropin
Drug: DA-2802|Drug: Viread®
Drug: Irinotecan|Drug: Folfox Protocol
Drug: Clopidogrel or Aspirin and/or Dypyridamole
Drug: Lenvatinib|Drug: Placebo
Drug: Standard adjuvant systemic chemotherapy|Procedure: Hyperthermic intraperitoneal chemotherapy (HIPEC) with raltitrexed|Procedure: Hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin
Drug: PAC-14028 cream 1.0%|Drug: PAC-14028 cream Vehicle
Drug: roxadustat
Drug: Fremanezumab- A|Drug: Fremanezumab- B|Drug: Placebo
Drug: Tolvaptan|Drug: Matching Placebo
Drug: liraglutide|Drug: placebo|Behavioral: CMS Intensive Behavior Therapy
Drug: Liraglutide 3.0 mg|Drug: Placebo
Drug: Dulaglutide|Drug: Placebo
Drug: Mupirocin|Other: Placebo
Drug: Iron Isomaltoside
Drug: everolimus
Drug: Oxybutynin Chloride|Other: Placebo|Other: Quality-of-Life Assessment|Other: Questionnaire Administration
Drug: IOHEXOL
Drug: cabazitaxel|Drug: Prednisone|Drug: Granulocyte colony-stimulating factor (G-CSF)
Drug: Metformin Hydrochloride 850 MG Oral Tablet [Glucophage]|Drug: Ludipress, mg stereate, micronized hydrated silica, talcum
Drug: UX007|Drug: Placebo
Drug: Aspirin|Drug: Clopidogrel
Drug: Neoadjuvant chemotherapy|Procedure: D2 radical resection|Drug: Hyperthermic intraperitoneal perfusion chemotherapy|Drug: Adjuvant chemotherapy
Drug: ibrutinib|Drug: Placebo|Drug: Prednisone
Drug: Ropivacaine|Drug: Placebos
Drug: Galcanezumab
Drug: Capecitabine
Drug: Cytisine|Behavioral: Behavioural support|Drug: Varenicline
Drug: standard chemotherapy for colorectal cancer|Other: Nurse practitioner consultation|Other: Medical practitioner consultation
Drug: Pitavastatin|Drug: Placebo
Drug: Nicotine only|Drug: THC only|Drug: Nicotine and THC|Device: PAX Loose Leaf Vaporizer
Drug: Upadacitinib|Drug: Placebo
Drug: GWP42003-P
Drug: ferumoxytol
Drug: TED|Other: SOC|Device: Syringe|Device: Needle
Drug: Bevacizumab in combination with Paclitaxel/Carboplatin|Drug: Avastin in combination with Paclitaxel/Carboplatin
Drug: Tacrolimus|Drug: Vedolizumab|Other: Placebo
Drug: EMS Mometasone gel|Drug: Mometasone spray nasal
Drug: SPI-2012|Drug: Pegfilgrastim|Drug: Docetaxel|Drug: Cyclophosphamide
Drug: VX-661|Drug: Ivacaftor
Drug: Pegvisomant
Drug: lemborexant|Drug: Placebo
Drug: Avelumab|Other: Chemoradiation
Drug: Rapastinel|Drug: Placebo-matching Rapastinel
Drug: Guselkumab|Drug: Fumaric Acid Esters
Drug: Cabotegravir (CAB) tablet|Drug: Rilpivirine (RPV) tablet|Drug: Cabotegravir - Injectable Suspension (CAB LA)|Drug: Rilpivirine - Injectable Suspension (RPV LA)|Drug: 2 NRTIs plus an INI, NNRTI, or PI
Drug: Progesterone|Drug: Placebo
Drug: NMDA active|Drug: Steroid active|Drug: NMDA placebo|Drug: Steroid placebo
Drug: Rituximab|Drug: Sodium Chloride solution
Drug: Fludarabine|Drug: Cyclophosphamide|Biological: Rituximab|Drug: Bendamustine|Drug: Venetoclax|Biological: Obinutuzumab|Drug: Ibrutinib
Drug: Ropivacaine|Drug: Bupivacaine
Drug: Teduglutide|Other: SOC
Drug: Dupilumab|Other: Placebo|Drug: Asthma Controller Therapies (incl. prednisone/prednisolone)|Drug: Asthma Reliever Therapies
Drug: Mistletoe extract (Iscador Qu)|Drug: Placebo
Drug: palbociclib|Drug: trastuzumab|Drug: pertuzumab|Drug: letrozole|Drug: Anastrozole|Drug: Exemestane|Drug: Fulvestrant
Drug: Metformin/Atorvastatin 1500mg/40mg, QD|Drug: Metformin 1500mg, QD|Drug: Atorvastatin 40mg, QD
Drug: Albendazole and praziquantel|Drug: Albendazole and praziquantel placebo
Drug: Metformin HCL 850 CF
Drug: EPREX®|Drug: EPIAO®
Drug: ibrutinib|Drug: placebo to match ibrutinib|Drug: rituximab
Drug: Prucalopride|Drug: Placebo Oral Capsule
Drug: triple combination therapy|Drug: Stepwise add-on therapy
Drug: buprenorphine|Other: Placebo
Drug: Fremanezumab - A|Drug: Fremanezumab - B|Drug: Placebo
Drug: aspirin intake|Drug: placebo intake|Procedure: Surgical resection of colonic adenocarcinoma stage III or II high risk|Biological: Molecular analysis of exon 9 and 20 of PI3K|Biological: blood intake
Drug: Conventional chemotherapy|Drug: Maintenance chemotherapy 1|Drug: Maintenance chemotherapy 2
Drug: Clopidogrel 75 mg|Drug: Prasugrel 5 mg|Drug: Ticagrelor 45 mg
Drug: Methylprednisolone|Drug: Placebo
Drug: Edoxaban-based Regimen|Drug: VKA-based Regimen
Drug: combined contraceptive pills (microcept)|Drug: medroxyprogesterone acetate (progest)|Drug: mefenamic acid (ponstan forte)
Drug: lidocaine in-situ gel|Drug: placebo in-situ gel
Drug: Edoxaban|Drug: VKA-Based Regimen
Drug: Vitamin C 10mg/Kg Vitamin E 10 mg/Kg|Drug: Placebo
Drug: Ribociclib|Drug: Letrozole|Drug: Goserelin
Drug: HCP1202|Drug: HGP1011|Drug: HCP0910
Drug: Iron isomaltoside|Drug: Iron sucrose
Drug: Iron isomaltoside|Drug: Iron Sucrose
Drug: Sofosbuvir|Drug: ABT-493/ABT-530|Drug: Ribavirin
Drug: Aprepitant|Drug: Olanzapine
Drug: Testosterone|Drug: Placebo gel|Behavioral: Supervised exercise training
Drug: turoctocog alfa
Drug: Cabotegravir (CAB) tablet|Drug: Rilpivirine (RPV) tablet|Drug: Cabotegravir - Injectable Suspension (CAB LA)|Drug: Rilpivirine - Injectable Suspension (RPV LA)|Drug: ABC/DTG/3TC STR - Tablet|Drug: DTG Tablet
Drug: L19IL2 + L19TNF|Procedure: Surgery
Drug: ABP 710|Drug: Infliximab
Drug: Interferon beta 1a|Drug: Mitoxantrone
Drug: Bezafibrate|Drug: Ursodeoxycholic Acid|Drug: Placebo (for Bezafibrate)
Drug: tirasemtiv
Drug: MD1003 100mg capsule|Drug: PLACEBO
Drug: Irinotecan|Drug: 5-fluorouracil|Drug: Leucovorin
Drug: Test Drug (JDP-205)|Drug: Active Control (Diphenhydramine)
Drug: s-LMWH|Drug: LMWH|Drug: Argatroban
Drug: Irinotecan|Drug: Folinic Acid|Drug: 5-FU|Drug: Cetuximab|Drug: Bevacizumab|Drug: Capecitabine|Drug: regorafenib|Drug: Irinotecan 125mg|Drug: Cetuximab wkly
Drug: RAMUCIRUMAB|Drug: Paclitaxel|Drug: FOLFOX 4|Drug: mFOLFOX 6|Drug: XELOX
Drug: Apixaban|Drug: Phenprocoumon
Drug: Aprepitant+palonosetron+dexamethasone|Drug: palonosetron+dexamethasone
Drug: Macitentan|Other: Standard-of-care
Drug: Adapalene 0.3% / BPO 2.5% gel
Drug: Maribavir|Drug: Investigator-Assigned Treatment
Drug: Sildenafil 100 mg oral morning dose|Drug: Placebo oral morning dose
Drug: Recombinant Factor VIII (50 IU/kg)|Drug: Recombinant Factor VIII (On-demand treatment)
Drug: NA-1, 2.6 mg/kg|Drug: Placebo
Drug: gefitinib|Drug: Yiqi-yangyin-jiedu decoction|Drug: placebo
Drug: Ibuprofen|Drug: Opioid Medication|Drug: Placebo|Drug: Ibuprofen + Opioid medication
Drug: Pantoprazole|Drug: Placebo (for pantoprazole)
Drug: Trabectedin
Drug: Omecamtiv Mecarbil|Drug: Placebo
Drug: Doxycycline|Drug: Placebo
Drug: Minocycline|Drug: Placebo
Drug: Encorafenib|Drug: Binimetinib|Drug: Cetuximab|Drug: Irinotecan|Drug: Folinic Acid|Drug: 5-Fluorouracil
Drug: Donepezil|Drug: Placebo
Drug: Maribavir|Drug: Valganciclovir|Drug: Placebo
Drug: Sotagliflozin (SAR439954)|Drug: Placebo|Drug: Metformin
Drug: ZX008 - 0.2 mg/kg/day|Drug: ZX008 - 0.4 mg/kg/day|Drug: ZX008 - 20 mg/day maximum dose|Drug: Matching Placebo
Drug: MSB0010718C
Drug: Estradiol/Norethindrone Acetate|Drug: Elagolix
Drug: LCZ696 (sacubitril/valsartan)|Drug: Ramipril|Drug: Placebo of LCZ696|Drug: Placebo of ramipril|Drug: Valsartan|Drug: Placebo of valsartan
Drug: FF/UMEC/VI (100/31.25/25) mcg|Drug: FF/UMEC/VI (100/62.5/25) mcg|Drug: FF/UMEC/VI (200/31.25/25) mcg|Drug: FF/UMEC/VI (200/62.5/25) mcg|Drug: FF/VI (100/25) mcg|Drug: FF/VI (200/25) mcg|Drug: Fluticasone/salmeterol (FSC)|Drug: Albuterol/salbutamol|Device: ELLIPTA DPI|Device: DISKUS DPI|Device: METERED-DOSE INHALER (MDI)
Drug: Teneligliptin 20mg|Drug: Placebo|Drug: Metformin = 1000 mg
Drug: Hormone Replacement Therapy|Drug: Combined Oral Contraceptives
Drug: Ketamine|Drug: Placebo
Drug: guadecitabine|Drug: Treatment Choice (TC)
Drug: Chloroprocaine|Drug: Ropivacaine
Drug: Gabapentin|Other: Placebo
Drug: pegaspargase|Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Dexamethasone|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone|Radiation: IMRT
Drug: Aripiprazole|Drug: Placebo
Drug: Liraglutide|Drug: Placebo
Drug: Anastrozole or Letrozole or Exemestane
Drug: Teneligliptin 20mg|Drug: Placebo
Drug: Fuzhenghuayu|Drug: UDCA
Drug: Pomalidomide|Drug: Dexamethasone
Drug: human chorionic gonadotrophin|Drug: human chorionic gonadotrophin + gonadotrophin releasing hormone agonist
Drug: NKTR-102|Drug: Eribulin|Drug: Ixabepilone|Drug: Vinorelbine|Drug: Gemcitabine|Drug: Paclitaxel|Drug: Docetaxel|Drug: Nab-paclitaxel
Drug: Intravitreal ranibizumab
Drug: Filgotinib|Drug: Placebo
Drug: Travoprost|Other: Placebo Vehicle
Drug: Goserelin|Drug: Tamoxifen|Drug: Aromatase Inhibitors
Drug: Ruxolitinib|Drug: Best Available Therapy (BAT)
Drug: Letrozole
Drug: KamRAB - HRIG
Drug: Pegaspargase|Drug: doxorubicin hydrochloride liposome injection|Drug: etoposide|Drug: methylprednisolone|Drug: Etoposide|Drug: dexamethasone
Drug: Atezolizumab|Drug: Fluorouracil|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Oxaliplatin|Other: Quality-of-Life Assessment
Drug: JR-131
Drug: Dupilumab SAR231893 (REGN668)|Drug: Placebo|Drug: Mometasone furoate nasal spray
Drug: Peri-operative chemotherapy|Drug: postoperative chemotherapy
Drug: Mercaptopurine (Purinethol)|Drug: Placebo|Drug: Mesalamine|Drug: Prednisone
Drug: Aprepitant+Tropisetron|Drug: Dexamethasone+Tropisetron
Drug: Tacrolimus|Drug: Everolimus|Drug: Mycophenolate mofetil|Drug: Prednisolone, Prednisone or Methylprednisolone
Drug: aliskiren
Drug: Atezolizumab|Drug: Atezolizumab Placebo|Drug: Cobimetinib|Drug: Vemurafenib|Drug: Vemurafenib Placebo
Drug: Tocilizumab|Drug: Placebo
Drug: Minocycline|Drug: Placebo|Other: Probiotics
Drug: Guadecitabine|Other: Treatment Choice
Drug: Ponesimod|Other: Placebo
Drug: Intravenous colimycin|Drug: Intravenous placebo|Drug: Nebulized colimycin|Drug: Nebulized placebo
Drug: oral resveratrol|Drug: oral placebo
Drug: Furosemide|Drug: Placebo filling|Drug: Placebo furosemide|Drug: Vascular filling
Drug: Adalimumab
Drug: Desloratadine+Phenylephrine+Ibuprofen|Drug: Placebo
Drug: Trabectedin|Drug: Pegylated Liposomal Doxorubicin|Drug: Topotecan|Drug: Gemcitabine|Drug: Weekly Paclitaxel|Drug: Carboplatin
Drug: PLACEBO|Drug: ANAKINRA
Drug: Standard of care with placebo lock (saline and heparin)|Drug: Standard of care with Mino-Lok Therapy (MLT)|Drug: Standard of Care with an antibiotic lock
Drug: Atorvastatin 80mg|Drug: Atorvastatin 10mg
Drug: Zonisamide|Behavioral: Take Control|Drug: Placebo (for Zonisamide)
Drug: YiQiFang|Drug: YangYinFang|Drug: YiQiYangYinFang|Drug: Gemcitabine®|Drug: Pemetrexed®|Drug: Docetaxel®|Drug: placebo granules
Drug: LEO 90100 aerosol foam|Drug: LEO 90100 aerosol foam vehicle
Drug: Realgar-Indigo naturalis formula|Drug: all-trans retinoic acid|Drug: Arsenic trioxide|Drug: Hydroxyurea
Drug: Colchicine
Drug: Ramucirumab|Drug: Paclitaxel|Drug: Placebo
Drug: Grazoprevir 100 mg/d 8 weeks|Drug: Elbasvir 50 mg/d 8 weeks|Drug: Grazoprevir 100 mg/d 12 weeks|Drug: Elbasvir 50 mg/d 12 weeks
Drug: placebo|Drug: linagliptin|Drug: background therapy
Drug: betamethasone 24 mg|Drug: 12mg betamethasone +placebo
Drug: Bivalirudin|Drug: heparin
Drug: Docetaxel|Drug: Pertuzumab|Drug: Placebo|Drug: Trastuzumab
Drug: Secukinumab|Drug: Placebo
Drug: Aspirin|Other: Placebo
Drug: Lidocaine 20mg/ml|Drug: Glucose 5% (placebo)
Drug: Cannabis|Drug: Oxycodone|Drug: Placebo for Cannabis|Drug: Placebo for Oxycodone
Drug: Lu AF35700
Drug: QMF149 150/80 µg|Drug: MF 200 µg
Drug: vadadustat|Drug: darbepoetin alfa
Drug: L-citrulline|Other: Placebo
Drug: atezolizumab + avastin + platinum-based chemotherapy|Drug: placebo + avastin + platinum-based chemotherapy
Drug: Bupivacaine + CBD|Drug: Bupivacaine Only (control arm)
Drug: Adjuvant chemotherapy (Paclitaxel and Cisplatin)|Radiation: Adjuvant radiotherapy|Other: Control group (Surgery alone)
Drug: FS VH S/D 500 s-apr|Device: DuraSeal Dural Sealant
Drug: dasatinib (SPRYCEL®)
Drug: Filgotinib|Drug: Placebo to match filgotinib|Drug: Adalimumab|Drug: Placebo to match adalimumab|Drug: MTX
Drug: YiQiFang|Drug: YangYinFang|Drug: YiQiYangYinFang|Drug: placebo granules|Drug: Erlotinib®|Drug: Gefitinib®|Drug: Icotinib®
Drug: liraglutide|Drug: placebo
Drug: KPS-0373|Drug: Placebo
Drug: Tobramycin nebulized nasally|Drug: Physiologic serum nebulized nasally
Drug: Varenicline|Behavioral: Behavioural support|Drug: Placebo
Drug: Dinoprostone|Drug: Oxytocine
Drug: SoluMatrix Abiraterone Acetate|Drug: Methylprednisolone
Drug: Single intravenous bolus of cyclosporine A (2.5 mg/kg) at the onset of resuscitation|Drug: Single intravenous bolus of placebo at the onset of resuscitation
Drug: Filgotinib|Drug: Placebo to match filgotinib|Drug: MTX|Drug: Placebo to match MTX
Drug: pemetrexed|Drug: cisplatin|Drug: Erlotinib
Drug: Oxaliplatin intravenous|Drug: 5 Fu|Drug: Folinic Acid|Drug: Oxaliplatin intra-arteriel|Drug: Panitumumab|Drug: Bevacizumab
Drug: Pregabalin plus BBCET|Other: Placebo plus BBCET
Drug: Contrast agent: SonoVue®.
Drug: Estrogens
Drug: LCZ696|Drug: Valsartan|Drug: Placebo of LCZ696|Drug: Placebo of Valsartan
Drug: icotinib|Drug: Chemotherapy|Radiation: Radiotherapy
Drug: Clofarabine|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dasatinib|Drug: Dexamethasone|Drug: Doxorubicin Hydrochloride|Drug: Etoposide|Drug: Hydrocortisone Sodium Succinate|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Pegaspargase|Drug: Prednisone|Radiation: Radiation Therapy|Drug: Thioguanine|Drug: Vincristine Sulfate
Drug: Gefitinib 250mg po qd or Tarceva 150mg po qd or Icotinib 125mg po tid Other Name: Gefitinib/Tarceva/Icotinib|Radiation: WBRT|Radiation: HFSRS
Drug: Somatostatin
Drug: Daclizumab
Drug: Rituximab|Drug: Nelarabine|Drug: PEG-Asparaginase|Procedure: Cranial irradiation|Drug: Imatinib|Drug: Idarubicin|Drug: Dexamethasone|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Vincristine|Drug: Mercaptopurine|Drug: VP16|Drug: Daunorubicin (DNR)|Drug: Methotrexate|Procedure: Stem cell transplantation|Drug: Cytarabine|Drug: Vindesine|Drug: Adriamycin|Drug: Prednisolone
Drug: Fentanyl|Drug: Morphine|Drug: Dexmedetomidine
Drug: Paclitaxel|Drug: Cisplatin|Drug: Epirubicin|Drug: Cyclophosphamide|Drug: 5-fluoruracil
Drug: Daprodustat|Drug: rhEPO|Drug: Placebo|Drug: Iron therapy
Drug: Eltrombopag
Drug: Daprodustat|Drug: Darbepoetin alfa|Drug: Placebo|Drug: Iron Therapy
Drug: Cyclosporine A|Drug: Placebo
Drug: Plasma-Lyte|Drug: Saline 0.9%|Other: Slow infusion speed|Other: Fast Infusion Speed
Drug: apatinib;etoposide and cisplatin|Drug: placebo;etoposide and cisplatin
Drug: Filgotinib|Drug: Placebo to match filgotinib|Drug: csDMARDs
Drug: Vitamin D3 (High dose)|Drug: Vitamin D3 (Low dose)
Drug: Ubrogepant|Drug: Placebo-matching Ubrogepant|Drug: Usual Care
Drug: Triamcinolone Acetonide
Drug: Sevoflurane|Drug: Desflurane
Drug: Nivolumab|Drug: Ipilimumab|Drug: Oxaliplatin|Drug: Capecitabine|Drug: Leucovorin|Drug: Fluorouracil
Drug: Amitriptyline|Other: Kinesiotherapy|Device: IC (Quark)
Drug: BI 695501|Drug: HUMIRA
Drug: Omega 3|Drug: Optive Advanced|Drug: Optive
Drug: TDF/FTC
Drug: Donafenib|Drug: Placebo
Drug: Phytolacca decandra|Drug: Melissa officinalis|Drug: Phyt.decandra + Melissa offic.
Drug: Atropine
Drug: Benralizumab|Other: Placebo
Drug: arbaclofen ER Tablets|Drug: Placebo for arbaclofen ER tablets
Drug: Custodiol-N|Drug: Custodiol|Procedure: organ perfusion for heart transplantation
Drug: Pregabalin Release Tablets|Drug: Placebo
Drug: Oxaliplatin plus S-1|Drug: S-1 only
Drug: Indacaterol/Glycopyrrolate|Drug: Placebo
Drug: IBI301 plus CHOP|Drug: Rituximab plus CHOP
Drug: rituximab|Radiation: Multi-fields radiotherapy
Drug: Sorafenib
Drug: Thymosin alpha 1|Other: Placebo
Drug: XR-NTX|Other: place of residence|Other: opioid treatment program
Drug: Etonogestrel-Immediate|Drug: Etonogestrel-Delayed
Drug: Edoxaban|Drug: Clopidogrel|Drug: Prasugrel|Drug: ticagrelor
Drug: Ketamine Hydrochloride|Drug: Placebo-Comparator
Drug: MOB015B|Drug: Ciclopirox 80 mg/g
Drug: vadadustat|Drug: Darbepoetin alfa
Drug: Remodulin|Drug: distilled water
Drug: Ubiquinol|Drug: Placebo
Drug: endostar
Drug: BIIB093|Drug: Placebo
Drug: IV dexamethasone
Drug: Apomorphine|Other: Best Medical Treatment
Drug: Ibrutinib|Drug: Placebo
Drug: ketoprofen and cyclobenzaprine association with caffeine|Drug: Cyclobenzaprine with caffeine
Drug: hCG (Ovitrelle 250 mcg mcg - Merck Serono)|Drug: hCG (Ovitrelle 250 mcg mcg - Merck Serono) + GnRH agonist (Decapeptyl 0.2mg - Ferring Gmgh)
Drug: Tamsulosin 0.2mg|Drug: Tadalafil 5mg|Drug: Placebo for Tamsulosin
Drug: Dapivirine Vaginal Ring-004
Drug: Olanzapine|Drug: Olanzapine Placebo
Drug: Vericiguat|Drug: Placebo for Vericiguat
Drug: 1. Berberine hydrochloride tablets ; 2. ProMetS probiotics powder|Drug: 1. Berberine placebo tablets ; 2. ProMetS probiotics powder|Drug: 1. Berberine hydrochloride tablets; 2. Probiotics placebo powder|Drug: 1. Berberine placebo tablets; 2. Probiotics placebo powder
Drug: Exenatide|Drug: Placebo
Drug: Ketamine continuous infusion|Drug: Placebo
Drug: Doxercalciferol (GZ427397)|Drug: Calcitriol
Drug: MOB015B|Drug: MOB015B Vehicle
Drug: EGFR-TKI|Drug: Chemotherapy(pemetrexed/gemcitabine)|Drug: Chemotherapy(carboplatin)
Drug: AQX-1125 100 mg|Drug: AQX-1125 200 mg|Drug: Placebo
Drug: R-CHOP/R-DHAP|Drug: Ibrutinib (Induction)|Drug: ASCT conditioning|Drug: Ibrutinib (Maintenance)
Drug: Botulinum Toxin Type A|Other: Saline solution|Other: Indexes
Drug: Dexamethasone|Drug: Placebo|Drug: Ropivacaine|Drug: Sufentanil
Drug: Varenicline|Drug: Placebo|Other: Tobacco Cessation Counseling
Drug: Alogliptin Benzoate|Drug: Placebo
Drug: Chemotherapy|Drug: Rucaparib
Drug: Insulin glargine (U300)|Drug: Insulin glargine|Drug: Non-insulin antihyperglycemic drugs
Drug: GV1001|Drug: Gemcitabine|Drug: Capecitabine
Drug: ADXS11-001|Drug: Placebo
Drug: Busonid (budesonide 200mcg and 400mcg)
Drug: Varenicline
Drug: givinostat|Drug: placebo
Drug: Linagliptin|Drug: Placebo
Drug: Defibrotide|Other: Best Supportive Care
Drug: Statin|Drug: Atorvastatin|Other: Placebo
Drug: Vildagliptin|Drug: Placebo
Drug: Perampanel
Drug: GSK1358820|Drug: Placebo
Drug: semaglutide|Drug: sitagliptin
Drug: Crenolanib|Drug: Placebo
Drug: Exenatide|Other: placebo
Drug: Rivaroxaban|Drug: Acetylsalicylic Acid
Drug: Adjuvant chemotherapy by Fotemustin|Other: Intensive surveillance
Drug: Chemotherapy
Drug: R-DA-EPOCH-21|Drug: R-DA-EPOCH-21 + auto-SCT|Drug: R-mNHL-BFM-90|Drug: R-mNHL-BFM-90 + auto-SCT
Drug: Hydroxytyrosol plus Vitamin E|Drug: Placebo
Drug: F/TAF|Drug: F/TDF|Drug: F/TAF Placebo|Drug: F/TDF Placebo
Drug: Ivermectin 200 µg/kg|Drug: Ivermectin 400 µg/kg
Drug: St. John's Wort|Device: Photodynamic diagnostic and therapy
Drug: etanercept|Drug: adalimumab|Drug: Abatacept|Drug: Tocilizumab
Drug: 68Ga-DOTATATE PET/CT
Drug: Folinic Acid|Other: Placebo
Drug: Ibuprofen|Drug: Placebo
Drug: Rivastigmine|Drug: Placebo
Drug: Nitric Oxide|Other: Placebo
Drug: Mepolizumab 300 mg|Drug: Placebo matching mepolizumab|Drug: Active OCS capsules (5 mg prednisolone or prednisone)|Drug: Placebo matching OCS capsules
Drug: Perampanel|Drug: Placebo
Drug: bivalent HPV vaccine|Drug: nonavalent HPV vaccine
Drug: 5-fluorouracil and low molecular weight heparin|Drug: Placebo
Drug: DEX Combined With RTX, CSA and IVIG
Drug: Acetylicsalicylic acid|Drug: Clopidogrel|Drug: Rivaroxaban
Drug: Repatha (Evolocumab)|Drug: Placebo
Drug: Rivaroxaban (20 mg)|Drug: Vitamin K antagonists (VKA)
Drug: Rivaroxaban (15 mg)|Drug: Aspirin
Drug: Dolutegravir (DTG)|Drug: Lamivudine (3TC)|Drug: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
Drug: Motireb 5/100 mg|Drug: Mosapride citrate|Drug: Placebo
Drug: Glucosamine and chondroitin sulfate combination (Eurofarma)|Drug: Glucosamine and chondroitin sulfate combination (Zodic)
Drug: 8% arginine/1450ppm sodium monofluorophosphate dentifrice|Drug: 5% potassium nitrate/2500ppm sodium fluoride dentifrice
Drug: IN ketamine|Drug: IV ketamine|Drug: IN saline 0.9%|Drug: IV saline 0.9%
Drug: vonoprazan 20 mg bid|Drug: Amoxicillin 500 mg tid|Drug: Amoxicillin 750 mg bid|Drug: Clarithromycin 200 mg bid|Drug: Metronidazole 250 mg bid
Drug: ZX008 - 0.8 mg/kg/day|Drug: ZX008 - 0.2 mg/kg/day|Drug: Placebo
Drug: Secukinumab|Drug: Ustekinumab
Drug: Apatinib|Drug: Gefitinib|Drug: Placebo
Drug: Nalmefene (Selincro®) 18 mg tablet|Drug: placebo
Drug: Fenofibrate|Drug: UDCA
Drug: Topical Pirfenidone|Drug: Triamcinolone + Pirfenidone|Drug: Intralesional Triamcinolone
Drug: QUTENZA®|Other: hypnotic message|Other: music therapy
Drug: Donepezil 5 mg|Drug: Placebo
Drug: Etomidate|Drug: Succinylcholine|Drug: Propofol|Drug: Remifentanil|Drug: Lidocaine
Drug: ropivacaine|Drug: saline solution 0.9%
Drug: MEROPENEM|Drug: PIPERACILLIN-TAZOBACTAM|Drug: CEFEPIME
Drug: GSK1358820|Drug: Placebo|Drug: Antibiotic therapy|Other: Bladder diary|Other: King's Health Questionnaire (KHQ)|Other: Overactive Bladder Symptom Score (OABSS)|Other: Treatment Benefit Scale (TBS)
Drug: PROBIO-FIX INUM®|Drug: Placebo
Drug: Sodium chloride administration|Drug: Ropivacaine administration
Drug: Levamisole Hydrochloride|Other: Placebo
Drug: ITI-007|Drug: Placebo
Drug: 15 mg E4/3 mg DRSP
Drug: Dalbavancin single dose|Drug: Dalbavancin two dose|Drug: Comparator
Drug: Intravenous recombinant tissue plasminogen activator (rtPA) Alteplase|Drug: Intravenous Tenecteplase
Drug: Idebenone 150 mg film-coated tablets|Drug: placebo
Drug: Acetylsalicylic acid lysinate 300 mg|Drug: Placebo (for Aspirin 300)|Drug: Acetylsalicylic acid lysinate 100 mg|Drug: Placebo 100 (for Aspirin 100)
Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody|Drug: Docetaxel
Drug: Bortezomib|Drug: Dexamethasone
Drug: lenvatinib|Drug: everolimus|Drug: pembrolizumab|Drug: Sunitinib
Drug: Naloxone Hydrochloride Lotion, 0.5%|Drug: Placebo Lotion
Drug: Normal saline placebo|Drug: Erythropoietin
Drug: ddAC-CP-Olaparib|Drug: ddAC-mini CTC
Drug: FKB238 (bevacizumab)|Drug: Avastin (bevacizumab)|Drug: Paclitaxel|Drug: Carboplatin
Drug: polymixin/bacitracin|Drug: cephalexin, or levofloxacin, or clindamycin|Drug: Saline
Drug: Atezolizumab|Drug: Carboplatin|Drug: Gemcitabine|Other: Placebo|Drug: Cisplatin
Drug: Acetylsalicylic acid
Drug: Rituximab|Drug: Placebo-rituximab|Drug: Cyclophosphamide|Drug: Placebo-cyclophosphamide
Drug: Bifidobacteria|Drug: placebo
Drug: Aerosolized plus intravenous colistin|Drug: Intravenous colistin
Drug: Tacrolimus BID|Drug: Advagraf QD
Drug: 23.4% Hypertonic saline|Drug: Saline
Drug: Aspirin 100mg|Drug: Aspirin 300mg|Drug: Placebo 100mg|Drug: Placebo 300mg
Drug: Bemiparin
Drug: Tafenoquine|Drug: Matched-Placebo for Tafenoquine|Drug: Primaquine|Drug: Matched-Placebo for Primaquine|Drug: Dihydroartemisinin-piperaquine (DHA-PQP)|Drug: ACT plus PQ (Rescue medication)|Drug: PQ (End of study treatment)
Drug: EcN-Suspension|Drug: Placebo
Drug: Du-176b|Drug: placebo
Drug: Midazolam|Drug: Bupivacaine
Drug: 15g L-citrulline daily p.o.|Drug: Placebo
Drug: Trehalose|Drug: Maltose
Drug: Degarelix|Drug: approved GnRH agonist|Radiation: Radiotherapy
Drug: BAY1841788 / darolutamide (ODM-201)|Drug: Standard ADT (androgen deprivation therapy)|Drug: Docetaxel|Drug: Placebo
Drug: Reslizumab|Drug: Placebo
Drug: ABT-SLV187|Drug: optimized antiparkinsonian treatment
Drug: CJ Plasma Solution A Injection|Drug: CJ 0.9% Normal Saline Injection
Drug: somatostatin infusion|Drug: placebo infusion
Drug: Short DAPT|Drug: Long DAPT
Drug: Edoxaban|Drug: Standard of Care
Drug: Aspirin|Other: Blank
Drug: Eflornithine|Drug: Lomustine
Drug: Antipseudomonal beta-lactam antibiotic|Drug: De-escalation(short-spectrum antibiotic)
Drug: Oxytocin
Drug: VAS203|Drug: Saline
Drug: Pleyris|Drug: Crinone8
Drug: Monthly Sulfadoxine-Pyrimethamine (SP) During Pregnancy|Drug: Monthly Dihydroartemisinin-Piperaquine (DP) During Pregnancy
Drug: Montelukast|Drug: Placebo
Drug: MitoGel instillations
Drug: ABP 798|Drug: Rituximab
Drug: Ofatumumab subcutaneous injection|Drug: Placebo orally matching to teriflunomide|Drug: Teriflunomide orally|Drug: Placebo subcutaneous injection matching to ofatumumab
Drug: Ofatumumab subcutaneous injection|Drug: Placebo orally matching to teriflunomide|Drug: Teriflunomide orally|Drug: Placebo subcutanous injection matching to ofatumumab
Drug: 1 to 4 mg tablets of GSK1278863|Drug: 6 mg GSK1278863 tablet|Drug: Epoetin beta pegol
Drug: TAK-536 2.5 mg|Drug: TAK-536 5 mg
Drug: Tafamidis meglumine
Drug: EG-1962 (nimodipine microparticles)|Drug: Enteral Nimodipine
Drug: ß-adrenergic blocker propranolol|Behavioral: Treatment as usual
Drug: Atezolizumab (MPDL3280A), an Engineered Anti-PDL1 Antibody|Drug: Cobimetinib|Drug: Regorafenib
Drug: insulin glargine/lixisenatide fixed ratio combination|Drug: liraglutide|Drug: exenatide|Drug: exenatide extended-release|Drug: albiglutide|Drug: dulaglutide|Drug: metformin|Drug: pioglitazone|Drug: SGLT2 inhibitor
Drug: HLX01|Drug: Rituximab|Drug: CHOP
Drug: Mirabegron|Drug: Placebo
Drug: Ropivacaine and Normal saline|Drug: Ropivacaine and Dexamethasone|Drug: Ropivacaine and Dexmedetomidine
Drug: Rotigotine|Drug: Placebo
Drug: Docetaxel|Drug: Cisplatin 1|Drug: Xeloda|Radiation: IMRT|Drug: Cisplatin 2
Drug: Botulinum Toxin Type A for Injection|Drug: Placebo
Drug: grazoprevir/elbasvir, ribavirin|Behavioral: Behavioural Intervention
Drug: Lanabecestat|Drug: Placebo
Drug: Cannabidiol|Drug: Placebo
Drug: GZ402666|Drug: alglucosidase alfa (GZ419829)
Drug: Intranasal Esketamine
Drug: Nebulized ipratropium bromide|Drug: Nebulized combination ipratropium bromide with salbutamol|Drug: Nebulized Placebo
Drug: Once weekly subcutaneous injection of TransCon hGH|Drug: Once daily subcutaneous injection of Genotropin
Drug: Prochlorperazine
Drug: Oral Micronized Progesterone|Drug: Placebo
Drug: Abatacept|Drug: Placebo
Drug: Ketamine|Drug: Fentanyl
Drug: Dolutegravir 50 mg|Drug: Tenofovir disoproxil fumarate 300 mg / lamivudine 300 mg|Drug: Efavirenz 200 mg
Drug: BI 695502|Drug: Avastin
Drug: Brotizolam|Drug: placebo
Drug: Docetaxel|Drug: Erlotinib
Drug: Vancomycin|Drug: Fecal microbiota transplantation|Drug: Rectal bacteriotherapy
Drug: Human normal immunoglobulin G (IgG)
Drug: Sorafenib|Procedure: Hepatic arterial infusion chemotherapy|Drug: Folfox Protocol
Drug: Botulinum Toxin Type A|Drug: Sterile Saline Solution
Drug: Risperidone implant
Drug: Regorafenib|Other: Placebo
Drug: Azithromycin|Drug: Co-trimoxazole
Drug: Methotrexate|Other: Sugar pill (placebo)
Drug: SCT400 plus CHOP|Drug: Rituximab plus CHOP
Drug: Herceptin (trastuzumab)|Drug: SB3 (proposed trastuzumab biosimilar)
Drug: Sofosbuvir|Drug: Ribavirin|Drug: Simeprevir|Drug: daclatasvir|Drug: Ledipasvir
Drug: EDS-EP dose range of ~5-10 mg DSP/infusion|Drug: EDS-EP dose range of ~14-22 mg DSP/infusion|Drug: Placebo
Drug: Terlipressin acetate|Other: Placebo Comparator
Drug: Cilostazol|Drug: Aspirin
Drug: DA-3002|Drug: Genotropin®
Drug: Bexagliflozin|Drug: Placebo for Bexagliflozin|Drug: Glimepiride|Drug: Placebo for Glimepiride
Drug: Letrozole (Aromatase Inhibitors)|Drug: AC*4-T*4
Drug: X-396 (ensartinib)|Drug: crizotinib
Drug: Rituximab|Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone
Drug: Capecitabine|Drug: Aromatase Inhibitor
Drug: Recombinant tissue plasminogen activator (rt-PA)|Drug: Standard Anticoagulation Therapy
Drug: bevacizumab|Drug: 5-fluorouracil|Drug: Dexamethasone
Drug: Ultrasound contrast agent (Contrast-enhanced ultrasound)|Device: Logiq E9 Scanner (Contrast-enhanced ultrasound)
Drug: Brimonidine 0.33% gel
Drug: MEDA|Procedure: Auto-HSCT
Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody|Drug: Carboplatin|Drug: Etoposide|Drug: Placebo
Drug: Abemaciclib|Drug: Anastrozole|Drug: Letrozole|Drug: Placebo|Drug: Fulvestrant
Drug: Cleanoze®|Drug: Saline (Syringe irrigation)
Drug: CJ-12420 50 mg QD|Drug: CJ-12420 100 mg QD|Drug: Lansoprazole 30 mg QD
Drug: PEG-rhG-CSF
Drug: Temozolomide|Drug: Bevacizumab
Drug: Olokizumab q4w|Drug: Olokizumab q2w|Drug: Placebo q2w
Drug: Olokizumab 64mg q4w|Drug: Olokizumab 64mg q2w|Drug: Adalimumab 40mg q2w|Drug: Placebo q2w
Drug: Bevacizumab|Drug: Erlotinib
Drug: Antimicrobial therapy: Co-trimoxazole or Doxycycline|Other: No Intervention: Standard of Care
Drug: Phosphocreatine sodium tetrahydrate after anaesthesia induction|Drug: 5% Glucose after anaesthesia induction|Drug: Phosphocreatine sodium tetrahydrate added to cardioplegia|Drug: 5% Glucose|Drug: Phosphocreatine sodium tetrahydrate after heart recovery|Drug: 5% Glucose after heart recovery|Drug: Phosphocreatine sodium tetrahydrate after ICU admission|Drug: 5% Glucose after ICU admission
Drug: Ibrutinib combined with As2O3|Drug: ibrutinib
Drug: Placebo|Drug: Bortezomib|Drug: Dexamethasone|Drug: Venetoclax
Drug: Bevacizumab|Drug: SB8|Drug: Carboplatin|Drug: Paclitaxel
Drug: Bedaquiline|Drug: Delamanid|Drug: Clofazimine|Drug: Levofloxacin|Drug: Moxifloxacin|Drug: Linezolid|Drug: Pyrazinamide
Drug: MPH|Drug: Placebo
Drug: Chlorhexidine|Device: NaCl 0.9 %
Drug: Napabucasin|Drug: Fluorouracil|Drug: Leucovorin|Drug: Irinotecan|Drug: Bevacizumab
Drug: Opioid-free general anesthetic|Drug: Traditional general anesthetic
Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010)|Drug: Insulin glargine U100 (HOE901)|Drug: Metformin
Drug: Empagliflozin and Linagliptin|Drug: Metformin and Insulin sc
Drug: pembrolizumab + epacadostat|Drug: pembrolizumab + placebo
Drug: Mirabegron
Drug: ferumoxtran-10|Device: 7 Tesla MRI|Device: 3 Tesla MRI
Drug: secukinumab 150mg
Drug: Amiodarone|Drug: N-Acetylcysteine|Drug: Placebo
Drug: Suvorexant 10 mg|Drug: Suvorexant 20 mg|Drug: Placebo
Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010)|Drug: Lixisenatide (AVE0010)|Drug: Oral anti-diabetic drugs
Drug: 0.25% Desoximetasone cream (Topoxy®)|Drug: 0.25% Desoximetasone cream (Topicorte®)|Drug: Placebo
Drug: Botulinum Toxin Type A|Other: Robot-assisted therapy|Other: Mirror therapy|Other: Control intervention
Drug: Parecoxib|Drug: Morphine
Drug: Placebo|Drug: Secukinumab 2 mL form|Drug: Secukinumab 1 mL form
Drug: Two Anti-angiogenesis Drugs(Endostar and Thalidomide)|Drug: Pure chemotherapy(Xelox)
Drug: Sham Injection|Drug: FAI Insert
Drug: Rituximab|Drug: Dimethyl fumarate|Drug: Sodium Chloride solution
Drug: LBAL|Drug: Humira®
Drug: rivaroxaban|Drug: Low-molecular-weight heparin
Drug: AXS-02|Drug: Placebo
Drug: risedronate|Drug: placebo
Drug: carboplatin|Drug: paclitaxel|Drug: Bevacizumab|Drug: Pemetrexed|Drug: cisplatin
Drug: AXS-05|Drug: Bupropion
Drug: DX-2930
Drug: Udenafil|Drug: Placebo
Drug: Octaplex|Drug: Beriplex P/N (Kcentra)
Drug: Bupivacaine|Drug: Liposomal Bupivacaine|Drug: Oxycodone|Behavioral: Pill Diary|Behavioral: Symptom Questionnaire
Drug: ART-123|Drug: Placebo
Drug: Adjuvant chemotherapy|Procedure: Follow-up
Drug: Brigatinib|Drug: Xalkori (crizotinib)
Drug: Acetaminophen|Other: Placebo
Drug: Valbenazine
Drug: SPN-812 ER
Drug: DHEA|Drug: Growth Hormone-Releasing Hormone|Drug: Placebo 1|Drug: Placebo 2
Drug: S-1 for 6 months|Drug: S-1 for 1 year
Drug: Oral Budesonide Suspension (OBS)|Drug: Placebo
Drug: Celecoxib|Drug: Tramadol|Drug: Placebo 1|Drug: Placebo 2
Drug: insulin glargine (U300)|Drug: insulin glargine|Drug: fast-acting insulin analogue
Drug: sedation with propofol
Drug: GELAD|Radiation: Radiotherapy
Drug: Infacort®
Drug: disodium EDTA|Dietary Supplement: Oral Multi Vitamins/Minerals (OMVM)|Drug: Placebo disodium EDTA|Dietary Supplement: Placebo Oral Multi Vitamins/Minerals (OMVM)
Drug: Oxycodone, 1.00 mg dose|Drug: Oxycodone, 0.03 mg/kg dose|Drug: Oxycodone, 0.02 mg/kg dose
Drug: Intrastromal voriconazole|Drug: Natamycin
Drug: lurasidone|Other: Placebo
Drug: NiCord®|Other: Cord Blood Unit
Drug: Letrozole|Drug: Anastrozole|Drug: Vinorelbine
Drug: Octagam 10%|Other: Placebo
Drug: Squalamine lactate ophthalmic solution, 0.2%|Drug: Placebo Ophthalmic solution|Drug: ranibizumab
Drug: Celecoxib|Drug: Placebo
Drug: Red yeast rice and atorvastatin|Drug: Atorvastatin alone
Drug: Dapagliflozin|Drug: Dapagliflozin placebo
Drug: ivacaftor
Drug: collagenase injection|Procedure: limited palmar fasciectomy
Drug: Celecoxib|Biological: Tanezumab 5 mg|Biological: Tanezumab 10 mg|Drug: Placebo for celecoxib|Biological: Placebo for tanezumab
Drug: Inhaled Nitric Oxide 75 mcg/kg IBW/hr|Drug: Placebo
Drug: Gemtuzumab ozogamicin|Drug: Liposomal daunorubicin|Drug: Mitoxantrone|Drug: Fludarabine|Drug: Cytarabine|Drug: Busulfan|Drug: Cyclophosphamide
Drug: BACLOFEN|Drug: PLACEBO
Drug: Subcutaneous(SC) Abatacept|Other: Placebo|Drug: Methotrexate
Drug: gabapentin|Drug: tramadol|Other: placebo tramadol|Other: placebo gabapentin
Drug: rivaroxaban|Drug: Placebo
Drug: Ursodeoxycholic Acid|Drug: Placebo|Radiation: Gallbladder Ultrasound
Drug: dihydroartemisinin-piperaquine|Other: message(SMS) reminder|Other: Health worker reminder|Other: short message(SMS) reminder
Drug: NRL-1
Drug: Intravenous oxytocin|Drug: vaginal prostaglandin
Drug: Placebo|Drug: Morphine Sulfate|Drug: Plus laxative (Docusate with senna)|Drug: Plus placebo laxative|Device: FitBit charge HR (Accelerometer)
Drug: Sodium Oxybate|Drug: Placebo
Drug: Deferasirox
Drug: carboplatin|Drug: paclitaxel|Drug: Avelumab
Drug: Intravitreal aflibercept injection [IAI]|Drug: Sham
Drug: Risperidone|Drug: Olanzapine|Drug: Lu AF35700
Drug: Chronocort®|Drug: standard glucocorticoid therapy
Drug: Tempocol-ColoPulse® (Peppermint oil)|Drug: Placebo|Drug: Tempocol® (Peppermint oil)
Drug: pegaspargase 1250 IU/m2 x 2|Drug: pegaspargase 2500 IU/m2 x 1
Drug: alirocumab SAR236553 (REGN727)|Drug: placebo for alirocumab|Drug: ezetimibe|Drug: placebo for ezetimibe|Drug: atorvastatin|Drug: rosuvastatin|Drug: simvastatin
Drug: Amiodarone|Drug: Placebo
Drug: LMWH|Procedure: TACE
Drug: S-649266|Drug: Best Available Therapy
Drug: EGFR-TKI|Radiation: whole brain radiotherapy
Drug: Modulation of Inspired Fraction of Oxygen (FiO2)
Drug: Preoperative Gabexate Mesilate group|Drug: Intraoperative Gabexate Mesilate group|Drug: hepatectomy with dextrose water
Drug: Vortioxetine 10 mg/day|Drug: Vortioxetine 20 mg/day|Drug: Fluoxetine 20 mg/day|Other: Placebo
Drug: Vortioxetine 10 mg/day|Drug: Vortioxetine 20 mg/day|Drug: Fluoxetine 20mg/day|Other: Placebo
Drug: Misoprostol 400 sublingual|Drug: placebo 400 sublingual
Drug: Tanezumab|Drug: Placebo
Drug: ibalizumab|Drug: Optimized Background Regimen
Drug: Thalidomide (100mg)|Drug: Thalidomide (50mg)|Drug: placebo
Drug: Methotrexate|Drug: ABT-494|Drug: ABT-494 matching placebo|Drug: Methotrexate matching placebo
Drug: ABT-494 matching placebo|Drug: Methotrexate|Drug: Methotrexate matching placebo|Drug: ABT-494
Drug: ABT-494|Drug: Placebo
Drug: Cefaliv® & Placebo|Drug: Neosaldina® & Placebo
Drug: Somatostatin-Analog
Drug: Mannitol
Drug: Polyethylene glycol|Drug: naloxegol
Drug: Elafibranor|Drug: Placebo
Drug: ORADUR®-Methylphenidate
Drug: concurrent chemotherapy with cisplatin|Drug: concurrent chemotherapy with docetaxel|Radiation: pelvic radiotherapy|Radiation: brachytherapy|Drug: adjuvant chemotherapy with cisplatin and docetaxel
Drug: Minocycline|Drug: Celecoxib|Drug: Placebo
Drug: Ibrutinib|Drug: Rituximab|Drug: Ifosfamide|Drug: Carboplatin|Drug: Etoposide|Drug: Vincristine|Drug: Idarubicin|Drug: Dexamethasone
Drug: Tranexamic Acid|Drug: saline solution
Drug: Levofloxacin|Drug: Rifampicin|Procedure: Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine
Drug: Amoxicillin|Procedure: Conventional IV treatment of streptococci/enterococci IE following European guidelines 2015 including amoxicillin, gentamicin, amicillin, vancomycin, penicillin G, ceftriaxone, netilmicin
Drug: Dexamethasone|Drug: Ropivacaine|Drug: Paracetamol|Drug: Morphine|Drug: Lidocaine
Drug: Ustekinumab 0.75 mg/kg|Drug: Ustekinumab 45 mg|Drug: Ustekinumab 90 mg
Drug: osilodrostat|Drug: osilodrostat Placebo
Drug: Intravenous Immunoglobulin|Drug: Placebo/Normal Saline
Drug: CER-001|Drug: Placebo
Drug: Ixekizumab|Drug: Placebo|Drug: Adalimumab
Drug: Mitomycin C|Drug: Gemcitabine
Drug: Platelet rich plasma|Drug: Hylan G-F 20
Drug: Indomethacin|Drug: Placebo
Drug: Elagolix|Drug: Placebo|Drug: Estradiol/Norethindrone Acetate
Drug: Fruquintinib|Drug: Placebo
Drug: SPN-810
Drug: Pirfenidone|Drug: Placebo
Drug: Ocrelizumab|Procedure: Lumber Puncture
Drug: PA21 (Velphoro®)|Drug: Calcium Acetate (Phoslyra®)
Drug: Diacerein|Drug: Celecoxib|Drug: Placebo
Drug: Arsenic trioxide|Drug: Idarubicin|Drug: Cytarabine|Drug: Tretinoin|Drug: Mitoxantrone|Drug: Mercaptopurine|Drug: Methotrexate
Drug: Oxymorphone HCl|Drug: Placebo
Drug: oral methadone|Drug: oral morphine
Drug: Tenapanor|Drug: Placebo
Drug: Octreotide capsules|Drug: Injectable Somatostatin Analogs (octreotide or lanreotide)|Drug: Cabergoline
Drug: GFF MDI (PT003)|Drug: Placebo MDI
Drug: cyclophosphamide, vincristine, prednisone, dacarbazine|Drug: cyclo, vcr, pred, dacarb,etop and doxo
Drug: Dasotraline
Drug: Avelumab (MSB0010718C)|Drug: Axitinib (AG-013736)|Drug: Sunitinib
Drug: Lanreotide (Autogel formulation)|Drug: Placebo
Drug: Acthar
Drug: Fluoxetine|Drug: Placebo
Drug: ZX008 (Fenfluramine Hydrochloride)|Drug: Matching Placebo
Drug: CB-03-01 cream, 1%
Drug: Ropivacaine after dilution with sodium chloride 0.9%
Drug: Melatonin|Drug: Placebo
Drug: HIPEC|Procedure: No HIPEC
Drug: Ferric Maltol|Drug: Ferric Carboxy Maltose
Drug: Delafloxacin|Drug: Moxifloxacin|Drug: Linezolid
Drug: Atorvastatin|Drug: Placebo
Drug: Pregabalin & Placebo|Drug: Magnesium sulphate & Placebo|Drug: Pregabalin & Magnesium sulphate|Drug: Placebo
Drug: Enzalutamide|Drug: Placebo
Drug: Cisplatin Combined With S-1|Drug: Cisplatin Combined With Paclitaxel
Drug: Botulinum Toxin A|Drug: Placebo
Drug: CHF 5993 200/6/12.5 µg|Drug: CHF 1535 200/6 µg|Drug: CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg
Drug: CHF 5993 100/6/12.5 µg|Drug: CHF 1535 100/6 µg
Drug: Moderate Dose Hydroxyurea|Drug: Low Dose Hydroxyurea
Drug: dexchlorpheniramine (Polaramine®) injection|Drug: Placebo injection
Drug: Clopidogrel|Drug: Ticagrelor|Drug: aspirin
Drug: Aspirin
Drug: Investigational Medical Product (IMP) administered in parent study
Drug: Iodopovidone solution|Drug: Talc
Drug: ABBV-066|Drug: Placebo
Drug: Enoxaparin|Other: Usual care
Drug: dihydroartemisinin-piperaquine|Drug: dihydroartemisinin-piperaquine placebo
Drug: Cytarabine|Drug: Vinblastine/prednisone
Drug: Imiquimod|Procedure: LLETZ
Drug: Vitamin D|Drug: Budesonide Nasal Spray|Other: placebo
Drug: Chemotherapy|Drug: Quizartinib|Drug: Placebo
Drug: Paclitaxel Micelles for Injection|Drug: Paclitaxel Injection|Drug: Cisplatin
Drug: Nivolumab|Drug: Temozolomide|Radiation: Radiotherapy|Other: Nivolumab Placebo
Drug: Granexin gel|Other: Vehicle gel
Drug: ETC-1002|Drug: Placebo
Drug: Mylan's insulin glargine|Drug: Lantus®
Drug: Granexin gel|Drug: Vehicle gel
Drug: 5-ASA|Drug: Corticosteroids
Drug: ANP
Drug: Iomab-B|Drug: Conventional Care|Drug: Fludarabine|Radiation: Total Body Irradiation|Procedure: HCT|Drug: Mycofenolate mofetil (MMF)|Drug: Cyclosporine or Tacrolimus
Drug: 56 days of weight-adjusted L-Carnitine treatment|Drug: 10 days of intravenous placebo (isotonic saline)
Drug: Apixaban|Drug: Standard of care
Drug: Exenatide|Drug: placebo
Drug: Apixaban|Drug: Rivaroxaban|Drug: Heparin|Drug: VKA
Drug: Regorafenib|Drug: Placebo
Drug: Degarelix|Drug: Leuprolide
Drug: AIN457 (secukinumab)|Drug: Placebo
Drug: Valsartan 160mg + Rosuvastatin 20mg|Drug: Valsartan 320mg + Rosuvastatin 20mg|Drug: Diovan® 160mg + Crestor® 20mg|Drug: Diovan® 320mg + Crestor® 20mg
Drug: Bleomycin|Drug: Etoposide|Drug: Doxorubicin|Drug: Cyclophosphamide|Drug: Vincristine|Drug: Procarbazine|Drug: Prednisone|Drug: Brentuximab Vedotin|Drug: Dacarbazine|Drug: Dexamethasone
Drug: Nimorazole
Drug: E/C/F/TAF;|Drug: Ledipasvir-Sofosbuvir
Drug: AbobotulinumtoxinA|Drug: AbobotulinumtoxinA Placebo
Drug: hexaminoavolunate|Procedure: WL cystoscopy
Drug: 68Ga- PSMA-HBED-CC|Device: Biograph mMR, Siemens
Drug: Lenalidomide|Drug: Carfilzomib|Drug: Dexamethasone|Drug: Lenalidomide (Control)
Drug: Dexmedetomidine|Drug: Bupivacaine
Drug: Volanesorsen
Drug: Atezolizumab|Drug: Carboplatin|Drug: Cisplatin|Drug: Pemetrexed
Drug: Placebo capsules|Drug: Bardoxolone methyl capsules
Drug: Irlanda-2-Association|Drug: Placebo
Drug: Irlanda-1-Association|Drug: Placebo
Drug: Iobenguane I -123 Injection|Device: Implantable Cardioverter Defibrillator|Drug: Thyroid blocking
Drug: Ropivacaine|Drug: Clonidine|Drug: Sodium Chloride
Drug: Niraparib|Drug: Placebo
Drug: OSE2101|Drug: Docetaxel|Drug: Pemetrexed
Drug: Melatonin
Drug: Elagolix|Drug: Placebo|Drug: Elagolix + Estradiol/Norethindrone Acetate
Drug: E/C/F/TAF|Drug: E/C/F/TDF|Drug: ATV|Drug: RTV|Drug: FTC/TDF|Drug: B/F/TAF
Drug: Inhaled Nitric Oxide
Drug: CM-AT
Drug: Rituximab|Drug: Dexamethasone|Drug: Mycophenolate mofetil|Drug: Placebo
Drug: smoked plum|Drug: gum chewing
Drug: CF101 1 mg|Drug: CF101 2 mg|Drug: Placebo|Drug: MTX
Drug: Acetylsalicylic acid|Drug: Placebo
Drug: Transarterial chemoembolization (TACE)|Procedure: Radiofrequency ablation combined with TACE|Procedure: Microwave ablation combined with TACE
Drug: 12 weeks without Ribavirin|Drug: 12 weeks with Ribavirin|Drug: 24 weeks with Ribavirin
Drug: Megestrol(Yining)|Radiation: radiotherapy|Other: chemotherapy
Drug: Day 1: Cisplatin 75 mg/m2|Drug: Day 1: Vinorelbine 25 mg/m2|Drug: Day 8: Capsule vinorelbine 50 mg/m2|Drug: Day 1: Carboplatin AUC=5|Drug: Day 1: Vinorelbine 30 mg/m2|Drug: Day 8: Capsule vinorelbine 60 mg/m2|Dietary Supplement: Tocotrienol 300 mg x 3 daily until progression|Drug: Placebo 1 capsule x 3 daily until progression
Drug: SPI-2012|Drug: Pegfilgrastim
Drug: Methocarbamol|Drug: Calcium Carbonate
Drug: Cyclobenzaprine|Drug: Calcium Carbonate
Drug: Gabapentin|Drug: Calcium Carbonate
Drug: Inosine|Drug: Placebo
Drug: Ranibizumab
Drug: 18F-choline PET-MR imaging
Drug: Etoposide|Drug: actinomycin D|Drug: methotrexate|Drug: vincristine|Drug: cyclophosphamide|Drug: Paclitaxel|Drug: Cisplatin|Drug: Carboplatin
Drug: NewGam
Drug: TEV-48125 - 1|Drug: TEV-48125 - 2|Drug: Placebo
Drug: Bimatoprost SR|Drug: Sham Bimatoprost SR|Procedure: Selective Laser Trabeculoplasty|Procedure: Sham Selective Laser Trabeculoplasty
Drug: Desmopressin|Drug: Placebo
Drug: Peramivir
Drug: Unique Pharmaceutical Laboratories, India|Drug: Roxane Laboratories Inc., USA
Drug: Exenatide once weekly (EQW )|Drug: Dapagliflozin (DAPA)|Drug: EQW plus DAPA|Drug: Dapagliflozin plus Glucophage (MET ER)|Drug: Phentermine /Topiramate (PHEN/ TRP) ER
Drug: Fumaric Acid Esters|Drug: Methotrexate|Drug: Ixekizumab
Drug: ALKS 8700
Drug: Paritaprevir/ritonavir/ombitasvir|Drug: Dasabuvir|Drug: Ribavirin|Drug: Glecaprevir/pibrentasvir
Drug: Mifepristone|Drug: Placebo|Drug: Misoprostol 200mcg
Drug: Cisplatin|Drug: Etoposide|Radiation: radiotherapy
Drug: Erlotinib|Drug: Bevacizumab
Drug: Cetuximab|Drug: Cisplatin|Drug: Docetaxel|Drug: Capecitabine|Radiation: Radiotherapy
Drug: IMGN853|Drug: Paclitaxel|Drug: Doxorubicin|Drug: Topotecan
Drug: Lévétiracetam|Drug: Placebo
Drug: Methotrexate|Drug: Etoposide|Drug: Dexamethasone|Drug: Pegaspargase|Radiation: Radiotherapy
Drug: Pegaspargase|Drug: doxorubicin|Drug: etoposide|Drug: methylprednisolone
Drug: Luspatercept|Other: Placebo
Drug: ß-elemene
Drug: NACT (Paclitaxel + Cisplatin or carboplatin)|Procedure: radical surgery
Drug: Placebo for Adalimumab|Drug: ABT-494|Drug: Adalimumab|Drug: Placebo for ABT-494
Drug: photosensitizer(photofrin)|Device: 630 nm laser irradiation (DIOMED)
Drug: Colesevelam|Drug: Clonidine|Other: Placebo
Drug: Vinorelbine plus Epirubicin|Drug: Paclitaxel plus Carboplatin
Drug: Liposomal Amikacin for Inhalation
Drug: tivozanib hydrochloride|Drug: Sorafenib
Drug: ponatinib 30 mg QD|Drug: ponatinib 15 mg QD|Drug: nilotinib 400 mg BID
Drug: Dapsone (Disulone®)|Drug: Prednisone (Cortancyl®) alone followed by monitoring and "standard of care"|Drug: Prednisone (Cortancyl®)
Drug: Octanorm 16.5%
Drug: Copanlisib (BAY 80-6946)|Drug: Placebo|Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Bendamustine|Drug: Prednisone
Drug: Docosahexaenoic acid - 800mg/day|Drug: Docosahexaenoic acid - 200mg/day|Other: Placebo
Drug: Nifurtimox (BAYA2502)|Drug: Nifurtimox (BAYA2502) followed by Placebo
Drug: SOF/VEL for 6 weeks|Drug: SOF/VEL for 12 weeks
Drug: Avelumab|Drug: Irinotecan|Drug: Paclitaxel|Other: Best Supportive Care (BSC)
Drug: Avelumab|Drug: Oxaliplatin|Drug: 5-Fluorouracil|Drug: Leucovorin|Drug: Capecitabine|Other: Best supportive care
Drug: Pertuzumab|Drug: Trastuzumab
Drug: Digoxin (monotherapy)|Drug: Sotalol (monotherapy)|Drug: Flecainide (monotherapy)|Drug: Digoxin (dual therapy)|Drug: Sotalol (dual therapy)|Drug: Flecainide (dual therapy)
Drug: insulin glargine|Drug: sitagliptin/metformin|Behavioral: lifestyle therapy
Drug: Dexamethasone intravitreal implant 0.7 mg|Drug: Intravitreal Methotrexate 400 µg|Drug: Intravitreal Ranibizumab 0.5 mg
Drug: Zoledronic acid
Drug: Emicizumab|Drug: rFVIIa|Drug: aPCC
Drug: Cisplatin 1|Drug: Cisplatin 2|Drug: Docetaxel|Drug: Xeloda|Radiation: Intensity-modulated radiotherapy
Drug: Nitazoxanide|Drug: Levofloxacin|Drug: Doxycyclin|Drug: Omeprazole
Drug: Late Cabergoline 0.5mg|Drug: Early Cabergoline 0.5mg
Drug: Fimsartan 60mg~120mg|Drug: Losartan 50mg~100mg
Drug: Carboplatin|Drug: Abraxane|Drug: MPDL3280A|Procedure: Surgery|Drug: Anthra
Drug: Vedolizumab SC
Drug: ornidazole|Drug: Placebo
Drug: Edoxaban|Drug: ASA
Drug: SPN-810|Drug: Placebo
Drug: Nivolumab|Drug: Temozolomide|Radiation: Radiotherapy
Drug: Buspirone|Drug: Placebo
Drug: Dichloroacetate (DCA)|Other: Placebo|Genetic: Genotype
Drug: E/C/F/TAF
Drug: Accordion Pill Carbidopa/Levodopa
Drug: MITOMYCIN-C 40 mg
Drug: Fesoterodine
Drug: metformin|Drug: control
Drug: LDV/SOF
Drug: Nivolumab|Drug: Docetaxel
Drug: Dupilumab
Drug: Vedolizumab IV 300 mg|Drug: Placebo IV|Drug: Vedolizumab SC 108 mg|Drug: Placebo SC
Drug: Vedolizumab SC 108 mg|Drug: Placebo|Drug: Vedolizumab IV 300 mg
Drug: Nimotuzumab|Drug: Paclitaxel|Drug: Cisplatin|Drug: Placebo
Drug: Nilotinib|Drug: Methotrexate|Drug: Aracytine (Ara C)|Drug: Granulocyte Colony-Stimulating Factor (G-CSF)|Drug: Depomedrol|Drug: Dexamethasone|Drug: Vincristine|Drug: Imatinib|Drug: 6 Mercaptopurine (6MP)
Drug: QPI-1002|Other: Placebo
Drug: Cisplatin|Radiation: Intensity-modulated radiotherapy
Drug: Tanezumab
Drug: CB-03-01 cream, 1%|Drug: Vehicle cream
Drug: DTG|Drug: F/TAF|Drug: B/F/TAF|Drug: DTG Placebo|Drug: F/TAF Placebo|Drug: B/F/TAF Placebo
Drug: Insulin Glargine|Drug: Regular Insulin
Drug: ABC/DTG/3TC|Drug: B/F/TAF|Drug: ABC/DTG/3TC Placebo|Drug: B/F/TAF Placebo
Drug: cisplatin and pemetrexed|Drug: nadaplatin+pemetrexed
Drug: FS-1|Drug: Placebo
Drug: Acetylsalicylic acid (ASA)/aspirin 200 mg daily|Drug: Acetylsalicylic acid (ASA)/aspirin 100 mg daily|Drug: Placebo
Drug: recombinant von Willebrand factor|Drug: tranexamic acid
Drug: OBS|Drug: Placebo
Drug: Accordion Pill Carbidopa/Levodopa|Drug: Sinemet®|Drug: Placebo -AP-CD/LD|Drug: Placebo- Sinemet
Drug: Capecitabine(Aibin)|Drug: Oxaliplatin(Aiheng)|Radiation: Radiotherapy
Drug: FDC Bromopride 10 mg and Simethicone 80 mg|Drug: Bromopride 10 mg
Drug: Tapentadol|Drug: Oxycodone|Drug: Placebo|Drug: usual pain treatment
Drug: SC411|Drug: Placebo
Drug: Alectinib|Drug: Docetaxel|Drug: Pemetrexed
Drug: Alteplase
Drug: Methoxyflurane|Drug: Placebo
Drug: Capecitabine(Aibin)|Radiation: radiotherapy
Drug: RTV|Drug: ATV|Drug: DRV|Drug: COBI|Drug: ATV/co|Drug: DRV/co|Drug: FTC/TDF|Drug: ABC/3TC|Drug: B/F/TAF
Drug: Hydrocortisone|Drug: NaCL 0.9%
Drug: Naridrin|Drug: Afrin
Drug: Palbociclib|Drug: Letrozole
Drug: Grazoprevir/Elbasvir 100mg/50mg
Drug: Tenofovir disoproxil fumarate
Drug: Nivolumab|Drug: Ipilimumab
Drug: Imetelstat|Drug: Placebo
Drug: Pre-operative SN mapping with Nanocis|Drug: Intra-operative SN mapping with patent V blue dye|Drug: Intra-operative SN mapping with indocyanin green|Procedure: Full bilateral laparoscopic lymphadenectomy and Hysterectomy|Procedure: Current initial staging protocols
Drug: SPARC1507|Drug: Reference1507
Drug: Irbesartan|Drug: Placebo
Drug: Ledipasvir/Sofosbuvir
Drug: dolutegravir 50mg +abacavir 600mg +lamivudine 300mg|Drug: dolutegravir
Drug: Cardiovascular Polypill|Drug: Treatment Prevention for Secondary CV
Drug: Oraxol|Drug: IV paclitaxel
Drug: nusinersen
Drug: Metformin|Drug: Matching Placebo
Drug: Clonidine hydrochloride|Other: Single bolus of physiologic sodium chloride serum administered IV after induction and obtaining a stable anaesthetic level
Drug: glutamate infusion|Drug: saline infusion
Drug: CP-690,550 (tofacitinib)|Other: placebo
Drug: Glucose-Insulin-Potassium|Drug: Glucose 5%
Drug: Morphine|Drug: Ketamine|Drug: Placebo|Drug: Chitosan
Drug: Bromocriptine|Other: Guideline-driven medical therapy (GDMT)
Drug: Vancomycin|Drug: Moxifloxacin|Drug: Placebo
Drug: Sulfatinib|Other: Placebo
Drug: Antiretroviral Therapy (Experimental)
Drug: Peppermint Oil|Other: Placebo
Drug: Metoprolol succinate|Other: Placebo
Drug: Teriflunomide
Drug: RVX000222|Drug: Placebo (for RVX000222)|Drug: atorvastatin|Drug: rosuvastatin
Drug: YH14755|Drug: Metformin|Drug: Rosuvastatin
Drug: FEC Chemotherapy|Procedure: Surgery|Drug: Docetaxel|Drug: Pertuzumab|Drug: Placebo|Drug: Trastuzumab
Drug: Apixaban|Drug: Dalteparin|Other: Questionnaire Administration
Drug: Hydroxyethyl starch 130/0.4 in an isotonic electrolyte solution|Drug: Hydroxyethyl starch 130/0.4 in 0.9% sodium chloride
Drug: ivabradine|Drug: lactose capsule (placebo)
Drug: Meaning-Making intervention (MMi)|Behavioral: Empathic Visitor
Drug: Rivaroxaban|Drug: low-molecular heparine
Drug: Acetaminophen+Caffeine+Dihydroergotamine+Metoclopramide.|Drug: Acetaminophen
Drug: Lacosamide
Drug: Bleomycin (active name: Bleomycin Sulfate)|Drug: Etoposide|Drug: Cisplatin|Drug: Pegylated G-CSF (Pegfilgrastim)|Drug: Filgrastim
Drug: Acetaminophen, Analgesics, Non-Narcotic|Drug: Hyoscine butylbromide, Analgesics, Non-Narcotic
Drug: Ketoconazole + betamethasone dipropionate|Drug: Clotrimazole + Dexamethasone acetate
Drug: Rifampicin 1200mg|Drug: Rifampicin 1800mg|Drug: 4FDC
Drug: OnabotulinumtoxinA
Drug: Prophylactic anticoagulation ( INNOHEP®)|Drug: Curative anticoagulation ( INNOHEP®)
Drug: lenalidomide|Drug: dexamethasone|Biological: pembrolizumab
Drug: PXT3003 dose 1|Drug: PXT3003 dose 2|Drug: placebo
Drug: Gemcitabine|Drug: Vinorelbine|Drug: Paclitaxel|Drug: Pemetrexed|Drug: Oncorine|Drug: Endostar|Drug: Cisplatin
Drug: Smoflipid 20% (investigational lipid for parenteral nutrition)|Drug: Intralipid® 20%
Drug: cephalosporins|Drug: aminoglycoside|Drug: metronidazole|Drug: Clindamycin|Drug: aminoglycoside/ sulbactam|Drug: Fluoroquinolones
Drug: 5-Fluorouracil|Drug: Leucovorin|Drug: Oxaliplatin|Drug: Docetaxel|Drug: Trastuzumab|Drug: sodium folinate|Procedure: Surgery
Drug: AG-221|Other: BSC|Drug: Azacitidine|Drug: Low-dose cytarabine (LDAC)|Drug: Intermediate-dose cytarabine (IDAC)
Drug: RPC1063
Drug: Avelumab|Drug: Pemetrexed|Drug: Paclitaxel|Drug: Gemcitabine|Drug: Carboplatin|Drug: Cisplatin
Drug: Nivolumab|Drug: Sorafenib
Drug: Imatinib|Other: Surveillance
Drug: Low dose methotrexate|Drug: Placebo
Drug: Clarithromycin|Drug: Lenalidomide|Drug: Dexamethasone
Drug: Sacituzumab govitecan|Drug: Eribulin|Drug: Capecitabine|Drug: Gemcitabine|Drug: Vinorelbine
Drug: Insulin
Drug: Temozolomide|Drug: ABT-414|Radiation: Radiation|Drug: Placebo for ABT-414
Drug: Perioperative chemotherapy with mFOLFOX6 or CAPOX regimens|Drug: Postoperative chemotherapy with mFOLFOX6 or CAPOX regimens
Drug: QVM149|Drug: QMF149|Drug: salmeterol/fluticasone
Drug: DFN-11|Other: Placebo
Drug: Nivolumab|Drug: Docetaxel/Paclitaxel
Drug: Cyclophosphamide|Biological: Dactinomycin|Drug: Irinotecan Hydrochloride|Other: Laboratory Biomarker Analysis|Other: Questionnaire Administration|Radiation: Radiation Therapy|Drug: Temsirolimus|Drug: Vincristine Sulfate
Drug: Denosumab subcutaneous injections|Drug: Placebo subcutaneous injections
Drug: Lurbinectedin (PM01183)|Drug: Doxorubicin (DOX)|Drug: Cyclophosphamide (CTX)|Drug: Vincristine (VCR)|Drug: Topotecan
Drug: tofacitinib
Drug: VX-661/ivacaftor|Drug: ivacaftor
Drug: lasmiditan 100 mg|Drug: lasmiditan 200 mg
Drug: Apaziquone|Other: Placebo
Drug: Rifapentine|Drug: Moxifloxacin|Drug: Rifampin|Drug: Isoniazid|Drug: Pyrazinamide|Drug: Ethambutol|Dietary Supplement: Pyridoxine
Drug: Esmolol|Drug: Dexmedetomidine
Drug: mFOLFOX6|Drug: FOLFIRI|Biological: pembrolizumab|Biological: bevacizumab|Biological: cetuximab
Drug: Oxygen|Other: Air
Drug: rigosertib|Drug: Any approved or standard-of-care therapy|Drug: best supportive care (BSC)
Drug: Riociguat (Adempas, BAY63-2521)
Drug: amifampridine phosphate|Drug: Placebo
Drug: Fluoxetine|Drug: Combined oral contraceptives|Drug: Placebo 1|Drug: Placebo 2
Drug: DHEA|Drug: Placebo
Drug: Hydroxyurea (Moderate Dose)|Drug: Hydroxyurea (Low Dose)
Drug: ALD403|Drug: Placebo
Drug: Dexmedetomidine sedation|Drug: General sevoflurane anaesthesia|Procedure: Caudal anaesthesia|Procedure: Inguinal hernia surgery
Drug: prednisone discontinuation
Drug: Bexagliflozin|Drug: Placebo
Drug: Macitentan|Drug: Tadalafil|Drug: Selexipag
Drug: Urapidil|Drug: Nicardipine
Drug: Methadone|Other: Normal Saline|Drug: Morphine
Drug: Standard triple therapy|Drug: Bismuth quadruple therapy
Drug: IL2|Drug: placebo
Drug: Ketamine|Drug: Midazolam
Drug: Dexamethasone|Drug: Triamcinolone
Drug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Acetylsalicylic acid|Drug: Clopidogrel
Drug: BOTOX ® 200 Unités|Drug: Placebo
Drug: docetaxel,0xaliplatin,capecitabine|Drug: oxaliplatin,capecitabine
Drug: dimethyl fumarate
Drug: Xarelto
Drug: QMF149|Drug: MF 400|Drug: salmeterol /fluticasone
Drug: Amoxicillin-clavulanate|Drug: Placebo
Drug: Lumason
Drug: colchicine|Drug: colchicine placebo
Drug: donepezil
Drug: ABT-SLV187
Drug: P-3058 10%|Drug: vehicle of P-3058 10%|Drug: amorolfine 5%
Drug: Calcifediol|Drug: Placebo
Drug: Obeticholic Acid|Drug: Placebo
Drug: oxaliplatin and gemcitabine|Drug: capecitabine
Drug: ALZT-OP1a|Drug: ALZT-OP1b|Other: Placebo ALZT-OP1a|Other: Placebo ALZT-OP1b
Drug: Rosuvastatin|Drug: Placebo
Drug: Andecaliximab|Drug: Placebo|Drug: Leucovorin|Drug: 5-fluorouracil|Drug: Oxaliplatin
Drug: Cytarabine|Drug: Idasanutlin|Other: Placebo
Drug: Ipilimumab|Drug: Dacarbazine
Drug: Finerenone (BAY94-8862)|Drug: Placebo
Drug: Digoxin|Drug: Placebo
Drug: GWP42003-P|Drug: Placebo
Drug: Ivacaftor|Drug: Lumacaftor
Drug: Lenalidomide|Drug: Dexamethasone|Other: No further treatment
Drug: APL-130277
Drug: Ferric carboxymaltose|Drug: Ferrous sulfate + folic acid
Drug: Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD)|Drug: Bortezomib, Thalidomide, Dexamethasone (VTD) + daratumumab|Drug: Daratumumab
Drug: metadoxine|Other: placebo
Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
Drug: Additional oral preparation (3L of PEG+Asc, "Coolprep®")|Drug: Standard oral preparation (2L of PEG+Asc, "Coolprep®")
Drug: Gemcitabine|Drug: Folinic Acid|Drug: 5-Fluoro-uracil|Drug: Oxaliplatin|Drug: Irinotecan|Drug: L-folinic
Drug: eliglustat GZ385660
Drug: Melatonin|Drug: Sugar pill
Drug: Idelalisib
Drug: Sitagliptin|Drug: Placebo
Drug: sunitinib or pazopanib|Procedure: Cytoreductive nephrectomy
Drug: Goserelin+TAM+AI|Drug: Epirubicin+CTX+5-Fu
Drug: YKP3089
Drug: Omegaven
Drug: Neoadjuvant endocrine therapy|Drug: Neoadjuvant chemotherapy
Drug: Azithromycin
Drug: Arm A (Fortecortin®-ETOPOPHOS®-IFO-cell®-CARBO-cell®)|Drug: Arm B (TEPADINA®-CARMUBRIS®-Busilvex®)
Drug: Apalutamide|Drug: Bicalutamide|Drug: Bicalutamide Placebo|Drug: Apalutamide Placebo|Drug: GnRH (agonist)|Radiation: 74-80 Grays (units of radiation)
Drug: NSAID|Biological: Tanezumab 2.5 mg|Biological: Tanezumab 5 mg
Drug: DFD01 Spray
Drug: Paclitaxel|Drug: Capecitabine|Drug: Mitomycins|Radiation: Radiotherapy
Drug: dalcetrapib|Drug: Placebo
Drug: Alicaforsen|Drug: Placebo
Drug: UVADEX® (methoxsalen) Sterile Solution in Conjunction with the THERAKOS® CELLEX® Photopheresis System
Drug: Mesalamine|Drug: Placebo
Drug: Warfarin|Drug: tecarfarin
Drug: Nicotine patch|Device: e-cigarette|Drug: Nicotine|Behavioral: Behavioural support
Drug: Asparaginase|Drug: Asparaginase Erwinia chrysanthemi|Drug: Cytarabine|Drug: Daunorubicin Hydrochloride|Drug: Etoposide|Other: Laboratory Biomarker Analysis|Drug: Mitoxantrone Hydrochloride|Drug: Thioguanine
Drug: Lower Dose Sodium Bicarbonate|Drug: Higher Dose Sodium Bicarbonate|Drug: Placebo
Drug: Silver Nitrate|Drug: Kenalog (Triamcinolone)|Other: Washcloth Abrasion
Drug: Placebo|Drug: Metformin
Drug: Tamsulosin|Drug: Placebo
Drug: Gefitinib|Drug: Pemetrexed
Drug: Vaginal progesterone|Drug: Placebo|Device: Arabin Pessary
Drug: GnRHa
Drug: Dexamethasone Phosphate Ophthalmic Solution|Drug: Prednisolone Acetate Ophthalmic (1%)
Drug: Hydrocortisone|Drug: Placebo
Drug: ixazomib|Drug: lenalidomide|Drug: dexamethasone|Drug: zoledronic acid
Drug: MEDI4736 (Durvalumab)|Drug: Tremelimumab|Drug: Cisplatin|Drug: Carboplatin|Drug: Gemcitabine
Drug: 18F-AV-1451
Drug: Trastuzumab|Drug: Pertuzumab|Drug: Docetaxel|Drug: Paclitaxel|Drug: Nab-paclitaxel|Drug: Vinorelbine|Drug: Eribulin|Drug: Capecitabine|Drug: Gemcitabine
Drug: Neoadjuvant chemotherapy Folfirinox, 4 cycles|Radiation: 50 Gy, 2 Gy/session; 25 fractions|Procedure: Local excision in good responders|Procedure: Rectal excision in bad responders|Drug: Capecitabine
Drug: Palbociclib|Drug: Standard Adjuvant Endocrine Therapy
Drug: Docetaxel;oxaliplatin;s1|Drug: oxaliplatin;s1
Drug: Docetaxel (DOC)|Drug: Cisplatin (DDP)|Radiation: Concurrent chemoradiation (CRT)
Drug: Everolimus|Drug: Aromatase Inhibitors
Drug: VB-111 + bevacizumab|Drug: Bevacizumab
Drug: AZD9291 80 mg/40 mg|Drug: Placebo AZD9291 80 mg/40 mg
Drug: NTRA-2112|Drug: Placebo
Drug: Patisiran (ALN-TTR02)
Drug: 5-Fluorouracil|Drug: Leucovorin|Drug: Oxaliplatin|Drug: Docetaxel|Drug: Carboplatin|Drug: Paclitaxel|Radiation: Neoadjuvant radiation
Drug: Clonidine|Drug: Midazolam
Drug: cisastracurium besylate
Drug: Bimatoprost SR|Other: Sham Bimatoprost SR|Procedure: Selective Laser Trabeculoplasty|Other: Sham Selective Laser Trabeculoplasty
Drug: Darbepoetin alfa
Drug: nab-paclitaxel|Drug: gemcitabine|Drug: oxaliplatin|Drug: folinic acid|Drug: fluorouracil
Drug: Delayed-Release Prednisone|Drug: Placebo
Drug: Nadolol|Drug: Propranolol
Drug: Infliximab
Drug: Docetaxel + Plinabulin (DP)|Drug: Docetaxel (D)
Drug: Abatacept|Drug: Methotrexate|Other: Abatacept Placebo|Other: Methotrexate Placebo
Drug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Rivaroxaban-Placebo
Drug: AXS-02 (oral zoledronate)|Drug: Placebo
Drug: Hydroxethyl starch
Drug: observation alone|Drug: LV5FU2|Drug: FOLFOX
Drug: opium|Drug: methadone
Drug: Cisplatin|Drug: Carboplatin|Drug: Paclitaxel|Radiation: Radiation Therapy
Drug: Fesoterodine PR 4 mg|Drug: Fesoterodine PR 8 mg|Drug: Fesoterodine BIC 2 mg|Drug: Fesoterodine BIC 4 mg
Drug: insulin degludec/liraglutide|Drug: insulin glargine
Drug: Cisplatin|Drug: Fluorouracil|Radiation: Radiation therapy|Drug: Leucovorin
Drug: SRP-4045|Drug: SRP-4053|Drug: Placebo
Drug: TAS-102|Drug: Placebo
Drug: Vedolizumab|Drug: Adalimumab placebo|Drug: Adalimumab|Drug: Vedolizumab placebo
Drug: elotuzumab|Drug: Lenalidomide|Drug: Bortezomib|Drug: Dexamethasone
Drug: Symbicort|Drug: Generic Budesonide/Formoterol fumarate dihydrate|Drug: Placebo
Drug: Mycophenolate Mofetil|Drug: placebo
Drug: Imipenem|Drug: Relebactam|Drug: Cilastatin|Drug: Piperacillin|Drug: Tazobactam|Drug: Linezolid
Drug: Budesonide 0.5mg orodispersible tablet twice daily|Drug: Budesonide 1mg orodispersible tablet twice daily|Drug: Placebo orodispersible tablet twice daily
Drug: Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg|Drug: Olmesartan medoxomil 20mg + Chlortalidone 25mg|Drug: Olmesartan 20mg + hydrochlorothiazide 12,5mg
Drug: Ferric Citrate
Drug: Eplerenone|Drug: Placebo
Drug: 2% chlorhexidine gluconate cloths
Drug: DWJ1319|Drug: Placebo
Drug: Apalutamide|Drug: Placebo|Drug: Androgen Deprivation Therapy (ADT)
Drug: Carboplatin|Drug: Cyclophosphamide|Drug: Doxorubicin Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel
Drug: Combined oral contraceptives|Drug: Fluoxetine|Drug: Combined oral contraceptives placebo|Drug: Fluoxetine placebo|Procedure: Daily record of severity of problems
Drug: Prophylactic treatment with Wilfactin
Drug: Onartuzumab|Drug: Bevacizumab|Drug: Erlotinib
Drug: Atezolizumab|Drug: Cisplatin|Drug: Vinorelbine|Drug: Docetaxel|Drug: Gemcitabine|Drug: Pemetrexed
Drug: Rivaroxaban
Drug: Prezista|Drug: Norvir|Drug: Tivicay|Drug: Truvada|Drug: Kivexa
Drug: spinosad topical suspension, 0.9%|Other: Placebo
Drug: Cetuximab|Drug: FOLFIRI
Drug: Aducanumab (BIIB037)|Drug: Placebo
Drug: Ketotifen|Drug: Placebo
Drug: ESL 800 mg|Drug: ESL 1200 mg|Drug: ESL 1600 mg|Drug: ESL 400 mg
Drug: Olmesartan medoxomil 40mg + chlorthalidone 12,5mg|Drug: Olmesartan medoxomil 40mg + chlorthalidone 25mg|Drug: Olmesartan 40mg + Hydrochlorothiazide 12,5mg|Drug: Olmesartan 40mg + Hydrochlorothiazide 25mg
Drug: Chidamide|Drug: exemestane|Drug: placebo
Drug: Nivolumab|Drug: Topotecan|Drug: Amrubicin
Drug: Remifentanil and/or propofol|Drug: propofol
Drug: Subjects do not receive study medication in this study 202094
Drug: Lacosamide|Other: Placebo
Drug: Nivolumab|Drug: Ipilimumab|Drug: Carboplatin|Drug: Cisplatin|Drug: Gemcitabine|Drug: Pemetrexed|Drug: Paclitaxel
Drug: ACP-196|Drug: ibrutinib
Drug: Olaparib|Drug: Placebo
Drug: Spiromax Budesonide/formoterol|Drug: Diskus Fluticasone/salmeterol
Drug: tocilizumab|Drug: saline solution
Drug: Paracetamol|Drug: Ibuprofen|Drug: paracetamol + ibuprofen|Drug: Placebo
Drug: Sodium Bicarbonate
Drug: ALIROCUMAB SAR236553 (REGN727)|Drug: placebo (for injection training only)
Drug: Acalabrutinib|Drug: Obinutuzumab|Drug: Chlorambucil
Drug: BB3|Other: Placebo
Drug: Bovine Colostrum|Drug: Placebo
Drug: Ceftriaxone|Drug: Piperacillin tazobactam|Drug: Norepinephrine|Drug: Hydrocortisone
Drug: Veliparib|Drug: Paclitaxel|Drug: Carboplatin|Other: Placebo
Drug: Merional|Procedure: IUI|Drug: Choriomon|Device: shepherd catheter|Procedure: Ovulation detection
Drug: AB103 0.5 mg/kg|Other: NaCl 0.9%
Drug: Merional|Drug: Choriomon|Procedure: IUI|Procedure: Ovulation detection|Device: Shepherd catheter
Drug: NSAIDs|Drug: anti-TNF
Drug: F/TAF|Drug: ABC/3TC|Drug: ABC/3TC Placebo|Drug: F/TAF Placebo|Drug: Third ARV agent
Drug: LCZ696|Drug: Enalapril|Drug: Placebo to LCZ696|Drug: Placebo to Enalapril
Drug: metoclopramide intravenous
Drug: levomilnacipran|Drug: Placebo
Drug: SPD489
Drug: Clonidine (Catapresan®) 0,150 mg/ml, ampoule 1 ml
Drug: Docetaxel|Drug: Cisplatin|Radiation: Radiation|Procedure: Surgery|Drug: Vinorelbine
Drug: BGF MDI 320/14.4/9.6 µg|Drug: GFF MDI 14.4/9.6 µg|Drug: BGF MDI 160/14.4/9.6 µg|Drug: BFF MDI 320/9.6 µg
Drug: In111-Pentetréotide|Other: simple monitoring without active therapy
Drug: abicipar pegol|Drug: ranibizumab|Other: sham procedure
Drug: HAM|Drug: LDAC and/or Mitoxantrone
Drug: Single red blood packed cells Transfusion|Drug: Two packed red blood cells Transfusion
Drug: Merional|Procedure: IUI|Procedure: Ovulation detection|Drug: Choriomon|Device: shepherd catheter
Drug: paclitaxel; cisplatin|Radiation: radiation
Drug: Varenicline|Behavioral: Positively Smoke Free|Drug: Placebo|Behavioral: Standard of Care
Drug: Cyclophosphamide|Drug: Placebo|Drug: Corticosteroid (prednisolone)
Drug: capecitabine|Other: Best supportive care (BSC)
Drug: Fotemustine|Drug: Fotemustine and Ipilimumab|Drug: Ipilimumab and nivolumab
Drug: Paclitaxel and Cisplatin|Drug: Paclitaxel and Fluorouracil|Drug: Paclitaxel and Carboplatin|Radiation: Radiotherapy
Drug: Tacrolimus capsules|Drug: Cyclophosphamide injections|Drug: Prednisone
Drug: Intravenous magnesium sulfate|Drug: Inhaled budesonide|Drug: normal saline
Drug: Carboplatin|Drug: Vincristine
Drug: Simeprivir (SMV)|Drug: Sofosbuvir (SOF)|Drug: Ribavirin (RBV)
Drug: Epirubicin plus Cyclophosphamide|Drug: Taxanes|Drug: Taxanes plus Carboplatin
Drug: AZD9291|Drug: MEDI4736
Drug: melatonin|Drug: placebo
Drug: Raltitrexed-based chemotherapy|Drug: 5-fluorouracil-based chemotherapy
Drug: Injectafer|Other: Normal Saline
Drug: Placebo|Drug: Tocilizumab
Drug: Leuprolide Acetate 45 mg
Drug: Olaratumab|Drug: Doxorubicin|Drug: Placebo
Drug: Placebo First, then ORADUR®|Drug: ORADUR® First, then Placebo
Drug: MPA|Drug: placebo
Drug: Nicorandil
Drug: Icotinib|Drug: Chemotherapy
Drug: SGX301 (synthetic hypericin)|Drug: Placebo
Drug: Ranibizumab|Drug: Triamcinolone Acetonide
Drug: Hydralazine/Magnesium|Drug: Placebo|Drug: Carboplatin|Drug: Paclitaxel
Drug: Carboplatin|Drug: Cediranib Maleate|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Olaparib|Drug: Paclitaxel|Drug: Pegylated Liposomal Doxorubicin Hydrochloride|Other: Pharmacological Study|Other: Quality-of-Life Assessment
Drug: Enzalutamide|Drug: Conventional NSAA|Drug: LHRHA|Radiation: External Beam Radiotherapy (78 Gy in 39 fractions or 46 Gy in 23 fractions plus brachytherapy boost)
Drug: Enzalutamide|Drug: NSAA|Drug: LHRHA or Surgical Castration
Drug: AVP-786
Drug: Capecitabine|Drug: Carboplatin|Drug: Cisplatin|Other: Laboratory Biomarker Analysis|Procedure: Quality-of-Life Assessment|Other: Questionnaire Administration
Drug: Hydroxychloroquine|Drug: Cyclophosphamide|Drug: Azathioprine|Drug: Methylprednisolone
Drug: Corticosteroid boluses Methylprednisolone|Other: No therapeutic modification|Other: Stop maintenance corticotherapy
Drug: PCV chemotherapy alone|Drug: Radiotherapy+PCV chemotherapy
Drug: Cefotaxime|Drug: ceftriaxone
Drug: AVP-786|Drug: Placebo
Drug: G-CSF (Filgrastim injection)|Drug: steroid|Drug: placebo
Drug: taxane plus carboplatin|Drug: Taxane
Drug: LY2951742|Drug: Placebo
Drug: Fulvestrant|Drug: Alpelisib|Drug: Alpelisib placebo
Drug: Vilazodone
Drug: RPC1063|Drug: Placebo
Drug: Ramucirumab|Drug: Placebo
Drug: Docetaxel,Cisplatin,Fluorouracil|Radiation: Intensity-modulated radiation therapy (IMRT)|Drug: Cisplatin
Drug: rituximab|Drug: Placebo
Drug: Rivipansel
Drug: Vancomycin 1.1%|Drug: Placebo
Drug: UX003
Drug: Placebo|Drug: Levomilnacipran ER|Drug: Fluoxetine
Drug: Aripiprazole|Drug: Haloperidol|Drug: Olanzapine|Drug: Oral Paliperidone ER|Drug: Perphenazine|Drug: Quetiapine|Drug: Oral Risperidone|Drug: Paliperidone Palmitate Injection (PP1M)|Drug: Paliperidone Palmitate Injection (PP3M)
Drug: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC|Drug: DRV/COBI FDC|Drug: FTC/TDF FDC|Drug: D/C/F/TAF FDC - Matching Placebo|Drug: FTC/TDF FDC Matching Placebo|Drug: DRV/COBI FDC Matching Placebo
Drug: Weekly INH / RRT given by DOT
Drug: DTG 50 mg|Drug: RPV 25 mg|Drug: CAR
Drug: Paclitaxel|Drug: Carboplatin|Drug: Bleomycin|Drug: Etoposide|Drug: Cisplatin
Drug: Celecoxib|Other: Placebo
Drug: Ticagrelor|Drug: Clopidogrel|Procedure: Percutaneous Coronary Intervention (PCI)|Procedure: Coronary Angiography
Drug: Tramadol|Drug: Diclofenac|Drug: Placebo
Drug: Pegylated liposomal doxorubicin|Drug: Doxorubicin|Drug: Rituximab|Drug: Cyclophophamide|Drug: Vincristine|Drug: Prednisone
Drug: Dienogest|Drug: Fluoxetine|Drug: Placebo
Drug: Carglumic Acid
Drug: fentanyl transmucosal|Drug: Placebo
Drug: Ramucirumab|Drug: Docetaxel|Drug: Placebo
Drug: Azithromycin|Drug: Placebo
Drug: Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody|Drug: Nab-Paclitaxel|Drug: Placebo
Drug: Diclofenac|Drug: Tramadol|Drug: Placebo
Drug: ponesimod|Drug: teriflunomide
Drug: Vedolizumab
Drug: Ceftriaxone|Drug: Ofloxacine|Drug: Placebo of ofloxacine
Drug: Epidural analgesia|Other: Intraoperative Complication Management and Prevention|Procedure: Pain Therapy
Drug: Rituximab, bendamustine
Drug: orphenadrine|Drug: Placebo
Drug: Nitazoxanide|Drug: Metronidazole(MTZ)|Drug: Omeprazole|Drug: Clarithromycin|Drug: Levofloxacin|Drug: Doxicycline
Drug: Ribociclib|Drug: fulvestrant|Drug: Ribociclib placebo
Drug: gilteritinib|Drug: LoDAC (Low Dose Cytarabine)|Drug: Azacitidine|Drug: MEC (Mitoxantrone, Etoposide, Cytarabine)|Drug: FLAG-IDA (Granulocyte-Colony Stimulating Factor (G-CSF), Fludarabine, Cytarabine, Idarubicin)
Drug: Lurbinectedin (PM01183)|Drug: Pegylated liposomal doxorubicin (PLD)|Drug: Topotecan
Drug: Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody|Drug: Bevacizumab|Drug: Sunitinib
Drug: Saxagliptin|Drug: Dapagliflozin|Drug: Glimepiride|Other: Placebo
Drug: Testosterone|Drug: Colecalciferol|Drug: Placebo drink solution|Drug: Placebo transdermal gel
Drug: 0.2 mg/kg ketamine|Other: placebo
Drug: Testosterone gel|Drug: Placebo gel
Drug: vonapanitase|Drug: Placebo
Drug: Imatinib
Drug: Nitroglycerin
Drug: Carfilzomib|Drug: Dexamethasone
Drug: rexlemestrocel-L|Drug: rexlemestrocel-L + HA|Drug: Placebo
Drug: Ramucirumab|Drug: Placebo|Drug: Erlotinib|Drug: Gefitinib|Drug: Osimertinib
Drug: rifapentine|Drug: rifapentine and moxifloxacin|Drug: control
Drug: Carbetocin|Drug: Ergometrine
Drug: Ropivacaine|Drug: Morphine
Drug: Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody|Drug: Carboplatin|Drug: Cisplatin|Drug: Gemcitabine|Drug: Pemetrexed
Drug: Regimen A locally-used WHO-approved MDR-TB regimen|Drug: Moxifloxacin|Drug: Clofazimine|Drug: Ethambutol|Drug: Pyrazinamide|Drug: Isoniazid|Drug: Prothionamide|Drug: Kanamycin|Drug: Levofloxacin|Drug: Bedaquiline
Drug: Nimotuzumab|Radiation: radiotherapy|Drug: chemoradiotherapy Paclitaxel|Drug: chemoradiotherapy Cisplatin|Other: placebo
Drug: Lacosamide Tablet|Drug: Lasosamide Oral Solution
Drug: Lacosamide Tablet|Drug: Lasosamide Oral Solution|Other: Placebo Tablet|Other: Placebo Oral Solution
Drug: Saline|Drug: Ropivacaine
Drug: misoprostol/placebo
Drug: Placebo IV|Drug: Placebo SC|Drug: Ustekinumab IV|Drug: Ustekinumab SC
Drug: 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin|Drug: Placebo, Omeprazole or Rabeprazole, Clarithromycin
Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone|Drug: Fludarabine
Drug: Exenatide|Other: Remote Ischemic Conditioning (RIC)|Drug: Placebo
Drug: Clopidogrel|Drug: Placebo
Drug: Everolimus|Drug: Exemestane|Drug: Fulvestrant
Drug: MK-1439A|Drug: ATRIPLA|Drug: Placebo
Drug: ABIRATERONE - Group 1|Drug: ABIRATERONE - Group 2
Drug: etrolizumab
Drug: FUDR +oxaliplatin|Drug: oxaliplatin+Leucovorin+5-FU
Drug: Docetaxel|Drug: pertuzumab [Perjeta]|Drug: trastuzumab [Herceptin]
Drug: Dexamethasone 0.2 mg/kg|Drug: Dexamethasone 0.4 mg/kg|Drug: Ketoprofen 1 mg/kg
Drug: nutrison|Radiation: radiotherapy|Drug: Docetaxel, cisplatin
Drug: Tenecteplase|Drug: Antiplatelet treatment
Drug: MK-1439A|Drug: Baseline regimen of ritonavir- or cobicistat-boosted protease inhibitor|Drug: Baseline regimen of cobicistat-boosted elvitegravir|Drug: Baseline regimen of a non-nucleoside reverse transcriptase inhibitor|Drug: Baseline regimen of two nucleoside reverse transcriptase inhibitors
Drug: Injectafer|Other: Placebo
Drug: Fidaxomicin
Drug: cisplatin and paclitaxel
Drug: Avelumab|Drug: Docetaxel
Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab|Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, bevacizumab
Drug: Imiquimod|Radiation: Radiotherapy
Drug: Etrolizumab|Drug: Placebo
Drug: Blinatumomab|Drug: Conventional Consolidation Chemotherapy
Drug: Cyclophosphamide|Drug: Doxorubicin hydrochloride|Drug: Epirubicin hydrochloride|Drug: Fluorouracil|Drug: Methotrexate|Procedure: Adjuvant therapy|Drug: Docetaxel|Drug: Paclitaxel
Drug: Evolocumab|Drug: Placebo
Drug: Famitinib|Drug: Placebo
Drug: R2-MANT|Drug: R-MANT
Drug: Vitamin C|Drug: Placebo
Drug: Latanoprost|Drug: Bimatoprost|Drug: Travoprost|Drug: Timolol|Drug: Dorzolamide|Drug: Brinzolamide|Drug: Acetazolamide|Drug: Methazolamide
Drug: SDD Paste|Drug: SDD Suspension|Drug: Intravenous Antibiotic
Drug: Compound danshen dripping pills|Drug: Placebo
Drug: Ipilimumab|Drug: Nivolumab|Other: Placebo matching Ipilimumab|Other: Placebo matching Nivolumab
Drug: Vonoprazan|Drug: Lansoprazole|Drug: Vonoprazan Placebo|Drug: Lansoprazole Placebo
Drug: Rivaroxaban|Drug: Acetylsalicylic acid
Drug: Imiquimod|Drug: paracetamol|Drug: lidocaine in Vaseline ointment
Drug: Cetuximab|Drug: Cisplatin/Carboplatin|Drug: 5-fluorouracil
Drug: Mycophenolate Mofetil Placebo|Drug: Mycophenolate Mofetil|Drug: Rituximab|Drug: Rituximab Placebo
Drug: Peginterferon-a-2a
Drug: Enoxaparin|Drug: Placebo
Drug: sitagliptin OR saxagliptin|Drug: placebo
Drug: bosentan|Drug: placebo
Drug: Erythropoietin|Other: placebo
Drug: Etanercept + Oral Methotrexate|Drug: Etanercept + Placebo for Methotrexate|Drug: Oral Methotrexate + Placebo for Etanercept
Drug: paclitaxel|Drug: ifosfamide|Drug: cisplatin|Drug: pegylated G-CSF|Drug: G-CSF|Drug: carboplatin|Drug: etoposide phosphate|Procedure: stem cell reinfusion
Drug: Privigen (Human normal immunoglobulin G (IgG > 98 % purity))
Drug: etanercept pre-filled syringe sq injection|Drug: Oral methotrexate|Drug: Placebo for etanercept sq injection|Drug: Placebo for methotrexate
Drug: Vilazodone|Drug: Placebo|Drug: Fluoxetine
Drug: Pexidartinib|Drug: Placebo
Drug: MEDI4736|Drug: MEDI4736 + Tremelimumab|Drug: Standard of Care
Drug: Dakin's solution|Other: Placebo|Other: Questionnaire Administration
Drug: Apixaban|Other: No systemic anticoagulant prophylaxis
Drug: Micro-particle Curcumin|Drug: Placebo
Drug: Peramivir|Drug: Oseltamivir
Drug: Copanlisib (BAY 80-6946)
Drug: Zonisamide|Drug: Placebo
Drug: NKTR-181 BID tablets
Drug: Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody|Drug: Carboplatin|Drug: Nab-Paclitaxel|Drug: Paclitaxel
Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody|Drug: Carboplatin|Drug: Nab-Paclitaxel|Drug: Pemetrexed
Drug: Duloxetine|Behavioral: Pelvic Floor Muscle Training
Drug: Testosterone|Other: Lifestyle Therapy|Drug: Placebo
Drug: Copanlisib (BAY 80-6946)|Drug: Placebo|Drug: Rituximab
Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody|Drug: Bevacizumab|Drug: Carboplatin|Drug: Paclitaxel
Drug: Beta-Lactam
Drug: Sofosbuvir/ledispasvir fixed dose combination (SOF + LDP)
Drug: MEP
Drug: Dexamfetamine sulphate|Drug: placebo
Drug: BMS-663068|Other: Placebo
Drug: Sargramostim: Leukine (Genzyme USA)|Drug: Placebo
Drug: Ketorolac, intranasal|Drug: Ketorolac, intravenous|Drug: Placebo, intravenous|Drug: Placebo, intranasal
Drug: 10 mg Rupatadine on demand|Drug: 10 mg Rupatadine|Drug: 20 mg Rupatadine|Drug: 10 mg Rupatadine on demand (sham updosing to 20 mg)
Drug: Intralipid 20% I.V. Fat Emulsion
Drug: LV5FU2 or capectitabine|Drug: FOLFOX4 or XELOX|Other: Observation|Drug: LV5FU2 or capecitabine
Drug: FOLFOXIRI|Drug: Gemcitabine
Drug: Pasireotide LAR
Drug: Eplerenone|Drug: Spironolactone
Drug: Lenalidomide
Drug: Flutemetamol (Vizamyl)
Drug: MEDI4736 (durvalumab)|Drug: Vinorelbine|Drug: Gemcitabine|Drug: Erlotinib|Drug: MEDI4736 (durvaluman) in combination with tremelimumab (anti-CTLA4)|Drug: tremelimumab (anti-CTLA4)
Drug: Placebo|Drug: Ixekizumab 80 mg Q4W|Drug: Ixekizumab 80 mg Q2W
Drug: Artemether-lumefantrine + Primaquine|Drug: Chloroquine + Primaquine
Drug: SGI-110 (guadecitabine)|Drug: Treatment Choice
Drug: vinflunine|Drug: Methotrexate
Drug: LPV/RTV pellets and AZT/3TC or ABC/3TC
Drug: AV2|Drug: Placebo
Drug: Haloperidol|Other: Placebo|Other: non-pharmacologic measures
Drug: Furosemide
Drug: FTC/RPV/TAF|Drug: FTC/RPV/TDF Placebo|Drug: FTC/RPV/TDF|Drug: FTC/RPV/TAF Placebo
Drug: FTC/RPV/TAF|Drug: EFV/FTC/TDF Placebo|Drug: EFV/FTC/TDF|Drug: FTC/RPV/TAF Placebo
Drug: pertuzumab|Drug: Trastuzumab|Drug: Capecitabine|Drug: Paclitaxel|Drug: Vinorelbine|Drug: Docetaxel|Drug: Exemestane|Drug: Letrozole|Drug: Anastrozole|Drug: Fulvestrant|Drug: Tamoxifen
Drug: Guselkumab
Drug: Moxifloxacin|Drug: PA-824|Drug: Pyrazinamide|Drug: HRZE (Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol combination tablet)|Drug: HR (rifampicin plus isoniazid combination tablets)
Drug: Propranolol|Drug: Atenolol
Drug: Bleomycin Etoposide and Cisplatin|Drug: Carboplatin
Drug: Taselisib|Drug: Placebo|Drug: Fulvestrant
Drug: Arsenic Trioxide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Idarubicin|Other: Laboratory Biomarker Analysis|Drug: Mitoxantrone Hydrochloride|Other: Questionnaire Administration|Drug: Tretinoin
Drug: fluoruracil|Drug: Oxaliplatin|Drug: Irinotecan|Drug: Bevacizumab
Drug: apomorphine infusion
Drug: oxaliplatin|Drug: etoposide|Drug: pharmorubicin|Drug: S-1
Drug: Aromatase Inhibitors
Drug: DAPA/MET XR|Drug: DAPA|Drug: MET XR
Drug: Aprepitant|Drug: Mirtazapine
Drug: canakinumab
Drug: Everolimus|Drug: Tacrolimus|Drug: Mycophenolate sodium
Drug: Bedaquiline|Drug: PA-824|Drug: Linezolid
Drug: Sarilumab|Drug: Adalimumab|Drug: Placebo (for sarilumab)|Drug: Placebo (for adalimumab)
Drug: Apatinib|Drug: Placebo
Drug: naloxone|Drug: Placebo
Drug: azathioprine or adalimumab and infliximab
Drug: Tranexamic Acid (TXA)|Drug: Sodium Chloride 0.9%
Drug: Fesoterodine|Drug: Oxybutynin XL
Drug: Y peginterferon alfa-2b|Drug: Granulocyte-macrophage colony stimulating factor|Drug: Entecavir and or adefovir dipivoxil
Drug: imatinib|Drug: nilotinib|Drug: dasatinib
Drug: Aspirin|Drug: Ticagrelor|Drug: Aspirin Placebo|Drug: Ticagrelor Placebo
Drug: CNTO 1959 50 mg|Drug: CTNO 1959 100 mg|Drug: Placebo 50 mg|Drug: Placebo 100 mg
Drug: Amoxicillin (Amoksicillintrihydrat)|Drug: Placebo
Drug: IAC regimen|Drug: High-dose IA regimen|Drug: Intermediate-dose IA regimen
Drug: TAS-118 plus Oxaliplatin|Drug: S-1 plus Cisplatin
Drug: Hydromorphone HCl ER Tablets
Drug: Triostat|Drug: Placebo
Drug: Pertuzumab
Drug: Enzalutamide|Drug: Placebo|Drug: Leuprolide
Drug: Azacitadine|Drug: Fludarabine|Drug: Cytarabine|Drug: Lenograstim|Drug: Filgastrim
Drug: ACTH|Drug: Placebo
Drug: NA-1|Drug: Placebo
Drug: Ramucirumab|Drug: Capecitabine|Drug: Cisplatin|Drug: Placebo|Drug: Fluorouracil
Drug: Rituximab, Methotrexate, Temozolomide
Drug: Ixazomib|Drug: Placebo
Drug: Low dose hCG plus FSH co-trigger|Drug: Standard dose of hCG
Drug: Immunoglobulins, Intravenous (Privigen)|Drug: Placebo
Drug: Midodrine|Drug: Placebo
Drug: Apremilast (CC-10004)|Drug: Placebo
Drug: Ergometrine|Drug: Oxytocin
Drug: Advate
Drug: Cyclophosphamide|Drug: Doxorubicin Hydrochloride|Drug: Etoposide|Radiation: External Beam Radiation Therapy|Biological: Ganitumab|Drug: Ifosfamide|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Radiation: Stereotactic Radiosurgery|Procedure: Therapeutic Surgical Procedure|Drug: Vincristine Sulfate
Drug: Letrozole|Procedure: Laparoscopic ovarian drilling
Drug: FSH|Procedure: Laparoscopic ovarian drilling
Drug: Carbetocin|Drug: Oxytocin
Drug: Rituximab IV|Drug: Rituximab SC
Drug: Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody|Drug: Docetaxel|Drug: Paclitaxel|Drug: Vinflunine
Drug: triple therapy|Drug: dual therapy
Drug: Acetylsalicylic acid|Drug: Placebo Acetylsalicylic acid
Drug: Ublituximab|Drug: ibrutinib
Drug: Ciprofloxacin|Drug: Placebo
Drug: Prednisolone|Drug: Vigabatrin
Drug: chemotherapy (Mitoxantrone, Cytarabine)|Drug: Placebo|Drug: Crenolanib|Other: Allogeneic stem cell transplantation
Drug: Ticagrelor 180 mg|Drug: Clopidogrel
Drug: metyrapone
Drug: Palbociclib|Drug: Letrozole|Drug: Placebo
Drug: AZD9291 80 mg/40 mg + placebo|Drug: Placebo Erlotinib 150/100mg|Drug: Placebo Gefitinib 250 mg|Drug: Erlotinib 150/100 mg|Drug: Gefitinib 250 mg|Drug: Placebo AZD9291 80 mg/ 40 mg
Drug: Sodium oligo-mannurarate 900mg|Drug: Placebo
Drug: Retosiban|Drug: Atosiban|Drug: Placebo
Drug: Ruxolitinib
Drug: Adrenocorticotropic Hormone
Drug: cabergoline
Drug: PV-10 (10% rose bengal disodium)|Drug: Dacarbazine, temozolomide or talimogene laherparepvec
Drug: Enzalutamide|Drug: Docetaxel|Drug: Prednisolone|Drug: Placebo
Drug: Oxaliplatin|Drug: capecitabine|Radiation: Radiation
Drug: DSP-5423P 40mg|Drug: DSP-5423P 80mg|Drug: DSP-5423P Placebo
Drug: Acetylsalicylic acid lysinate|Drug: 0.9% sodium-chloride solution
Drug: lenalidomide|Drug: Placebo|Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: prednisone|Drug: vincristine
Drug: Vancomycin
Drug: dimethyl fumarate|Drug: Interferon ß-1a
Drug: Apixaban|Drug: Warfarin
Drug: ACTH (Acthar) Gel
Drug: Monthly dihydroartemisinin-piperaquine (DP) for adult women during pregnancy|Drug: Monthly dihydroartemisinin-piperaquine (DP) for infants|Drug: Placebo
Drug: sulphur hexafluoride lipid-type A microspheres
Drug: OLAPARIB|Drug: Single agent chemotherapy
Drug: Amoxicillin|Drug: Placebo|Drug: Prednisolone
Drug: vinorelbine plus cisplatin
Drug: LT-02|Drug: Placebo|Drug: Mesalamine
Drug: Romiplostim
Drug: NexoBrid|Procedure: Standard of Care
Drug: roxadustat|Drug: epoetin alfa|Drug: darbepoetin alfa
Drug: LEE011|Drug: Tamoxifen|Drug: Letrozole|Drug: Anastrozole|Drug: Goserelin|Drug: LEE011 Placebo
Drug: Golimumab|Drug: Methotrexate
Drug: Tedizolid Phophate 200 mg, IV and/or oral for 6 days|Drug: Antibiotic comparator
Drug: Doravirine|Drug: Darunavir|Drug: Ritonavir|Drug: TRUVADA or EPZICOM/KIVEXA
Drug: Tenofovir + lamivudine + raltegravir|Drug: Tenofovir + lamivudine + efavirenz
Drug: Epoetin Alfa|Drug: FG-4592
Drug: MEDI4736|Drug: Placebo
Drug: Arm A Mylotarg|Drug: Arm D Cladribine|Drug: AC220|Drug: Ganetespib
Drug: Enoxaparine
Drug: Vitamin D and fish oil|Dietary Supplement: Fish oil (EPA/DHA) alone|Drug: Vitamin D alone|Other: Placebo
Drug: IncobotulinumtoxinA|Drug: Placebo
Drug: D/C/F/TAF|Drug: Boosted Protease Inhibitor (bPI)|Drug: FTC/TDF
Drug: LF111 (drospirenone)
Drug: Diuretics : Furosemide|Drug: Placebo
Drug: MSM 1000mg twice a day (6000 mgs)|Other: Placebo capsules twice a day
Drug: ONO-4538|Drug: Placebo
Drug: Ketorolac|Drug: Dexamethasone
Drug: Anti-Infective Agents|Drug: Placebo
Drug: Paclitaxel|Drug: Pemetrexed|Drug: Carboplatin|Drug: Cisplatin|Drug: Veliparib
Drug: Human chorionic gonadotrophin|Drug: clomiphene citrate alone
Drug: Ibrutinib|Drug: Obinutuzumab|Drug: Chlorambucil
Drug: talimogene laherparepvec|Drug: pembrolizumab (MK-3475)|Drug: placebo
Drug: Entecavir|Drug: Lamivudine|Drug: Pegylated Interferon Alfa-2A
Drug: Metreleptin
Drug: Omeprazole|Drug: Placebo caplet of DLBS2411|Drug: DLBS2411|Drug: Placebo capsule of Omeprazole
Drug: Imatinib maintenance
Drug: Intragel|Drug: Saline
Drug: Nicotinamide|Drug: Lanthanum Carbonate|Drug: Placebo (for Nicotinamide)|Drug: Placebo (for lanthanum carbonate)
Drug: Apalutamide|Drug: Abiraterone acetate|Drug: Prednisone|Drug: Placebo
Drug: Mizoribine (MZR)|Drug: Cyclophosphamide (CTX)
Drug: Ropivacaine|Drug: Saline
Drug: eteplirsen
Drug: Curcumin
Drug: UTD1 Injection plus capecitabine|Drug: Capecitabine
Drug: Daratumumab|Drug: Lenalidomide|Drug: Dexamethasone
Drug: GM1|Drug: placebo|Drug: mFOLFOX6 or XELOX
Drug: DE-109
Drug: BYDUREON|Drug: Placebo
Drug: Tolvaptan (OPC-41061)
Drug: Bimatoprost sustained-release|Other: Sham|Drug: Timolol|Drug: Timolol Vehicle (placebo)
Drug: Clarithromycin|Drug: Thalidomide|Drug: Cyclophosphamide|Drug: Dexamethasone
Drug: Gel
Drug: Z-100|Drug: Placebo
Drug: Abemaciclib|Drug: Anastrozole|Drug: Letrozole|Drug: Placebo
Drug: Drug: Everolimus|Drug: STZ-5FU
Drug: Chlorambucil|Drug: Venetoclax|Drug: Obinutuzumab
Drug: Imiquimod 5% cream with prior curettage|Procedure: Standard surgical excision
Drug: Rifaximin DR|Drug: Placebo
Drug: optional ASA as comedication|Drug: placebo to ASA|Drug: placebo to optional ASA as comedication|Drug: placebo to dabigatran etexilate|Drug: ASA 100 mg|Drug: dabigatran etexilate
Drug: Bisoprolol|Drug: Ramipril|Drug: Placebo
Drug: Azilsartan Medoxomil|Drug: Losartan|Drug: Placebo for Azilsartan Medoxomil|Drug: Placebo for Losartan
Drug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Standard of Care
Drug: Losartan
Drug: Losartan|Drug: Placebo
Drug: Rosuvastatin and fenofibrate|Drug: Rosuvastatin alone
Drug: Plerixafor|Drug: G-CSF
Drug: cART(TDF/AZT+3TC+LPV/r)|Procedure: CTL infusion
Drug: NNC0195-0092|Drug: somatropin|Drug: placebo
Drug: Vancomycin antibiotic powder
Drug: DTG|Drug: LPV/RTV|Drug: Two NRTIs
Drug: E7389 (Eribulin Mesylate)|Drug: Vinorelbine injection
Drug: Dabrafenib|Biological: Ipilimumab|Other: Laboratory Biomarker Analysis|Biological: Nivolumab|Other: Quality-of-Life Assessment|Drug: Trametinib
Drug: GWP42003-P|Drug: Placebo Control
Drug: Xyrem
Drug: MD1003 100mg capsule|Drug: Placebo
Drug: Preventive administration of Rapaflo|Drug: Standard Care
Drug: MD1003 100mg capsule
Drug: Benzoyl Peroxide solution Plus Chlorhexidine Scrub|Other: Standard of Care - Chlorhexidine Scrub only
Drug: ABT-333|Drug: ABT-450/r/ABT-267|Drug: Ribavirin (RBV)
Drug: Lidocaine infusion|Drug: Saline infusion
Drug: Pegylated-Proline-interferon alpha-2b|Drug: Best available therapy (BAT)
Drug: Clopidogrel|Drug: Acetylsalicylic acid (ASA)
Drug: Carbetocin|Drug: Syntocinon|Drug: Syntometrine
Drug: Physostigmine|Other: Sodium Chloride solution
Drug: Lenalidomide|Drug: Dexamethasone
Drug: Decitabine|Drug: HYDROXYUREA
Drug: Platelet-Rich Plasma|Other: Usual treatment
Drug: Metronidazole (male partner)|Other: Placeob (male partner)
Drug: Rifapentine and Isoniazid for 3 months|Drug: Isoniazid for 9 months
Drug: Telavancin|Drug: Vancomycin|Drug: Daptomycin|Drug: Synthetic penicillin|Drug: Cefazolin
Drug: Guselkumab 100 mg|Drug: Placebo for guselkumab|Drug: Adalimumab|Drug: Placebo for adalimumab
Drug: Eculizumab|Drug: Placebo
Drug: Azithromycin|Device: Dynaport®|Drug: Placebo
Drug: Nilotinib (Tasigna ®), capsules of 150 mg|Drug: Nilotinib (Tasigna ®) and Pegylated interferon alfa 2a (Pegasys®)
Drug: Metabolic treatment
Drug: Topiramate|Drug: Levetiracetam
Drug: Teriflunomide HMR1726|Drug: Placebo
Drug: Darolutamide (BAY1841788)|Drug: Placebo
Drug: Cisplatin|Drug: Gemcitabine Hydrochloride|Radiation: Image Guided Radiation Therapy|Other: Laboratory Biomarker Analysis
Drug: SD-809|Drug: Placebo
Drug: dabigatran etexilate
Drug: Bortezomib-Melphalan|Drug: Melphalan
Drug: Velcade|Drug: Melphalan|Drug: Prednisone|Drug: Daratumumab|Drug: Dexamethasone
Drug: Ra223|Drug: Enzalutamide
Drug: Basal insulin and exenatide|Drug: Basal insulin only|Drug: Basal insulin and bolus insulin
Drug: Trastuzumab|Drug: Paclitaxel|Drug: Docetaxel
Drug: Diclofenac and Atropine combination drug|Drug: Placebo
Drug: Miltefosine
Drug: Sanfujiu|Drug: Placebo
Drug: human albumin 5%|Drug: HES 130/0.4 (Voluven)
Drug: Metformin alone|Drug: Metformin + Intermittent Insulin Therapy
Drug: Rivipansel|Other: Placebo
Drug: Calcium Carbonate|Drug: Vitamin D3|Drug: Risedronate|Behavioral: Bone-loading exercises
Drug: Tenofovir disoproxil|Drug: Placebo Oral Tablet
Drug: Vitamin D3: 3000 or 4000 UI/day then 2,000 UI/day|Drug: Vitamin D3 800 UI/day then 800 UI/day
Drug: Hydrochlorothiazide (HCTZ)|Drug: Chlorthalidone
Drug: Cholecalciferol 100 000 UI|Drug: Placebo
Drug: GB-0998|Drug: Placebo
Drug: Gemcitabine/Cisplatin|Drug: Gemcitabine/Cisplatin /S-1
Drug: Ixazomib Citrate|Drug: Placebo
Drug: aspirin plus hirudin|Drug: Warfarin
Drug: Nasal Fluticasone|Drug: Placebo
Drug: LCI699
Drug: Tacrolimus and MMF.
Drug: DTG 50 mg|Drug: EFV 600 mg
Drug: Buprenorphine|Drug: Placebo
Drug: Short term androgen deprivation|Drug: Long term androgen deprivation|Radiation: Short term androgen deprivation|Radiation: Long term androgen deprivation
Drug: IONIS-TTR Rx
Drug: Roxadustat|Drug: Epoetin alfa
Drug: Roxadustat|Drug: Placebo
Drug: Imatinib|Drug: Nilotinib
Drug: Chiglitazar|Drug: Sitagliptin
Drug: standard combination chemotherapy|Drug: decitabine
Drug: Adalimumab|Other: Adalimumab Placebo|Drug: Etrolizumab|Other: Etrolizumab Placebo
Drug: Gemcitabine|Drug: Cisplatin|Drug: Capecitabine
Drug: Isradipine|Drug: Placebo (for Isradipine)
Drug: ABT-450/r/ABT-267|Drug: ABT-333|Drug: Ribavirin (RBV)
Drug: Arm A : standard neoadjuvant chemoradiotherapy group|Drug: Arm B : adjuvant FOLFOX group
Drug: Pravastatin40mg/Fenofibrate160mg|Drug: Atorvastatin Sodium 10mg
Drug: Ibrutinib|Drug: Placebo|Drug: Rituximab
Drug: Flutemetamol (18F)|Drug: Florbetapir (18F)
Drug: Rivaroxaban|Drug: Aspirin
Drug: Paclitaxel|Drug: Veliparib|Drug: Carboplatin|Other: Placebo
Drug: Trastuzumab
Drug: FOLFOX/ FOLFIRI with bevacizumab|Drug: FOLFOXIRI with bevacizumab|Drug: FOLFOX/ FOLFIRI with panitumumab
Drug: Cisplatin|Drug: Pemetrexed|Drug: Bevacizumab|Radiation: Cerebral Radiotherapy
Drug: Secretin|Drug: Placebo
Drug: Intravenous Acetaminophen
Drug: Propanolol|Drug: Methylphenidate
Drug: Escitalopram|Other: Placebo
Drug: Methotrexate|Procedure: Uterine Evacuation|Other: Expectant Management
Drug: Abemaciclib|Drug: Erlotinib
Drug: Chemotherapy|Drug: Cross-over to AZD9291
Drug: Filgrastim
Drug: NexoBrid|Procedure: Standard of Care (SOC)|Drug: Gel Vehicle
Drug: BF-200 ALA|Drug: methyl-aminolevulinate
Drug: Fosfomycin sodium intravenous|Drug: Meropenem intravenous|Drug: Ceftriaxone intravenous
Drug: Pembrolizumab|Drug: Paclitaxel|Drug: Carboplatin|Drug: Pemetrexed|Drug: Cisplatin|Drug: Gemcitabine
Drug: Budesonide granules 9 mg|Drug: Placebo granules
Drug: nonacog beta pegol
Drug: Erlotinib
Drug: study part 1 - dose daunorubicin|Procedure: induction cycles
Drug: turoctocog alfa pegol
Drug: Fulvestrant|Drug: Anastrozole|Drug: Everolimus|Drug: Placebo - Anastrozole|Drug: Placebo - Everolimus
Drug: Daratumumab|Drug: VELCADE (Bortezomib)|Drug: Dexamethasone
Drug: etrolizumab|Drug: infliximab|Other: placebo (IV)|Other: placebo (injection)
Drug: metoclopramide|Drug: dexamethason|Drug: palonosetron
Drug: imiquimod|Drug: fluorouracil|Device: infrared photocoagulation therapy|Device: thermal ablation therapy|Device: laser therapy|Other: clinical observation|Other: laboratory biomarker analysis
Drug: Ticlopidine + Ginko biloba|Drug: Clopidogrel
Drug: Levosimendan|Drug: Dobutamine
Drug: Nifedipine|Drug: Placebo|Other: Usual care
Drug: Goserelin|Drug: Toremifene
Drug: ACTH
Drug: Carboplatin|Drug: Docetaxel|Drug: Pertuzumab|Drug: Trastuzumab|Drug: Trastuzumab Emtansine
Drug: Bosutinib|Drug: Imatinib
Drug: Denosumab|Other: None, standard chemotherapy only
Drug: Dydrogesterone|Drug: Placebo
Drug: Lenalidomide|Drug: Rituximab
Drug: Lanreotide|Drug: saline
Drug: Thymosin-a1
Drug: Limaprost|Drug: Placebo
Drug: MEDI4736|Other: PLACEBO
Drug: Icotinib|Drug: Placebo
Drug: FTC/TDF|Drug: F/TAF|Drug: Allowed third antiretroviral agent|Drug: FTC/TDF Placebo|Drug: F/TAF Placebo
Drug: Chiglitazar|Drug: Placebo
Drug: 700 µg dexamethasone|Procedure: Laser Photocoagulation
Drug: Rifaximin|Drug: Norfloxacin
Drug: Belimumab
Drug: Etrolizumab
Drug: Entinostat|Drug: Exemestane|Drug: Goserelin Acetate|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Other: Placebo|Other: Quality-of-Life Assessment
Drug: Everolimus|Drug: Tacrolimus
Drug: Capecitabine/cisplatin|Drug: S-1/cisplatin|Drug: Capecitabine/oxaliplatin|Drug: 5-fluorouracil/oxaliplatin|Drug: Capecitabine|Drug: S-1|Drug: 5-fluorouracil
Drug: Bortezomib|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Daunorubicin Hydrochloride|Drug: Dexamethasone|Drug: Doxorubicin Hydrochloride|Drug: Etoposide|Drug: Hydrocortisone Sodium Succinate|Drug: Ifosfamide|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Pegaspargase|Radiation: Radiation Therapy|Drug: Thioguanine|Drug: Vincristine Sulfate
Drug: ThermoDox|Drug: Dummy infusion
Drug: Meclizine|Drug: Dimenhydrinate
Drug: Macitentan
Drug: 10-day bismuth-based quadruple therapy|Other: Placebo
Drug: Rivaroxaban, 10 mg|Drug: Rivaroxaban, 7.5 mg|Drug: Placebo
Drug: PRT-201|Drug: Placebo
Drug: XR-NTX|Behavioral: XR-NTX+PN|Behavioral: ETAU
Drug: Abatacept|Drug: placebo
Drug: Celecoxib|Drug: Oseltamivir|Drug: Placebo
Drug: Abemaciclib|Drug: Fulvestrant|Drug: Placebo
Drug: abnobaVISCUM 900|Drug: Mitomycin C
Drug: carboplatin|Drug: veliparib|Drug: paclitaxel|Drug: placebo
Drug: AbobotulinumtoxinA
Drug: Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A)|Drug: Placebo to Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet
Drug: Nivolumab|Drug: Cetuximab|Drug: Methotrexate|Drug: Docetaxel
Drug: Epanova® (omega-3 carboxylic acids)|Drug: corn oil control
Drug: thryoid hormone T4 + oral potassium iodide (KI) for 42 days|Drug: D5W - 5% dextrose water
Drug: mFOLFOX6|Drug: HAI
Drug: Momelotinib|Drug: Best Available Therapy (BAT)
Drug: Etrozulimab|Drug: Placebo
Drug: hATG|Drug: CsA|Drug: Eltrombopag
Drug: intravenous metoclopramide|Other: Placebo
Drug: Custodiol-N|Drug: Custodiol
Drug: Anastrozole|Drug: Tamoxifen|Drug: Toremifene
Drug: MMX Mesalamine/Mesalazine (Low Dose)|Drug: MMX Mesalamine/Mesalazine (High Dose)
Drug: Eltrombopag|Drug: Placebo
Drug: Ataluren
Drug: Hyperbaric Oxygen|Drug: No Hyperbaric Oxygen
Drug: Irinotecan|Drug: 5-fluorouracil|Radiation: Local radiotherapy|Procedure: R0 resection
Drug: Tranexamic Acid|Other: Saline control
Drug: pegaspargase|Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Methotrexate|Drug: Dexamethasone|Drug: Thalidomide
Drug: clofarabine|Drug: daunorubicin hydrochloride|Other: clinical observation|Drug: cytarabine|Drug: decitabine|Other: laboratory biomarker analysis|Procedure: quality-of-life assessment|Other: questionnaire administration
Drug: Tapentadol 4 mg/mL|Drug: Tapentadol 20 mg/mL|Other: Placebo
Drug: 2.5 mg Chlorhexidine gluconate chip
Drug: IVM plus ALB|Drug: IVM
Drug: Fostamatinib Disodium
Drug: Docetaxel|Drug: Epirubicin|Drug: Oxaliplatin|Drug: Capecitabine
Drug: recombinant human Erythropoietin|Drug: Placebo
Drug: DTG 50 mg /ABC 600 mg /3TC 300 mg FDC tablets
Drug: placebo oral capsules|Drug: ziprasidone oral capsules
Drug: Gemcitabine, Cisplatin
Drug: satralizumab (SA237)|Drug: Placebo
Drug: Abatacept SC
Drug: Nivolumab
Drug: Mometasone 220mcg BID|Drug: Tiotropium Respimat 5mcg QD|Drug: Placebo
Drug: Adalimumab|Other: Placebo
Drug: Curcumin|Drug: placebo
Drug: R-CHOP or R-bendamustine|Drug: Observation|Drug: Maintenance weekly x4|Drug: Ibritumomab Tiuxetan + Maintenance|Drug: Standard Maintenance
Drug: Standard treatment (as per protocol ISG SSG III)|Drug: Intensified chemotherapy
Drug: imiquimod|Drug: fluorouracil|Other: questionnaire administration|Other: laboratory biomarker analysis
Drug: Telbivudine|Drug: Placebo
Drug: azithromycin|Drug: placebo|Drug: Tobramycin solution for inhalation
Drug: Orteronel|Drug: Placebo
Drug: FG-4592 (roxadustat)|Drug: Epoetin Alfa
Drug: Denosumab (reduced dosing)|Drug: Denosumab (standard dosing)
Drug: IPI-145 (duvelisib)|Drug: Ofatumumab
Drug: Cyclophosphamide|Drug: Fludarabine Phosphate|Drug: Ibrutinib|Other: Laboratory Biomarker Analysis|Other: Pharmacogenomic Study|Other: Quality-of-Life Assessment|Biological: Rituximab
Drug: Taxotere|Drug: Jevtana
Drug: Radium-223 dichloride (Xofigo, BAY88-8223)|Drug: Matching placebo (normal saline)|Drug: Abiraterone|Drug: Prednisone/Prednisolone
Drug: NC-6004|Drug: Gemcitabine
Drug: Hyperbaric oxygen
Drug: Quizartinib|Drug: Salvage Chemotherapy
Drug: Vedolizumab|Drug: Vedolizumab placebo
Drug: Best Available Therapy|Drug: ruxolitinib
Drug: Eribulin Mesylate|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Other: Quality-of-Life Assessment
Drug: Ketamine|Drug: Saline
Drug: Ce 1 ng/ml|Drug: Ce 2 ng/ml|Drug: Ce 3 ng/ml
Drug: Cyclophosphamide|Drug: Placebo|Drug: Doxorubicin|Drug: Paclitaxel|Drug: Carboplatin|Drug: Veliparib
Drug: Induction and gap chemotherapy (Capecitabine combine with oxaliplatin)|Radiation: standard chemoradiotherapy
Drug: Palbociclib|Drug: Capecitabine|Drug: Exemestane|Drug: Fulvestrant
Drug: Abraxane (Induction)|Drug: Carboplatin (Induction)|Drug: Abraxane (Maintenance)|Other: Best Supportive Care (Maintenance)
Drug: Telotristat etiprate tablets (250 mg)
Drug: 5-fluorouracil Injection|Drug: Triamcinolone Acetonide|Procedure: Incision and Curettage|Drug: Triamcinolone Acetonide/5-fluorouracil mixture
Drug: Lidocaine = group A|Drug: Group B placebo
Drug: Roxadustat|Drug: darbepoetin alfa
Drug: nitrofurantoin|Other: No prophylaxis|Drug: Amoxicillin-Potassium Clavulanate Combination|Drug: Trimethoprim/sulfamethoxazole|Drug: Cefixime
Drug: Tedizolid phosphate IV|Drug: Linezolid
Drug: 25% AgNO3 solution followed by 5% NaF varnish|Drug: 38% SDF solution followed by placebo varnish
Drug: Allopurinol|Drug: Placebo
Drug: Dasatinib|Drug: Cytarabine|Drug: Daunorubicin
Drug: Misoprostol|Drug: Mifepristone
Drug: Solanezumab|Drug: Placebo
Drug: Atezolizumab|Drug: Docetaxel
Drug: Combined aspirin and multinutrient supplement|Other: Daily text reminder text messages
Drug: Apomorphine hydrochloride|Drug: Placebo
Drug: Bendamustine|Drug: Venetoclax|Drug: Rituximab
Drug: Aromatase Inhibition Therapy|Drug: Carboplatin|Other: Cytology Specimen Collection Procedure|Drug: Docetaxel|Drug: Goserelin Acetate|Other: Laboratory Biomarker Analysis|Biological: Pertuzumab|Other: Quality-of-Life Assessment|Procedure: Therapeutic Conventional Surgery|Biological: Trastuzumab|Radiation: Whole Breast Irradiation
Drug: IncobotulinumtoxinA (8 Units per kg body weight)|Drug: IncobotulinumtoxinA (6 Units per kg body weight)|Drug: IncobotulinumtoxinA (2 Units per kg body weight)
Drug: Tissue-type plasminogen activator (alteplase)|Other: Standard care
Drug: sodium selenite|Drug: Placebo
Drug: Pemetrexed|Drug: Docetaxel|Drug: rh-Endostatin|Drug: Cis-platinum
Drug: Memantine|Drug: Placebo
Drug: Olaparib|Drug: Physician's choice chemotherapy
Drug: Prednisolone|Drug: Placebo
Drug: DLBS3233|Drug: Metformin XR|Drug: Placebo metformin|Drug: Placebo DLBS3233
Drug: 20 mL topically used during alginate dressing NAROPEINE|Drug: 20 mL topically used during alginate dressing NaCl
Drug: PTC+Pertuzumab|Drug: FEC-T+Pertuzumab
Drug: 6-month Icotinib|Drug: 12-month icotinib
Drug: Chemotherapy|Other: Surveillance
Drug: Ticagrelor 60 mg|Drug: Ticagrelor placebo
Drug: oral levofloxacin|Drug: nebulized levofloxacin
Drug: Ertugliflozin|Drug: Placebo
Drug: Adalimumab|Drug: placebo
Drug: SM-13496 (lurasidone HCl)
Drug: Candesartan|Drug: Lisinopril
Drug: Cabazitaxel + Androgen deprivation therapy|Drug: Androgen deprivation therapy
Drug: Intravitreal bevacizumab|Procedure: Small-gauge pars plana vitrectomy
Drug: Tofacitinib|Drug: Methotrexate|Drug: Placebo Methotrexate
Drug: Bendamustine|Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone|Drug: PCI-32765 (Ibrutinib)|Drug: Placebo
Drug: Triptoreline 11.25 i.v.; Estradiol 0.5% percutaneous gel;|Procedure: rectal shaving; rectal disc excision; colorectal resection|Drug: Cyproterone acetate 50 mg; estradiol 0.5% percutaneous|Drug: Estradiol 0.5% percutaneous gel; Cyproterone acetate 50 mg oral
Drug: Dexmedetomidine|Drug: Placebo
Drug: G-CSF administration
Drug: cetuximab|Drug: cisplatin
Drug: Momelotinib|Drug: Ruxolitinib|Drug: Placebo to match momelotinib|Drug: Placebo to match ruxolitinib
Drug: aflibercept|Drug: bevacizumab
Drug: Rucaparib|Drug: Placebo
Drug: Trastuzumab Emtansine|Drug: Trastuzumab|Drug: Pertuzumab|Drug: Paclitaxel|Drug: Epirubicin|Drug: Doxorubicin|Drug: Docetaxel|Drug: Cyclophosphamide|Drug: 5-Fluorouracil
Drug: Ethiodized Oil + Doxorubicin
Drug: nab-Paclitaxel 125 mg/m2|Drug: gemcitabine 1000 mg/m2
Drug: Trastuzumab|Drug: Doxorubicin|Drug: Cyclophosphamide|Drug: Paclitaxel|Drug: Docetaxel|Drug: Carboplatin|Drug: Neo-adjuvant chemotherapy
Drug: Erythropoietin alfa|Drug: Placebo
Drug: Reversion
Drug: Fosphenytoin|Drug: Levetiracetam|Drug: Valproic acid
Drug: Neonatal Morphine Solution|Drug: Methadone|Drug: Phenobarbital
Drug: LEE011|Drug: Letrozole|Drug: LEE011 Placebo
Drug: abiraterone acetate|Radiation: radiotherapy|Other: Androgen Deprivation Therapy|Drug: Docetaxel
Drug: Enteral nutrition alanyl-glutamin, Dipeptiven
Drug: TACROLIMUS|Drug: RITUXIMAB|Drug: METHYLPREDNISOLONE|Drug: CYCLOPHOSPHAMIDE
Drug: Glufosfamide|Drug: Fluorouracil
Drug: Afatinib
Drug: fulvestrant|Drug: anastrozole
Drug: Cabazitaxel|Radiation: Pelvic radiotherapy|Radiation: prostate radiotherapy
Drug: tacrolimus|Drug: methotrexate|Drug: Mycophenolate mofetil|Drug: Methotrexate (low dose)
Drug: RHB-104|Drug: Placebo
Drug: Nimorazole|Radiation: Radiotherapy
Drug: Endocrine therapy combined with trastuzumab|Drug: Chemotherapy combined with trastuzumab
Drug: enzalutamide|Drug: abiraterone|Drug: prednisone
Drug: Dupilumab (REGN668/SAR231893)
Drug: Atorvastatin
Drug: Apalutamide|Drug: Placebo
Drug: talazoparib|Drug: Physician's-Choice
Drug: US-guided tenotomy with PRP|Drug: US-guided tenotomy with lidocaine
Drug: Palbociclib|Drug: Fulvestrant|Drug: Placebo
Drug: Doxorubicin|Drug: Docetaxel|Drug: Paclitaxel|Drug: Trastuzumab
Drug: 5 mg Prednisone|Drug: 0 mg Prednisone
Drug: Rituximab|Drug: Lenalidomide|Drug: Placebo
Drug: besifovir 150mg|Drug: tenofovir 300mg
Drug: Docetaxel and capecitabine and oxaliplatin|Drug: capecitabine and oxaliplatin
Drug: Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine
Drug: Selumetinib|Drug: Docetaxel|Drug: Placebo|Drug: Pegylated G-CSF
Drug: 5 mg prednisone|Drug: 0 mg prednisone
Drug: rituximab
Drug: Pioglitazone|Drug: Pioglitazone placebo
Drug: rigosertib sodium
Drug: somatropin
Drug: trastuzumab [Herceptin]
Drug: Oxaliplatin|Radiation: SBRT|Drug: Irinotecan|Drug: Leucovorin|Drug: 5FU
Drug: Olaparib|Drug: Paclitaxel|Drug: Placebo
Drug: Belatacept|Drug: Calcineurin inhibitor therapy|Drug: Mycophenolate mofetil|Drug: prednisone
Drug: LCZ696|Drug: Valsartan
Drug: Capecitabine|Drug: Oxaliplatin
Drug: Chemotherapy|Radiation: External Beam Radiotherapy|Radiation: Brachytherapy|Procedure: Radical Hysterectomy
Drug: Docetaxel plus Capecitabine|Drug: Capecitabine
Drug: Nitisinone
Drug: 0.5% lignocaine 60mM
Drug: Lurasidone 20, 40, 60, 80 mg, flexibly dosed
Drug: Sildenafil|Drug: Placebo
Drug: Placebo|Drug: Polysaccharide iron complex
Drug: Dolutegravir/abacavir/lamivudine FDC|Drug: Atazanavir|Drug: Ritonavir|Drug: Tenofovir/emtricitabine FDC
Drug: MOD-4023|Other: Placebo
Drug: LGX818|Drug: MEK162|Drug: vemurafenib
Drug: Lamazym
Drug: Beraprost Sodium 314d Modified Release Tablets|Drug: Placebo
Drug: Cabozantinib tablets|Drug: Placebo tablets
Drug: Nintedanib|Drug: Pemetrexed|Drug: Cisplatin|Drug: Placebo
Drug: 3 cycles chemotherapy|Drug: 6 cycles chemotherapy
Drug: intranasal fentanyl spray|Drug: slow release morphine
Drug: Bendamustine|Drug: Chlorambucil|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Obinutuzumab
Drug: niraparib|Drug: Physician's choice
Drug: metformin hydrochloride|Other: placebo
Drug: Escitalopram|Drug: Memantine|Drug: Placebo
Drug: abacavir/lamivudine + raltegravir|Drug: abacavir/lamivudine + darunavir/ritonavir
Drug: WH-1 ointment|Other: Aquacel® Hydrofiber® dressing
Drug: Switch to Maraviroc + Raltegravir or Dolutegravir
Drug: dabigatran etexilate|Drug: standard of care
Drug: Nicotine replacement therapy - Transdermal nicotine patch|Drug: Nicotine replacement therapy - Nicotine gum|Drug: Nicotine replacement therapy - Nicotine lozenge|Drug: Bupropion|Drug: Varenicline|Drug: Combination pharmacotherapy - Transdermal nicotine patch + nicotine gum|Drug: Combination pharmacotherapy - Transdermal nicotine patch + nicotine lozenge|Drug: Combination pharmacotherapy - Transdermal nicotine patch + bupropion|Behavioral: Tobacco quitline referral|Behavioral: Tailored behavioral intervention|Behavioral: Alcohol use risk reduction|Behavioral: Behavioral activation for depressive symptoms|Behavioral: Behavioral management of postcessation weight gain
Drug: Interferon beta-1a i.m. injections|Drug: Fingolimod oral capsules|Drug: Placebo oral capsule|Drug: Placebo i.m. injection
Drug: Eculizumab
Drug: Lenalidomide|Drug: Dexamethasone|Biological: Elotuzumab
Drug: BMN165 20mg/day|Drug: BMN165 40mg/day|Drug: Placebo
Drug: Rituximab|Drug: Cyclophosphamide|Drug: Vincristine|Drug: Doxorubicin|Drug: Prednisone|Drug: Bendamustine
Drug: Bendamustine Hydrochloride|Drug: Ibrutinib|Other: Laboratory Biomarker Analysis|Other: Quality-of-Life Assessment|Biological: Rituximab
Drug: [18F]NAV4694
Drug: Cetuximab|Drug: Methotrexate
Drug: HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) with oxaliplatin|Procedure: Curative gastrectomy
Drug: Cisplatin|Radiation: Radiotherapy|Drug: Placebo|Drug: Nimorazole
Drug: N-acetyl cysteine|Drug: Saline
Drug: Arm A: FOLFIRI or FOLFOX + Bevacizumab|Drug: Arm B: FOLFIRI or FOLFOX|Drug: Arm D: FOLFIRI or FOLFOX plus CETUXIMAB|Drug: Arm F: FOLFIRI or FOLFOX plus BEVACIZUMAB and CETUXIMAB
Drug: NAC|Drug: Saline
Drug: Rivaroxaban|Drug: Placebo|Other: Standard of care for heart failure and coronary artery disease
Drug: Alemtuzumab|Drug: Fludarabine|Drug: Melphalan|Procedure: Stem Cells
Drug: Vandetanib (SAR390530)|Drug: Placebo
Drug: Clonidine|Drug: SodiumChloride
Drug: Trastuzumab subcutaneous inyection vial|Device: Trastuzumab subcutaneous device administration
Drug: Placebo|Drug: SST-0225 Topical Ibuprofen Cream
Drug: Olaparib 300mg tablets|Drug: Placebo to match olaparib 300mg
Drug: Cisplatin|Drug: Cetuximab
Drug: gemcitabine and cisplatin (Induction chemotherapy)|Radiation: IMRT and concurrent cisplatin
Drug: E7777
Drug: Clonazepam|Drug: Fosphenytoin|Drug: Placebo|Drug: Lorazepam
Drug: Recombinant Human Adenovirus Type 5 Injection|Procedure: Transartery Chemoembolization
Drug: Dexamethasone acetate|Drug: dexamethasone and cyclophosphamide|Drug: dexamethasone and rituximab
Drug: Cabozantinib tablets|Drug: Everolimus (Afinitor) tablets
Drug: R-CHOP|Drug: R-CHOP / R-HAD|Drug: Rituximab|Drug: Lenalidomide
Drug: Palbociclib PD-0332991|Drug: Placebo
Drug: Certolizumab Pegol|Drug: Placebo
Drug: Bortezomib|Drug: Carfilzomib|Drug: Dexamethasone|Other: Laboratory Biomarker Analysis|Drug: Lenalidomide|Other: Quality-of-Life Assessment
Drug: Imiquimod|Procedure: Surgery
Drug: Eplerenone
Drug: methotrexate|Drug: afatinib
Drug: Sirukumab 100 mg|Drug: Sirukumab 50 mg|Drug: Placebo
Drug: Ibrutinib|Drug: Placebo|Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone (or equivalent)
Drug: Cetuximab|Radiation: RT (70 Gy in 35 fractions)|Drug: Cisplatin
Drug: Hyoscine butyl bromide|Drug: Normal saline
Drug: afatinib
Drug: Regorafenib (BAY73- 4506)
Drug: R-CEOP-70|Drug: R-CEOP-90|Drug: R-CHOP-50
Drug: IXAZOMIB + Lenalidomide + Dexamethasone|Drug: Placebo + Lenalidomide + Dexamethasone
Drug: Pemetrexed|Drug: Gemcitabine|Drug: Induction chemotherapy
Drug: MEK162, MEK inhibitor; oral|Drug: Physician's choice chemotherapy
Drug: Spironolactone|Drug: Placebo
Drug: Trabectedin|Drug: DOXIL|Drug: Dexamethasone
Drug: Berinert|Drug: Clemastin|Drug: Cortisone acetate|Drug: NaCl
Drug: Selumetinib|Drug: Placebo|Drug: Radioactive Iodine Therapy
Drug: Intravenous injection of 177Lu-octreotate
Drug: Placebo|Drug: dimethyl fumarate
Drug: COR-003
Drug: rhTSH stimulation|Drug: I131|Other: Follow up
Drug: Carboplatin|Drug: PLD|Biological: Bevacizumab
Drug: Abatacept
Drug: moxetumomab pasudotox|Drug: IV Bag Protectant for Moxetumomab pasudotox
Drug: Mycophenolate mofetil|Drug: Methotrexate|Drug: Prednisone
Drug: Randomisation course 1 mitoxantrone versus DaunoXome|Drug: Randomisation course 2 ADxE versus FLADx
Drug: Ceritinib|Drug: pemetrexed|Drug: docetaxel
Drug: Ceritinib|Drug: Pemetrexed|Drug: Cisplatin|Drug: Carboplatin
Drug: Induction chemotherapy with gemcitabine or FOLFIRINOX|Radiation: Radiotherapy, 28 x 1.8 Gy|Drug: Chemotherapy, gemcitabine|Drug: Chemotherapy with gemcitabine or FOLFIRINOX according to induction chemotherapy
Drug: rt-PA
Drug: S-1|Drug: Oxaliplatin|Drug: Cisplatin
Drug: Tadalafil|Drug: Placebo
Drug: MTX 1|Drug: MTX 2|Biological: Act-d
Drug: Abraxane|Drug: Paclitaxel
Drug: botulinum toxin type A|Drug: injection of NaCl 0.9%
Drug: Paclitaxel|Drug: Paraplatin (Carboplatin Injection)|Radiation: Pelvic Radiation|Radiation: Vaginal Brachytherapy 1|Radiation: Vaginal brachytherapy 2
Drug: Belatacept|Drug: Tacrolimus|Drug: Cyclosporine
Drug: Vitamin D|Drug: Placebo|Other: Imaging|Biological: Lumbar puncture|Biological: Blood sampling|Biological: Urine samples
Drug: Chlorhexidine Gluconate|Procedure: Wound Care Management|Other: Questionnaire Administration|Other: Laboratory Biomarker Analysis
Drug: Acipimox|Drug: Placebo
Drug: E/C/F/TAF|Drug: E/C/F/TDF|Drug: EFV/FTC/TDF|Drug: RTV|Drug: ATV|Drug: FTC/TDF|Drug: COBI
Drug: Ticagrelor|Drug: Acetylsalicylic Acid|Drug: Clopidogrel
Drug: GEMCITABINE CISPLATINE|Drug: METHOTRXATE VINBLASTINE DOXORUBICINE CISPLATINE G-CSF
Drug: 5-aminolévulinique acid (5-ALA)|Drug: Placebo
Drug: TAK-700|Drug: Bicalutamide
Drug: Steroid + cyclophosphamide|Drug: Steroid + rituximab
Drug: neratinib|Drug: capecitabine|Drug: lapatinib
Drug: Ketorolac 30 mg IV
Drug: Everolimus|Drug: Placebo
Drug: mFolfirinox|Radiation: Radiotherapy 50Gy|Drug: Capecitabine|Procedure: TME surgery|Drug: mFolfox6 or capecitabine
Drug: PCI-32765 (Ibrutinib)
Drug: SR-A + Epratuzumab|Drug: SR-B + Epratuzumab
Drug: Bevacizumab|Drug: Paclitaxel|Drug: Carboplatin|Drug: pegylated liposomal doxorubicin|Drug: Gemcitabine
Drug: Sevoflurane|Drug: Midazolam
Drug: Oral Vancomycin
Drug: Nicotine Replacement Therapy (NRT)|Drug: Varenicline|Behavioral: HIV Tailored Quit Smoking Counseling
Drug: BIIB019 (Daclizumab)
Drug: E/C/F/TAF|Drug: E/C/F/TDF|Drug: E/C/F/TDF Placebo|Drug: E/C/F/TAF Placebo
Drug: SPARC1104
Drug: Romidepsin + CHOP|Drug: CHOP
Drug: S-1 plus oxaliplatin|Drug: S-1 single
Drug: Sulfonylurea (glimepiride)|Drug: DPP-4 inhibitor (sitagliptin)|Drug: GLP-1 receptor agonist (liraglutide)|Drug: Insulin (glargine)
Drug: Trimethoprim-Sulfamethoxazole|Drug: Clindamycin|Drug: Linezolid|Drug: Flucloxacillin|Drug: Cloxacillin|Drug: Vancomycin|Drug: Daptomycin|Drug: Cefazolin
Drug: Tocilizumab|Drug: Prednisone|Drug: Tocilizumab Placebo|Drug: Prednisone Placebo|Drug: Corticosteroids|Drug: Methotrexate
Drug: NSAID|Drug: Gabapentinoids|Drug: placebo
Drug: Dexamethasone, Rituximab, Cyclophosphamide|Drug: Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
Drug: DMARDs
Drug: Trastuzumab|Drug: Placebo
Drug: Posaconazole|Drug: Voriconazole
Drug: armodafinil 150 mg|Other: Placebo|Drug: armodafinil 250 mg
Drug: Metformin|Drug: Glargine
Drug: Metformin|Drug: Liraglutide|Drug: Glargine|Drug: Placebo
Drug: brentuximab vedotin|Drug: doxorubicin|Drug: prednisone|Drug: vincristine|Drug: cyclophosphamide
Drug: Bendamustine|Drug: Rituximab|Drug: Ibrutinib|Drug: Placebo
Drug: Gralise
Drug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Aspirin|Drug: Aspirin placebo|Drug: Rivaroxaban placebo|Drug: Pantoprazole
Drug: 5-Fluorouracil|Drug: Capecitabine|Drug: Cisplatin|Drug: Pertuzumab|Drug: Placebo|Drug: Trastuzumab
Drug: Dacomitinib (PF-00299804)|Drug: Gefitinib
Drug: Regorafenib (BAY73-4506)|Drug: Placebo
Drug: trastuzumab|Drug: trastuzumab emtansine
Drug: Temozolomide|Drug: a-IFN
Drug: MEK162|Drug: Dacarbazine
Drug: eltrombopag|Drug: placebo
Drug: TS-1, oxaliplatin
Drug: Lenvatinib|Drug: Sorafenib
Drug: Sitagliptin + Metformin XR FDC|Drug: Placebo to Sitagliptin + Metformin XR|Drug: Metformin XR|Drug: Placebo to metformin XR|Drug: Insulin glargine|Biological: Background insulin
Drug: 300 mg Oral Azacitidine|Drug: Placebo
Drug: SBC-102 [sebelipase alfa] (1 mg/kg)|Drug: Placebo
Drug: Varenicline|Drug: Placebo|Behavioral: Smoking Cessation Counseling
Drug: Paracetamol|Drug: Ibuprofen|Procedure: Closure of PDA
Drug: Orlistat 60 mg|Other: Placebo
Drug: Ticagrelor|Drug: Aspirin|Drug: Placebo - Ticagrelor|Drug: Placebo - Aspirin
Drug: Intermittent insulin therapy|Drug: Continuous metformin
Drug: Compound realgar natural indigo Tablet|Drug: placebo
Drug: Secukinumab (AIN457)|Drug: Placebo
Drug: Vitamin D|Drug: arachides oleum raffinatum
Drug: Pregabalin Dose Level 1|Drug: Pregabalin Dose Level 2|Drug: Placebo
Drug: tenofovir disoproxil fumarate|Drug: placebo
Drug: Nilotinib
Drug: Vitamin K1
Drug: PD-0332991|Drug: Letrozole|Drug: Placebo
Drug: Dexmedetomidine|Drug: Propofol
Drug: Antiplatelet Regimen Modification (aspirin or ticagrelor)
Drug: Pomalidomide|Drug: Bortezomib|Drug: Dexamethasone
Drug: DLBS3233|Drug: Metformin XR|Drug: Placebo caplet of Metformin XR|Drug: Placebo capsule of DLBS3233
Drug: sorafenib tosylate|Radiation: stereotactic body radiation therapy
Drug: Dapagliflozin 10 mg|Drug: Placebo tablet
Drug: Tildrakizumab 200 mg|Drug: Tildrakizumab 100 mg|Drug: Tildrakizumab Placebo|Drug: Etanercept Placebo|Drug: Etanercept 50 mg
Drug: chemotherapy
Drug: Azathioprine|Drug: Leflunomide
Drug: Epirubicin|Drug: Cisplatin|Drug: 5 Flourouracil/ Capecitabine|Radiation: (41.4 Gy/23 fractions)|Drug: Paclitaxel|Drug: Carboplatin
Drug: BEP(500)
Drug: Arm A - Post-Chlorambucil Therapy Follow-up|Drug: Arm B - PCI-32765|Drug: Second-line PCI-32765|Drug: Alternative Anticancer Treatment
Drug: Tildrakizumab 200 mg|Drug: Tildrakizumab 100 mg|Drug: Matching Placebo
Drug: Liraglutide 1.8mg|Drug: Placebo
Drug: FOLFOX6m|Device: SIR-Spheres microspheres
Drug: placebo|Drug: volasertib|Drug: low dose cytarabine
Drug: placebo|Drug: iv sildenafil
Drug: Imiquimod cream + surgery|Drug: Placebo + surgery
Drug: Bevacizumab|Drug: Oxaliplatin|Drug: levo-folinic acid|Drug: 5-fluorouracil|Drug: Capecitabine
Drug: Bevazizumab intravitreal injection
Drug: Abiraterone acetate|Drug: Prednisone|Other: Androgen deprivation therapy (ADT)|Drug: Abiraterone acetate Placebo|Drug: Prednisone Placebo
Drug: brentuximab vedotin|Drug: doxorubicin|Drug: bleomycin|Drug: vinblastine|Drug: dacarbazine
Drug: epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)|Drug: gemcitabine 900 mg/m2 (days 1 and 8) and docetaxel 75 mg/m2 (day 8)|Drug: trabectedin 1.3 mg/m2|Drug: high-dose ifosfamide 14 g/m2, given in in 14 days|Drug: etoposide 150 mg/m2/day (days 1, 2, 3) and ifosfamide 3g/m2/day (days 1, 2, 3)|Drug: gemcitabine 1800 mg/m2 (day 1) and dacarbazine 500 mg/m2 (day 1)
Drug: Methotrexate|Drug: ENIA11|Drug: Placebo
Drug: Rilpivirine|Drug: Efavirenz|Drug: Tenofovir disoproxil fumarate|Drug: Emtricitabine
Drug: CXL
Drug: E/C/F/TDF|Drug: RTV|Drug: ATV|Drug: FTC/TDF|Drug: E/C/F/TDF Placebo|Drug: RTV Placebo|Drug: ATV Placebo|Drug: FTC/TDF Placebo|Drug: E/C/F/TAF
Drug: Vincristine|Drug: Aldesleukin|Drug: ch14.18/CHO|Drug: Carboplatin|Drug: Etoposide|Drug: Cisplatin|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: G-CSF|Drug: Busulfan|Drug: Melphalan
Drug: Trastuzumab Emtansine
Drug: Metformin|Other: Placebo|Procedure: Endometrial Biopsy|Behavioral: Lifestyle Intervention|Behavioral: Questionnaires
Drug: Domperidone|Behavioral: Questionnaires|Other: Phone Calls
Drug: CPX-351|Drug: 7+3 (cytarabine and daunorubicin)
Drug: Abiraterone acetate|Drug: Placebo|Drug: Prednisone
Drug: FAI insert|Drug: Sham injection
Drug: Ferric carboxymaltose|Drug: Normal saline
Drug: Epirubicin|Drug: nab-Paclitaxel|Drug: Cyclophosphamide|Drug: Docetaxel
Drug: Placebo|Drug: Vemurafenib|Drug: Cobimetinib
Drug: 8-methoxypsoralen
Drug: Lenalidomide, Bortezomib|Biological: autologous stem cell transplant|Biological: allogeneic stem cell transplant
Drug: Asenapine
Drug: Dabrafenib|Drug: Trametinib|Drug: Placebos
Drug: interferon-alpha (IFN-alpha)
Drug: Placebo|Drug: LAC triple therapy
Drug: anastrozole|Drug: everolimus|Drug: exemestane|Drug: goserelin acetate|Drug: letrozole|Drug: leuprolide acetate|Drug: tamoxifen citrate|Other: placebo
Drug: Vemurafenib|Drug: Placebo
Drug: BAF312|Drug: Placebo
Drug: Ondansetron, dexamethasone, aprepitant|Drug: Ondansetron, Dexamethasone, placebo
Drug: IXAZOMIB|Drug: Dexamethasone|Drug: Melphalan|Drug: Cyclophosphamide|Drug: Thalidomide|Drug: Lenalidomide
Drug: Idelalisib|Drug: Ofatumumab
Drug: Peginterferon a2b|Drug: Nilotinib
Drug: PRO-118|Drug: Olopatadine Hydrochloride
Drug: NOVOCART® 3D plus|Procedure: Microfracture
Drug: Gemcitabine|Drug: Pemetrexed|Drug: Cisplatin
Drug: Doxorubicin|Drug: Best Standard of Care
Drug: Tenofovir DF|Drug: TDF Placebo
Drug: Rituximab|Drug: Lenalidomide|Drug: Rituximab - CHOP|Drug: Rituximab - CVP|Drug: Rituximab - Bendamustine
Drug: Secukinumab (75 mg)|Drug: Placebo|Drug: Secukinumab (150 mg)
Drug: Nebivolol|Drug: Placebo
Drug: Polycap|Drug: Aspirin|Drug: Vitamin D|Drug: Matching Placebo
Drug: Placebo|Drug: 50 mg etanercept|Drug: 80 mg ixekizumab
Drug: carboplatin, thiotepa, and cyclophosphamide|Drug: chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
Drug: Liposomal Cytarabine
Drug: Zoledronic acid|Drug: normal saline 0.9%
Drug: 5-Fu/epirubicin/CTX following Docetaxel|Drug: Docetaxel/capecitabine followed by XEC
Drug: Prasugrel|Drug: Clopidogrel
Drug: modified FOLFOX6 + bevacizumab|Drug: FOLFOXIRI + Bevacizumab
Drug: Crizotinib|Drug: Pemetrexed/Cisplatin|Drug: Pemetrexed/Carboplatin
Drug: Tamoxifen|Drug: Tamoxifen and GnRH analogue|Drug: Exemestane and GnRH analogue
Drug: peficitinib
Drug: 2.0 mg intravitreal aflibercept|Drug: 1.25 mg intravitreal bevacizumab|Drug: 0.3 mg intravitreal ranibizumab
Drug: Fibrinogen
Drug: Eltrombopag|Drug: IVIG infusion
Drug: Indapamide / Losartan|Drug: Hyzaar®
Drug: standard chemo- or endocrine therapy|Drug: standard chemo- or endocrine therapy + Lapatinib
Drug: BIBF 1120
Drug: E2007|Drug: Placebo
Drug: Lanreotide
Drug: Radiosynoviorthesis
Drug: tisseel|Other: no tisseel
Drug: Ibrutinib|Drug: Bendamustine hydrochloride|Drug: Rituximab|Drug: Placebo
Drug: BKM120 Matching placebo|Drug: Fulvestrant|Drug: BKM120
Drug: Cholecalciferol|Drug: Inj. Progesterone
Drug: Prednisone|Drug: Deflazacort
Drug: faslodex 500mg|Drug: arimidex 1mg|Drug: faslodex dummy|Drug: arimidex dummy
Drug: Phenylephrine
Drug: Tramadol|Drug: Placebo|Behavioral: Cognitive Behavior Therapy for FM|Behavioral: Health Education
Drug: duloxetine hydrochloride|Other: placebo
Drug: colistin and meropenem|Drug: colistin and placebo
Drug: Dabrafenib|Drug: Vemurafenib|Drug: Trametinib
Drug: 80 mg ixekizumab Dosing Regimen|Drug: 50 mg etanercept|Drug: Placebo
Drug: Paclitaxel plus 5-fluorouracil|Drug: Cisplatin plus 5-fluorouracil|Radiation: Radiation therapy
Drug: Placebo and prednisone|Drug: Abiraterone acetate and prednisone
Drug: Glycocholic Acid
Drug: dabrafenib|Drug: dabrafenib plus trametinib placebo|Drug: Trametinib
Drug: nab-Paclitaxel|Drug: Paclitaxel
Drug: Apremilast tablet 20 mg|Drug: Apremilast tablet 30 mg BID|Drug: Placebo
Drug: Tissue Plasminogen Activator (Alteplase)|Drug: Placebo
Drug: Tamoxifen|Drug: Placebo
Drug: Methylprednisolone|Drug: Esomeprazole
Drug: ofatumumab|Drug: ibrutinib
Drug: Brentuximab Vedotin|Drug: Methotrexate|Drug: Bexarotene
Drug: Octreotide LAR|Drug: 177Lu-DOTA0-Tyr3-Octreotate
Drug: Lanthanum Carbonate|Drug: Calcium Carbonate
Drug: Cathflo (Alteplase)|Drug: Saline
Drug: Pazopanib Hydrochloride|Other: Pharmacological Study|Other: Placebo|Other: Quality-of-Life Assessment|Other: Questionnaire Administration
Drug: testosterone|Other: placebo
Drug: Enoxaparin|Other: Graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization
Drug: Docetaxel|Drug: Nab-paclitaxel|Drug: Paclitaxel|Drug: Pertuzumab|Drug: Trastuzumab
Drug: Cyclophosphamide|Drug: Placebo
Drug: Idelalisib|Drug: Rituximab|Drug: Bendamustine|Drug: Placebo to match idelalisib
Drug: Tamsulosin hydrochloride|Other: Placebo
Drug: Herceptin
Drug: Oral Azacitidine|Drug: Placebo
Drug: Paclitaxel|Drug: Carboplatin|Radiation: Radiotherapy|Drug: Cisplatin
Drug: Ixazomib|Drug: Lenalidomide|Drug: Dexamethasone|Drug: Placebo
Drug: HORMONOTHERAPY|Drug: CHEMOTHERAPY then HORMONOTHERAPY
Drug: Weekly cisplatin with RT|Drug: Tri-weekly cisplatin with RT
Drug: UT-15C (treprostinil diethanolamine)
Drug: UT-15C (treprostinil diethanolamine)|Drug: Placebo
Drug: Fesoterodine PR 4 mg|Drug: Fesoterodine PR 8 mg|Drug: Oxybutynin|Drug: Fesoterodine PR|Drug: Fesoterodine BIC 2 mg|Drug: Fesoterodine BIC 4 mg
Drug: lenalidomide|Drug: Placebo
Drug: intravenous lipid
Drug: Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen|Drug: Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen|Drug: Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen|Drug: Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen|Drug: Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen|Drug: Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen|Drug: Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance|Drug: Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance|Drug: High dose melphalan therapy and autologous stem cell transplant (intensive pathway only)
Drug: Exenatide Once Weekly|Drug: Placebo
Drug: Certolizumab Pegol (CZP)
Drug: Doxorubicin|Drug: Cyclophosphamide|Drug: Docetaxel|Drug: Paclitaxel
Drug: bicalutamide|Drug: buserelin|Drug: flutamide|Drug: goserelin acetate|Drug: leuprolide acetate|Drug: orteronel|Drug: triptorelin
Drug: RAD001|Drug: MMF
Drug: Gefitinib|Drug: Placebo|Drug: Pemetrexed|Drug: Cisplatin
Drug: Granisetron|Drug: Ondansetron|Behavioral: Questionnaires|Behavioral: Study Drug Diary
Drug: Vigantol oil and MCT oil
Drug: Oxaliplatin capecitabine|Drug: Oxaliplatin S-1
Drug: Core decompression/PREOB® implantation|Drug: Core decompression/placebo implantation
Drug: Arm B : mFolfirinox
Drug: Alteplase|Drug: Placebo
Drug: Everolimus|Drug: Everolimus Placebo
Drug: Anacetrapib|Drug: Placebo for Anacetrapib
Drug: peginterferon alfa-2a [Pegasys]
Drug: Abiraterone acetate|Drug: Prednisone
Drug: Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C|Drug: Rituximab, Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C
Drug: DOCETAXEL (XRP6976)|Drug: OXALIPLATIN (SR96669)|Drug: S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + CDHP (Gemeracil) + Oxo (Oteracil)
Drug: ferric carboxymaltose|Drug: NaCl (0,9%)
Drug: Nevirapine, zidovudine, lamivudine
Drug: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)|Drug: experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
Drug: cisplatinum|Radiation: Conventional radiotherapy|Radiation: Adaptive radiotherapy
Drug: caspofungin acetate|Drug: fluconazole|Drug: voriconazole|Other: laboratory biomarker analysis
Drug: 5-Aminolevulinic acid (ALA)|Drug: Placebo - ascorbic acid
Drug: Magnesium sulphate
Drug: AMR101|Drug: Placebo
Drug: Ramipril|Drug: placebo to ramipril
Drug: Sitagliptin|Drug: Metformin|Drug: Placebo to sitagliptin|Drug: Placebo to metformin|Drug: Glycemic Rescue 1|Drug: Glycemic Rescue 2|Biological: Glycemic Rescue 3
Drug: idarubicin|Biological: microtransplantation
Drug: Eflornithine plus Sulindac|Drug: Eflornithine and Placebo|Drug: Sulindac and Placebo
Drug: 24-Hour Prophylactic Cefazolin* Antibiotic Regimen|Drug: 5-Days Prophylactic Cefazolin* Antibiotic Regimen
Drug: Conventional Vincristine|Drug: Liposomal Vincristine|Drug: Ricover-scheme rituximab|Drug: optimised rituximab-schedule
Drug: Rituximab|Drug: Lenalidomide|Drug: Rituximab-CHOP|Drug: Rituximab-CVP|Drug: Rituximab-Bendamustine
Drug: Loteprednol etabonate|Drug: Prednisolones acetate
Drug: 80 mg Ixekizumab Dosing Regimens 1, 2, and 3|Drug: Placebo
Drug: Obeticholic Acid (OCA)|Drug: Placebo
Drug: Metformin|Drug: Sitagliptin + Metformin FDC|Drug: Placebo to Metformin|Drug: Placebo to Sitagliptin + Metformin FDC|Biological: Insulin|Biological: Insulin glargine
Drug: Fludarabine|Drug: Clofarabine|Drug: Busulfan|Drug: Thymoglobulin|Procedure: Stem Cell Infusion|Drug: Tacrolimus|Drug: Methotrexate
Drug: CP-690,550
Drug: Oxaliplatin
Drug: Oral micronized progesterone|Drug: placebo
Drug: Pregabalin
Drug: Chemotherapy (Induction Period)|Drug: Rituximab
Drug: Neoadjuvant chemotherapy + Interval Debulking Surgery|Procedure: Primary Debulking Surgery + Adjuvant Chemotherapy
Drug: SPARC0921|Drug: Placebo0921
Drug: Tinzaparin
Drug: ATeGe-Fresenius
Drug: Rituximab|Drug: High dose Ara-C|Drug: Dexamethasone|Drug: Bortezomib
Drug: low molecular weight heparin
Drug: Leuprorelin Acetate
Drug: AFATINIB|Drug: Placebo of AFATINIB
Drug: TOPIC MUCOPOLYSACCHARIDE POLYSULFATE CREAM 5MG/G
Drug: Low-dose rtPA|Drug: Standard-dose rtPA|Other: Intensive blood pressure (BP) lowering|Other: BP management policies
Drug: etanercept
Drug: Treprostinil sodium
Drug: Carboplatin|Drug: Cisplatin|Radiation: External Beam Radiation Therapy|Radiation: Internal Radiation Therapy|Drug: Paclitaxel|Other: Quality-of-Life Assessment
Drug: Busulfan|Drug: Melphalan|Other: Questionnaire|Drug: G-CSF|Drug: High Dose Melphalan|Procedure: Stem cell transplant
Drug: Interferon beta-1a|Drug: Ocrelizumab-matching placebo|Drug: Ocrelizumab|Drug: Interferon beta-1a-matching placebo
Drug: MIGRANE|Drug: PARCEL
Drug: Gemcitabine|Drug: Cisplatin
Drug: Gefitinib|Drug: Vinorelbine+Cisplatin
Drug: Reumatocept (etanercept)|Drug: Enbrel (etanercept)
Drug: (99m Tc) ECDG (Ethylenedicysteine-Deoxyglucose)|Drug: 18 F FDG followed by PET/CT imaging
Drug: PegIntron|Drug: Pegasys|Drug: Hydrea
Drug: oral corticosteroids|Drug: placebo
Drug: Carboplatin|Drug: Pegylated Lipoxomal Doxorubicin (PLD)|Drug: Trabectedin
Drug: Epo|Other: Control
Drug: CMV hyperimmune globulin|Other: Placebo
Drug: prasterone|Other: placebo
Drug: Asparaginase|Drug: Bortezomib|Drug: Cytarabine|Drug: Daunorubicin Hydrochloride|Drug: Etoposide|Other: Laboratory Biomarker Analysis|Drug: Mitoxantrone Hydrochloride|Other: Pharmacological Study|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Drug: Sorafenib Tosylate
Drug: Placebo SC|Drug: Placebo IV|Drug: Ustekinumab 90 mg SC q8w|Drug: Ustekinumab 130 mg IV|Drug: Ustekinumab 90 mg SC q12w
Drug: IV insulin to maintain target glucose concentration of 80-130 mg/dL|Drug: Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
Drug: Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)|Drug: Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
Drug: Brivaracetam (BRV)
Drug: 5-Fluorouracil|Drug: Carboplatin|Drug: Cyclophosphamide|Drug: Docetaxel|Drug: Doxorubicin|Drug: Epirubicin|Drug: Paclitaxel|Drug: Pertuzumab|Drug: Placebo|Drug: Trastuzumab
Drug: Tamoxifen|Drug: placebo
Drug: BEACOPPescalated (Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone)|Drug: ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)|Radiation: 30Gy IF-RT (Involved-Field Radiotherapy)|Radiation: 30Gy IN-RT (Involved-Node Radiotherapy)
Drug: Enoxaparin, Heparin
Drug: Metformin|Drug: Placebo Comparator
Drug: DCS (D-Cycloserine ) + Prolonged Imaginal Exposure|Drug: DCS (D-Cycloserine ) + Virtual Reality Exposure|Drug: Placebo + Prolonged Imaginal Exposure|Drug: Placebo (sugar pill) + Virtual Reality Exposure
Drug: efavirenz/emtricitabine/tenofovir disoproxil fumarate|Drug: etoposide
Drug: Eflornithine placebo & sulindac placebo|Drug: eflornithine & sulindac placebo|Drug: Eflornithine placebo & sulindac|Drug: Eflornithine plus sulindac
Drug: Belimumab|Drug: Placebo
Drug: Rifaximin|Drug: Placebo
Drug: Denosumab|Drug: Zoledronic acid|Drug: Placebo to Denosumab|Drug: Placebo to zoledronic acid
Drug: Civamide nasal solution 0.01%
Drug: Lenalidomide|Drug: Dexamethasone|Biological: Elotuzumab (BMS-901608; HuLuc63)
Drug: Obinutuzumab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone|Drug: Bendamustine|Drug: Rituximab
Drug: Canakinumab|Drug: Placebo|Drug: Standard of care
Drug: Famciclovir|Drug: Aciclovir
Drug: Pixantrone + Rituximab|Drug: Gemcitabine + Rituximab
Drug: Bupivacaine & Triamcinolone Acetonide|Other: No intervention except EUS procedure
Drug: Ropivacaine + opioid epidurally|Drug: Morphine
Drug: Docetaxel Cyclophosphamide|Drug: Cyclophosphamide Fluorouracil Epirubicin Docetaxel|Drug: Epirubicin Cyclophosphamide Paclitaxel
Drug: Cabazitaxel (XRP6258)|Drug: Docetaxel (XRP6976)|Drug: Prednisone
Drug: Capecitabine (Xeloda)|Radiation: 50.4 Gy|Procedure: Transanal Endoscopic Microsurgery|Procedure: Total Mesorectal Excision
Drug: 5-Fluorouracil|Drug: Leucovorin|Drug: Oxaliplatin|Drug: Capecitabine
Drug: caspofungin acetate|Drug: fluconazole|Other: laboratory biomarker analysis
Drug: Apremilast 20mg|Drug: Apremilast 30mg|Drug: Placebo
Drug: MabCampath-1h
Drug: Placebo|Drug: Mirtazapine
Drug: RhIGF-1 with transdermal 17-beta estradiol|Drug: Placebo and transdermal 17-beta estradiol
Drug: Clarithromycin|Drug: Moxifloxacin
Drug: NPSP558
Drug: Bendamustine IV|Other: Treatment of Physicians Choice
Drug: caspofungin acetate
Drug: RCHOP21
Drug: S-1 (Tegafur/Gimeracil/Oteracil) /cisplatin (investigational arm)|Drug: Fluorouracil/cisplatin (control arm)
Drug: Darunavir|Drug: Ritonavir
Drug: Cyclophosphamide|Drug: Docetaxel|Drug: Doxorubicin Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Other: Quality-of-Life Assessment|Biological: Trastuzumab
Drug: Anastrozole|Drug: Exemestane|Other: Laboratory Biomarker Analysis|Drug: Letrozole|Other: Quality-of-Life Assessment|Drug: Systemic Chemotherapy|Drug: Tamoxifen Citrate
Drug: Regorafenib (Stivarga, BAY73-4506)|Drug: Placebo|Drug: Best supportive care
Drug: Azithromycin|Drug: Placebo control
Drug: Rilpivirine
Drug: riluzole|Drug: Placebo medication
Drug: Dapagliflozin|Drug: placebo
Drug: Anacetrapib|Drug: Placebo anacetrapib
Drug: Paclitaxel|Drug: RAD001
Drug: Polypill
Drug: Tacrolimus from EMS|Drug: Prograf
Drug: ruxolitinib tablets|Other: Best Available Therapy (BAT)
Drug: Lenalidomide|Other: Placebo
Drug: linagliptin|Drug: glimepiride|Drug: linagliptin placebo|Drug: glimepride placebo
Drug: ON 01910.Na
Drug: Lenalidomide|Drug: Dexamethasone|Drug: Dexamethasone (Oral)|Drug: Dexamethasone (IV)|Biological: Elotuzumab (BMS-901608; HuLuc63)
Drug: Cytarabine|Drug: Etoposide|Drug: All-trans retinoic acid (ATRA)
Drug: pazopanib|Drug: placebo
Drug: Metformin XR plus placebo|Drug: Metformin XR plus liraglutide
Drug: adult human mesenchymal stem cells
Drug: carboplatin|Drug: 5 fluorouracil|Radiation: radiation therapy
Drug: vincristine sulfate|Drug: doxorubicin hydrochloride|Drug: cyclophosphamide|Drug: ifosfamide|Drug: etoposide|Drug: topotecan hydrochloride|Other: laboratory biomarker analysis
Drug: GSK1349572|Drug: Raltegravir|Drug: GSK1349572 Placebo|Drug: Raltegravir Placebo
Drug: ATRA|Drug: ATRA + IDA
Drug: co.don chondrosphere®|Procedure: Microfracture
Drug: Betamethasone 3 MG/ML|Drug: Placebo
Drug: 5-Fluorouracil, Epirubicin, Cyclophosphamide, Docetaxel
Drug: tasimelteon
Drug: Haloperidol|Drug: Ziprasidone|Drug: Placebo
Drug: Diurisa®|Drug: Lasix ®
Drug: oxymorphone HCl
Drug: Bortezomib, Melphalan, Prednisone (VMP)|Drug: 1 or 2 cycle(s) HDM (High Dose Melphalan)|Drug: 2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)
Drug: Lenalidomide|Drug: Bortezomib|Drug: Dexamethasone|Procedure: Autologous Stem Cell Transplant
Drug: TOPIC MUCOPOLYSACCHARIDE POLYSULFATE 5MG/G
Drug: FTY720
Drug: Rituximab SC|Drug: Rituximab IV|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone/Prednisolone
Drug: open-label PTH(1-84)
Drug: zoledronic acid
Drug: Carboplatin|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Other: Quality-of-Life Assessment|Radiation: Radiation Therapy|Procedure: Therapeutic Conventional Surgery|Biological: Trastuzumab
Drug: Ocrelizumab|Other: Placebo
Drug: Omega-3 fish oil lipid emulsion
Drug: Lenalidomide, Bortezomib
Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Doxorubicin Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Pegaspargase|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Drug: Thioguanine|Drug: Vincristine Sulfate
Drug: paracetamol|Drug: dypirone
Drug: Pomalidomide 0.5 mg|Drug: Placebo
Drug: Caroverin
Drug: EC145|Drug: Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®)|Drug: placebo|Drug: EC20
Drug: lapatinib|Drug: trastuzumab|Drug: Aromatase inhibitor
Drug: Riboflavin/Dextran|Drug: Hypotonic Riboflavin
Drug: celecoxib|Drug: 5-fluorouracil|Other: placebo|Drug: oxaliplatin|Drug: leucovorin
Drug: bortezomib (Velcade)|Drug: cyclophosphamide|Drug: G-CSF
Drug: SAR153191 (REGN88)
Drug: adjuvant chemotherapy|Procedure: standard two field Lymphadenectomy|Procedure: Total two field Lymphadenectomy|Procedure: three field Lymphadenectomy
Drug: Epirubicin, CTX, Paclitaxel|Drug: Epirubicin, Paclitaxel
Drug: Aripiprazole
Drug: Paclitaxel/Cisplatin|Radiation: Reduced RT|Drug: 5-FU/Cisplatin|Radiation: Standard RT
Drug: BIBW 2992|Drug: trastuzumab|Drug: vinorelbine
Drug: Lenalidomide|Drug: Placebo
Drug: everolimus|Other: placebo
Drug: PEG-L-asparaginase|Drug: cyclophosphamide|Drug: cytarabine|Drug: daunorubicin hydrochloride|Drug: dexamethasone|Drug: doxorubicin hydrochloride|Drug: etoposide|Drug: ifosfamide|Drug: mercaptopurine|Drug: methotrexate|Drug: prednisone|Drug: thioguanine|Drug: vincristine sulfate|Drug: vindesine|Drug: daunoxome|Drug: fludarabine|Radiation: Radiation Therapy
Drug: ACT-293987
Drug: Lenalidomide|Drug: lenalidomide, bortezomib and dexamethasone
Drug: trastuzumab monotherapy|Drug: trastuzumab and chemotherapy
Drug: Oral Naltrexone (ON)|Drug: Implantable Naltrexone (IN)
Drug: Cisplatin|Radiation: External Beam Radiation Therapy|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Other: Quality-of-Life Assessment
Drug: Once-daily insulin detemir
Drug: brentuximab vedotin|Drug: placebo
Drug: liposomal vincristine sulfate|Other: clinical observation|Radiation: 3-dimensional conformal radiation therapy|Drug: carboplatin|Drug: cyclophosphamide|Drug: etoposide|Drug: cisplatin|Other: laboratory biomarker analysis
Drug: Melphalan, Prednisone, Lenalidomide|Drug: Cyclophosphamide, Prednisone, Lenalidomide|Drug: Lenalidomide, dexamethasone
Drug: oxaliplatin
Drug: Cyclophosphamide|Drug: Lenalidomide|Drug: Dexamethasone|Drug: Melphalan
Drug: Lenalidomide, Dexamethasone|Drug: Lenalidomide, Dexamethasone, PBSCT
Drug: Bacille Calmette-Guerin|Drug: uracil-tegafur
Drug: Entecavir|Drug: Placebo
Drug: Ofatumumab and Bendamustine infusions (Arm A)|Drug: Bendamustine infusion (Arm B)
Drug: ETOPOSIDE - Usual|Drug: ETOPOSIDE - Study
Drug: onaBoNT-A|Drug: Oxybutynin ER
Drug: Biperiden Lactate|Drug: Placebo
Drug: Treprostinil diethanolamine
Drug: paclitaxel/anthracycline
Drug: Doxorubicin Hydrochloride|Other: Laboratory Biomarker Analysis|Other: Pharmacogenomic Study|Drug: Sorafenib Tosylate
Drug: Carboplatin|Drug: Cisplatin|Drug: Cyclophosphamide|Drug: Dactinomycin|Drug: Doxorubicin|Drug: Etoposide|Drug: Irinotecan|Drug: Leucovorin|Drug: Methotrexate|Drug: Temozolomide|Drug: Vincristine
Drug: Cisplatin|Drug: Doxorubicin Hydrochloride|Drug: Doxorubicin-Eluting Beads|Other: Laboratory Biomarker Analysis|Drug: Mitomycin|Other: Pharmacological Study|Other: Placebo|Drug: Sorafenib Tosylate
Drug: Hydroxyprogesterone Caproate Injection, 250mg/mL|Drug: Vehicle
Drug: docetaxel - cisplatin - 5-fluorouracil|Radiation: radiotherapy|Drug: cetuximab|Drug: cisplatin
Drug: LNG20|Drug: Mirena
Drug: Rituximab|Radiation: Involved field irradiation
Drug: Liposomal cytarabine|Drug: Intrathecal triple
Drug: Clopidogrel|Drug: placebo
Drug: Senna alexandrina and associations
Drug: 800 mg QD Eslicarbazepine acetate|Drug: 1200 mg QD Eslicarbazepine acetate|Drug: Placebo
Drug: Eslicarbazepine acetate (BIA 2-093)|Drug: Eslicarbazepine acetate
Drug: Zoledronic acid|Drug: Busulfan|Drug: Treosulfan
Drug: Pemetrexed|Drug: Cisplatin|Biological: Necitumumab
Drug: carboplatin|Drug: cisplatin|Drug: paclitaxel
Drug: Etravirine
Drug: Cisplatin|Drug: Doxorubicin Hydrochloride|Drug: Fluorouracil|Drug: Irinotecan Hydrochloride|Other: Laboratory Biomarker Analysis|Procedure: Liver Transplantation|Drug: Temsirolimus|Procedure: Therapeutic Conventional Surgery|Drug: Vincristine Sulfate
Drug: Calcium Dobesilate
Drug: temozolomide|Radiation: 3-dimensional conformal radiation therapy|Radiation: intensity-modulated radiation therapy
Drug: FOLFOX regimen|Drug: fluorouracil|Drug: leucovorin calcium|Drug: oxaliplatin|Drug: XELOX regimen|Drug: Capecitabine
Drug: Escitalopram|Drug: Wellbutrin XL
Drug: Nimotuzumab|Drug: Placebo
Drug: Carboplatin|Drug: Ifosfamide|Drug: Paclitaxel|Other: Quality-of-Life Assessment
Drug: Pemetrexed|Drug: Carboplatin|Drug: Paclitaxel|Biological: Bevacizumab
Drug: Transdermal 17Beta-estradiol, progesterone|Drug: Ethinyl Estradiol + Desogestrel|Dietary Supplement: Sham Comparator
Drug: Varenicline|Drug: Bupropion|Other: Placebo|Behavioral: Counseling/Phone Calls
Drug: Carboplatin|Drug: Cisplatin|Radiation: Internal Radiation Therapy|Drug: Paclitaxel|Other: Quality-of-Life Assessment|Radiation: Radiation Therapy
Drug: bicalutamide|Drug: buserelin|Drug: flutamide|Drug: goserelin acetate|Drug: leuprolide acetate|Drug: triptorelin|Radiation: 3-dimensional conformal radiation therapy|Radiation: intensity-modulated radiation therapy
Drug: tafamidis
Drug: ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)
Drug: Tafamidis
Drug: Axitinib (AG-013736)|Drug: Sorafenib
Drug: Lenalidomide|Drug: Chlorambucil
Drug: Sorafenib (Nexavar, BAY43-9006)|Drug: Sorafenib (Nexavar, BAY43-9006) + Erlotinib, Tarceva
Drug: Gemtuzumab Ozogamicin (Mylotarg)|Drug: standard chemotherapy
Drug: Intravenous Immunoglobulins|Drug: plasma volume expander
Drug: bevacizumab|Drug: docetaxel|Drug: doxorubicin|Drug: cyclophosphamide|Drug: pegfilgrastim
Drug: Pre-radiotherapy commencement of anastrozole|Radiation: Radiotherapy|Drug: Post radiotherapy commencement of anastrozole
Drug: concomitant temozolomide (TMZ)|Radiation: radiotherapy|Drug: procarbazine|Drug: adjuvant temozolomide (TMZ)|Drug: CCNU|Drug: vincristine
Drug: Azacitidine
Drug: neratinib|Other: placebo
Drug: Rituximab|Drug: Rituximab / observation
Drug: trofosfamide, idarubicin, etoposide
Drug: Selenium|Drug: Placebo (for Selenium)
Drug: Riociguat (BAY63-2521)
Drug: PTH1-84 in parent study
Drug: sapropterin dihydrochloride
Drug: dimethyl fumarate|Drug: Placebo
Drug: Copper Histidine
Drug: AndroGel® (testosterone gel)|Drug: Placebo
Drug: dtEC?dtT|Drug: FEC?T
Drug: HAART
Drug: Paclitaxel|Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation|Drug: Ixabepilone|Biological: Bevacizumab|Other: Questionnaire Administration|Other: Laboratory Biomarker Analysis
Drug: Ambrisentan
Drug: MITOTANE
Drug: Lapatinib Ditosylate|Biological: Trastuzumab|Drug: Paclitaxel|Other: Laboratory Biomarker Analysis
Drug: follicle stimulating hormone
Drug: chlorambucil, tablets|Drug: ofatumumab (GSK1841157) infusion
Drug: Sildenafil
Drug: ABVD (Adriamycin, Bleomycin, Vincristine, Dacarbazine)|Radiation: 20 Gy IFRT (Involved Field Radiotherapy)
Drug: M-VTD-PACE|Drug: TT3-LITE Regimen (L-TT3)
Drug: Pazopanib|Drug: Sunitinib
Drug: Nilotinib|Drug: Imatinib
Drug: dexamethasone|Drug: mercaptopurine|Drug: methotrexate|Drug: vincristine sulfate
Drug: Cytarabine|Drug: Daunorubicin|Drug: Etoposide|Drug: Clofarabine|Device: CliniMACS
Drug: Lapatinib|Drug: Placebo|Drug: Capecitabine|Drug: Oxaliplatin
Drug: letrozole|Drug: Placebo
Drug: triptorelin|Procedure: adjuvant therapy|Radiation: 3-dimensional conformal radiation therapy
Drug: Adjuvant therapy|Drug: Neoadjuvant therapy|Radiation: Brachytherapy(iodine I 125)
Drug: Levodopa-carbidopa intestinal gel|Device: CADD-Legacy® 1400 ambulatory infusion pump
Drug: Placebo|Drug: Exenatide
Drug: irbesartan|Drug: methylprednisolone (MP) or prednisone (pred)|Drug: mycophenolate mofetil (MMF)
Drug: cetuximab|Drug: cisplatin|Drug: paclitaxel|Radiation: radiation therapy
Drug: docetaxel
Drug: cytarabine|Drug: daunorubicin|Drug: midostaurin|Other: placebo|Drug: dexamethasone acetate
Drug: Bortezomib|Drug: Dexamethasone|Other: Laboratory Biomarker Analysis|Drug: Lenalidomide
Drug: ipilimumab|Drug: Placebo
Drug: cyclophosphamide|Drug: Docetaxel|Drug: epirubicin hydrochloride|Drug: fluorouracil|Drug: ixabepilone
Drug: temozolomide|Genetic: DNA methylation analysis|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: quality-of-life assessment|Radiation: radiation therapy
Drug: Sorafenib (Nexavar, BAY43-9006)
Drug: Myeloablative Chemotherapy Regimen for Lymphoid Malignancies or Cord Blood Unit Recipients|Drug: Myeloablative Chemotherapy Regimen for Non-Cord Blood Unit Recipients with Myeloid Malignancies|Other: Hematopoietic Progenitor Cell Transplantation (HPCT)|Radiation: CNS radiation treatment for ALL with prior CNS disease patients
Drug: Alprostadil
Drug: cetuximab|Drug: Carboplatin, 5FU concomitant|Radiation: Radiotherapy
Drug: droxidopa|Drug: placebo|Drug: alpha-methyldopa|Drug: carbidopa|Drug: metyrosine|Drug: levodopa|Drug: atomoxetine|Drug: metoclopramide
Drug: Velcade|Drug: Thalidomide|Drug: Dexamethasone|Drug: Adriamycin|Drug: Cisplatin|Drug: Cyclophosphamide|Drug: Etoposide
Drug: bicalutamide|Drug: flutamide|Radiation: radiation therapy
Drug: Pertuzumab|Drug: Placebo|Drug: Trastuzumab|Drug: Docetaxel
Drug: Erythropoietin|Drug: Methylprednisolone
Drug: placebo|Drug: Alcohol
Drug: vincristine sulfate|Drug: daunorubicin hydrochloride|Drug: cyclophosphamide|Drug: pegaspargase|Drug: asparaginase|Drug: prednisone|Drug: methylprednisolone|Drug: dexamethasone|Drug: cytarabine|Drug: methotrexate|Drug: therapeutic hydrocortisone|Biological: filgrastim|Drug: leucovorin calcium|Drug: etoposide|Drug: mercaptopurine|Drug: lestaurtinib|Other: laboratory biomarker analysis|Other: pharmacological study
Drug: Placebo|Drug: Denosumab|Drug: Non-steroidal aromatase inhibitor therapy
Drug: Lapatinib|Biological: Trastuzumab|Drug: Paclitaxel
Drug: Melphalan|Drug: Lenalidomide|Drug: Prednisone
Drug: Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine|Drug: Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
Drug: anastrozole|Drug: exemestane|Drug: letrozole|Drug: tamoxifen citrate
Drug: bicalutamide|Drug: goserelin acetate|Drug: leuprolide acetate|Procedure: adjuvant therapy|Procedure: quality-of-life assessment|Radiation: radiation therapy
Drug: Carboplatin|Drug: Docetaxel
Drug: Rituximab|Drug: BEACOPP escalated
Drug: Cyclophosphamide|Drug: Epirubicin Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Procedure: Therapeutic Conventional Surgery|Biological: Trastuzumab
Drug: lapatinib in combination with capecitabine
Drug: Docetaxel|Drug: Doxorubicin|Drug: Cyclophosphamide
Drug: Lapatinib|Biological: Trastuzumab
Drug: arsenic trioxide|Drug: idarubicin|Drug: mercaptopurine|Drug: methotrexate|Drug: all-trans retinoic acid|Drug: all-trans retinoic acid (ATRA)
Drug: adult human mesenchymal stem cells|Drug: Placebo
Drug: leflunomide|Drug: methotrexate|Drug: ocrelizumab|Drug: placebo
Drug: nilotinib|Drug: imatinib
Drug: Paliperidone ER
Drug: chloroquine|Drug: dehydroepiandrosterone sulphate
Drug: anthracycline-based|Drug: docetaxel and capecitabine
Drug: Dalteparin|Other: Placebo
Drug: lenalidomide|Drug: placebo
Drug: docetaxel|Drug: LHRH agonist|Procedure: surgery
Drug: Dexamethasone|Drug: Etoposide|Drug: Cyclosporin|Procedure: Intrathecal therapy|Procedure: Stem cell transplant
Drug: Oral Insulin
Drug: Vandetanib|Drug: Pemetrexed
Drug: General anesthesia and opioids|Drug: Regional analgesia and propofol
Drug: tamoxifen|Drug: triptorelin|Drug: letrozole|Drug: zoledronic acid
Drug: ZD6474 (Vandetanib)
Drug: cisplatin+capecitabine|Radiation: radiotherapy|Drug: epirubicin+cisplatin+capecitabine
Drug: Erlotinib|Drug: Placebo
Drug: asparaginase|Drug: cyclophosphamide|Drug: cytarabine|Drug: dexamethasone|Drug: dexrazoxane hydrochloride|Drug: doxorubicin hydrochloride|Drug: etoposide|Drug: leucovorin calcium|Drug: mercaptopurine|Drug: methotrexate|Drug: methylprednisolone|Drug: pegaspargase|Drug: prednisolone|Drug: therapeutic hydrocortisone|Drug: vincristine sulfate|Radiation: radiation therapy
Drug: propafenone|Drug: flecainide|Drug: dofetilide|Drug: sotolol|Device: Pulmonary vein ablation|Drug: Amiodarone
Drug: Fulvestrant|Other: Laboratory Biomarker Analysis|Drug: Lapatinib Ditosylate|Other: Placebo
Drug: thiotepa|Drug: cyclophosphamide|Drug: tacrolimus|Drug: methotrexate|Drug: sirolimus|Radiation: total body irradiation
Drug: Letrozole|Other: Placebo
Drug: Capecitabine|Drug: Adjuvant chemotherapy using PF (5-Fluorouracil )|Drug: Induction chemotherapy using PF (5-Fluorouracil)
Drug: Adjuvant chemotherapy (gemcitabine and cisplatin)
Drug: veliflapon (DG-031)
Drug: ketamine
Drug: liposomal doxorubicin|Drug: carboplatin|Drug: paclitaxel
Drug: autologous immunoglobulin idiotype-KLH conjugate vaccine|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: prednisone|Drug: rituximab|Drug: sargramostim|Drug: vincristine|Procedure: Intervention/procedure|Procedure: antibody therapy|Procedure: biological therapy|Procedure: chemotherapy|Procedure: colony-stimulating factor therapy|Procedure: cytokine therapy|Procedure: monoclonal antibody therapy|Procedure: non-specific immune-modulator therapy|Procedure: therapeutic procedure|Procedure: tumor cell derivative vaccine|Procedure: vaccine therapy
Drug: Campto, Topotesin|Drug: TS-1|Drug: L-Plat|Drug: Isovorin|Drug: 5-FU
Drug: Retigabine (INN), Ezogabine (USAN)
Drug: Anastrozole|Drug: Exemestane|Other: Laboratory Biomarker Analysis|Drug: Letrozole|Other: Quality-of-Life Assessment|Radiation: Radiation Therapy|Drug: Tamoxifen Citrate
Drug: androgen-deprivation therapy|Drug: docetaxel
Drug: Traumeel S: intra-operative irrigation + oral ingestion|Drug: Placebo
Drug: Goserelin|Drug: Estradiol
Drug: Anastrozole
Drug: Dexamethasone|Drug: Prednisone|Drug: docetaxel|Drug: Oral antiandrogen|Radiation: Radiation therapy|Drug: LHRH agonist
Drug: lapatinib (GW572016) oral tablets|Drug: paclitaxel infusion
Drug: lapatinib|Drug: paclitaxel|Drug: trastuzumab
Drug: cetuximab|Drug: cisplatin|Radiation: Accelerated Fractionation by Concomitant Boost|Radiation: Intensity-modulated radiation therapy
Drug: anastrozole|Drug: exemestane|Drug: letrozole|Procedure: Therapeutic Conventional Surgery
Drug: topiramate
Drug: Androgen blockade + radiation therapy
Drug: Poly I: Poly C12U (Rintatolimod)
Drug: celecoxib
Drug: chlorambucil (drug)|Drug: rituximab+chlorambucil|Drug: rituximab
Drug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone|Drug: Fludarabine|Drug: Interferon-alpha|Drug: pegylated formula Interferon-alpha 2b|Procedure: chemotherapy: R-CHOP|Procedure: chemotherapy: R-FC|Procedure: Interferon maintenance|Procedure: Rituximab maintenance
Drug: NACT|Procedure: Radical abdominal hysterectomy (class III), BPLND & lower para aortic lymph node sampling|Drug: Inj.Cisplatin|Radiation: Concurrent chemo radiotherapy
Drug: Tab Premarin (Ethinyl estradiol)|Drug: Placebo
Drug: Tiagabine|Drug: Placebo
Drug: Brivaracetam (ucb 34714)
Drug: Prednisone, Dexamethasone, Vincristine, Daunorubicin|Drug: Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase|Drug: Methotrexate, Cyclophosphamide, Cytarabine, Etoposide|Drug: Mercaptopurine, Imatinib|Procedure: chemotherapy, intrathecal chemotherapy|Procedure: steroid therapy, hematopoietic stem cell transplantation
Drug: Cisplatin|Drug: Doxorubicin Hydrochloride|Drug: Etoposide|Drug: Ifosfamide|Drug: Methotrexate|Biological: Peginterferon Alfa-2b|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Procedure: Therapeutic Conventional Surgery
Drug: bevacizumab|Drug: erlotinib HCl|Drug: placebo
Drug: Docetaxel|Drug: Capecitabine
Drug: paclitaxel|Drug: Fluorouracil|Drug: Epirubicin|Drug: Cyclophosphamide
Drug: clodronate disodium|Drug: ibandronate sodium|Drug: zoledronic acid
Drug: Flutamide (Eulexin) and Lupron or Zoladex|Radiation: External Beam Radiotherapy
Drug: Docetaxel|Drug: Androgen Hormonal Suppression and Radiation|Drug: Androgen Suppression Therapy and Radiation Therapy
Drug: Radioactive iodine
Drug: Cyclophosphamide|Radiation: Radiotherapy|Drug: Vincristine|Drug: Prednisolone|Drug: Rituximab
Drug: Fulvestrant
Drug: Dexamethasone|Other: Laboratory Biomarker Analysis|Drug: Lenalidomide|Drug: Thalidomide
Drug: anastrozole|Drug: placebo
Drug: anastrozole|Drug: fulvestrant
Drug: tamoxifen citrate|Drug: Anastrozole
Drug: exemestane|Drug: tamoxifen|Drug: triptorelin
Drug: Exemestane|Other: Laboratory Biomarker Analysis|Procedure: Oophorectomy|Other: Quality-of-Life Assessment|Radiation: Radiation Therapy|Drug: Tamoxifen|Drug: Triptorelin
Drug: Carboplatin|Drug: Cisplatin|Drug: Doxorubicin Hydrochloride|Biological: Filgrastim|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Biological: Pegfilgrastim|Other: Quality-of-Life Assessment
Drug: bicalutamide|Drug: buserelin|Drug: cyproterone acetate|Drug: docetaxel|Drug: estramustine phosphate sodium|Drug: flutamide|Drug: goserelin acetate|Drug: leuprolide acetate|Drug: nilutamide|Drug: triptorelin|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy
Drug: cisplatin|Radiation: Standard fractionation RT|Radiation: Accelerated fractionation radiation therapy|Procedure: Conventional surgery for select patients
Drug: Chemotherapy|Radiation: Radiotherapy|Procedure: Surgery
Drug: Aromatase Inhibition Therapy|Drug: Cyclophosphamide|Drug: Doxorubicin Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Drug: Tamoxifen Citrate|Biological: Trastuzumab
Drug: Casodex|Drug: Eulexin|Drug: LHRH agonist|Radiation: radiation therapy
Drug: Herceptin (Her)|Drug: Herceptin (Her) + chemo
Drug: asparaginase|Drug: cyclophosphamide|Drug: cytarabine|Drug: daunorubicin hydrochloride|Drug: dexamethasone|Drug: doxorubicin hydrochloride|Drug: leucovorin calcium|Drug: mercaptopurine|Drug: methotrexate|Drug: prednisone|Drug: thioguanine|Drug: vincristine sulfate|Radiation: radiation therapy
Drug: bicalutamide|Drug: goserelin|Drug: mitoxantrone hydrochloride|Drug: prednisone
Drug: tamoxifen citrate|Procedure: adjuvant therapy|Radiation: radiation therapy
Drug: bicalutamide|Radiation: radiation therapy|Drug: placebo
Drug: CAF regimen|Drug: CMF regimen|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: fluorouracil|Drug: methotrexate|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy
Drug: Dendritic cell immunotherapy
Drug: Abacavir sulfate|Drug: Efavirenz|Drug: Emtricitabine|Drug: Stavudine
Drug: Topical ocular hypotensive eye drops.
Drug: Gastrogra?n|Other: Saline solution (control treatment)
Drug: Quetiapine|Other: Placebo
Drug: SUBA itraconazole|Drug: Conventional itraconazole
Drug: RT001
Drug: Edoxaban|Drug: Enoxaparin
Drug: JR-141
Drug: Gabapentin 300mg
Drug: Rivaroxaban 15 mg|Drug: Warfarin
Drug: EffCaMgCit|Other: CaAcS
Drug: Dexamethasone|Drug: vincristine|Drug: Cyclophosphamide|Drug: Idarubicin|Drug: Pegaspargase|Drug: Adriamycin|Drug: Methotrexate|Drug: 6-mercaptopurine.|Drug: Etoposide|Drug: Cytarabine|Procedure: Bone marrow aspiration|Procedure: Intrathecal injection|Radiation: Radiation therapy|Genetic: NGS|Procedure: allogeneic hematopoietic stem cell transplantation|Diagnostic Test: Flow-MRD|Diagnostic Test: FISH|Diagnostic Test: Flow immunophenotyping|Diagnostic Test: Karyotyping|Drug: Chidamide|Diagnostic Test: PET-CT scan
Drug: Chidamide|Drug: Dasatinib
Drug: intraarticular radiofrequency + intraarticular methylprednisolone|Drug: intraarticular methylprednisolone
Drug: TGF|Drug: TGFP
Drug: immunoglobulin IV
Drug: Masitinib
Drug: Chidamide|Drug: Dexamethasone|Drug: vincristine|Drug: Cyclophosphamide|Drug: Idarubicin|Drug: Pegaspargase|Drug: Adriamycin|Drug: Methotrexate|Drug: 6-Mercaptopurine|Drug: Etoposide|Drug: Cytarabine|Procedure: Bone marrow aspiration|Procedure: Intrathecal injection|Radiation: Radiation therapy|Genetic: NGS|Procedure: allogeneic hematopoietic stem cell transplantation|Diagnostic Test: Flow-MRD|Diagnostic Test: FISH|Diagnostic Test: Flow immunophenotyping|Diagnostic Test: Karyotyping
Drug: tildrakizumab 200 mg (two 1-mL injections of 100 mg/mL)|Drug: tildrakizumab 100 mg (one 1-mL injection of 100 mg/mL + 1 mL placebo)
Drug: Prednisone, cyclophosphamide
Drug: Clomiphene Citrate 50mg|Drug: Cabergoline Oral Tablet|Drug: Placebo Oral Tablet
Drug: Betamethason Sodium Phosphate|Drug: Normal saline
Drug: Daclatasvir and sofosbuvir
Drug: Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination|Other: Placebo
Drug: Astragalus Powder|Other: Routine medical care (active comparator)
Drug: Teduglutide + Normal Saline|Drug: Teduglutide + L-NMMA|Drug: Placebo + L-NMMA
Drug: Carboplatin|Drug: Cisplatin|Drug: Doxorubicin|Drug: Etoposide|Drug: Fluorouracil|Drug: Gemcitabine|Drug: Irinotecan|Other: Laboratory Biomarker Analysis|Drug: Oxaliplatin|Other: Patient Observation|Drug: Sorafenib|Drug: Vincristine Sulfate
Drug: Ropivacaine|Drug: Normal saline
Drug: herbal patch|Drug: placebo patch
Drug: Dronabinol|Drug: Placebo
Drug: Decitabine|Drug: Busulfan (BU)|Drug: Fludarabine(Flu)
Drug: Normal saline|Drug: Ondansetron 4 MG|Drug: Ondansetron 8mg
Drug: Sodium Lactate light dose|Drug: Sodium Lactate high dose|Drug: Normal saline
Drug: Albendazole|Drug: Albendazole and Ivermectin
Drug: MELATONIN (HIGH DOSE)|Drug: MELATONIN (LOW DOSE)|Drug: PLACEBO
Drug: Placebo oral capsule|Drug: Tamsulosin
Drug: Nicotine patch|Drug: Varenicline|Genetic: Nicotine metabolism|Genetic: Genetically-informed lung cancer risk score|Behavioral: NCI "Clearing the Air"
Drug: Mifepristone|Drug: Placebo
Drug: Methotrexate|Drug: Placebo|Drug: Folic Acid
Drug: Misoprostol Pfizer Brand|Other: Non-insertion of Misoprostol Pfizer Brand
Drug: Letrozole Plus Low-Dose Metronomic Capecitabine|Drug: EC-T
Drug: Metformin Hydrochloride 1000Mg Tablet|Drug: Placebo Oral Tablet
Drug: Gentamicin Sulfate|Drug: Saline
Drug: prednisolone|Drug: Acetyl Salicylic acid
Drug: Tacrolimus|Drug: Tacrolimus (Tacrolimus elimination)|Drug: Sirolimus|Drug: MMF and/or steroids
Drug: Ketamine Hydrochloride 50Mg/1mL Solution for Injection|Drug: Ketamine Hcl 50Mg/Ml Inj
Drug: MIBI-Tc99m/Iodine-123
Drug: Nalbuphine ER Tablets
Drug: Gabapentin|Drug: Tramadol|Drug: Panadol
Drug: F-DCFPyL Injection|Diagnostic Test: PSMA PET
Drug: Aspirin Low Dose|Drug: Placebo Oral Tablet
Drug: Simvastatin 10mg|Drug: sofosbuvir plus daclatasvir plus ribavirin
Drug: Misoprostol
Drug: Aripiprazole|Drug: Paliperidone|Other: Treatment as Usual
Drug: Vortioxetine|Other: Treatment as Usual
Drug: Vasopressin|Drug: Norepinephrine
Drug: BI 655130|Drug: Placebo
Drug: Sofosbuvir|Drug: Daclatasvir|Drug: Pegylated Interferon alfa-2a
Drug: Estradiol|Drug: Placebo Oral Tablet|Drug: Misoprostol
Drug: Placebo Medication|Drug: Metformin
Drug: Placebo|Drug: Selenium
Drug: Doxycycline|Drug: Standard of care therapy
Drug: Rifampicin|Drug: Isoniazid|Drug: Pyrazinamide|Drug: Ethambutol|Drug: Linezolid|Drug: Clofazimine|Drug: Rifapentine|Drug: Levofloxacin|Drug: Bedaquiline
Drug: Rifapentine daily for 6 weeks|Drug: Rifapentine and Isoniazid weekly for 12 weeks|Drug: Rifampin and Isoniazid daily for 12 weeks|Drug: Rifampin daily for 16 weeks
Drug: BCX7353
Drug: Rifaximin delayed released 400mg Tablet|Other: Placebo
Drug: Cannabidiol|Drug: Placebo oral capsule
Drug: Magnesium Sulfate|Drug: Pabrinex
Drug: Guselkumab Dose 1|Drug: Guselkumab Dose 2|Drug: Guselkumab Dose 3|Drug: Guselkumab Dose 4|Drug: Guselkumab Dose 5|Drug: Guselkumab|Drug: Ustekinumab|Drug: Placebo
Drug: Progesterone|Device: Mirena®|Drug: GnRH agonist
Drug: JCM-16021|Drug: Placebo
Drug: norepinephrine versus midodrine & octreotide
Drug: Nitric Oxide|Drug: Placebo|Device: INOmax
Drug: Botulinic toxin|Drug: Placebo
Drug: Placebo|Drug: sodium nitrite 45 mg|Drug: sodium nitrite 60 mg
Drug: Metformin|Drug: Pioglitazone|Drug: Placebo
Drug: 0.25% Timolol gel with paraffin gauze dressings|Other: Vaseline dressing
Drug: Isosorbide Mononitrate XL (ISMN)|Drug: Cilostazol|Drug: ISMN XL and Cilostazol|Other: Neither ISMN nor cilostazol
Drug: TRx0237 8 mg/day|Drug: Placebo
Drug: Teduglutide|Drug: Placebo
Drug: WSE|Drug: Placebo Oral Tablet
Drug: Ketamine|Drug: Midazolam|Drug: Placebo
Drug: Insulin Tregopil|Drug: Insulin Aspart
Drug: Dydrogesterone Oral Tablet|Drug: Placebo Oral Tablet
Drug: Rivaroxaban|Drug: ASA
Drug: Vinorelbine|Drug: Gemcitabine|Drug: Cisplatin|Drug: Capecitabine
Drug: CardioCell|Drug: Placebos
Drug: Standard Medical Therapy|Drug: Growth Hormone
Drug: The Yi-Qi-Qing-Jie Herbal Compound|Drug: Immunosuppressive Agents|Other: Optimized Supportive Care|Other: Yi-Qi-Qing-Jie herbal compound placebo
Drug: G-CSF|Drug: Standard Medical Therapy
Drug: Morphine Sulfate|Drug: Triamcinolone Acetonide
Drug: Suvorexant 20 mg
Drug: Rogaratinib (BAY1163877)|Drug: Chemotherapy
Drug: Quadratus Lumborum Block (QLB)|Drug: Standard of Care
Drug: Saline Solution|Drug: Ceftazidime
Drug: Cardiac Drug|Drug: Placebos
Drug: NRX-101|Drug: Lurasidone HCl|Drug: Placebo
Drug: risankizumab IV|Drug: placebo for rizankizumab|Drug: rizankizumab SC
Drug: NRX-101|Drug: Lurasidone HCl
Drug: D-Mannose
Drug: Propolis tablet to limit dental biofilm|Drug: Xilytol tablet to limit dental biofilm
Drug: N-acetyl-L-cysteine (NAC)|Other: supportive therapy
Drug: placebo infusion|Drug: Dexmedetomidine infusion
Drug: injection bevacizumab|Drug: injection Combined Bevacizumab and Fasudil
Drug: vitamin C, vitamin B1, hydrocortisone|Drug: Normal saline
Drug: Ga-68 PSMA-HBED-CC PET
Drug: EnvarsusXR|Drug: Tacrolimus
Drug: Busulfan (BU)|Drug: Cyclophosphamide (CY)|Drug: Etoposide (VP-16)|Drug: Melphalan
Drug: Maekmoondong-tang|Drug: Placebo
Drug: Endocervical Lidocaine spray
Drug: Ticagrelor|Drug: ticagrelor|Drug: clopidogrel
Drug: Buprenorphine|Drug: Placebo|Drug: Multimodal Oral Scheme
Drug: Triple therapy group
Drug: cisplatin plus pemetrexed
Drug: Varicella Vaccine
Drug: Sipjeondaebo-tang Granule|Drug: Placebo
Drug: Givinostat
Drug: Epirubicin|Drug: Cyclophosphamide|Drug: Docetaxel|Drug: Goserelin acetate|Drug: Tamoxifen|Drug: Letrozole
Drug: Padsevonil
Drug: Nivolumab|Drug: Rituximab|Drug: Gemcitabine|Device: Oxaliplatin
Drug: Misoprostol 200Mcg Tab|Procedure: elective cesarean section
Drug: Lidocaine Iv|Drug: Dexmedetomidine|Drug: Normal saline
Drug: Ravidasvir|Drug: Danoprevir|Drug: Ritonavir|Drug: Ribavirin 100 MG|Drug: Ravidasvir Placebo|Drug: Danoprevir Placebo|Drug: Ritonavir Placebo|Drug: Ribavirin Placebo
Drug: Tranexamic Acid|Drug: Vehicle
Drug: GP MDI 28.8 µg|Drug: GP MDI 14.4 µg|Drug: GP MDI 7.2 µg|Drug: Placebo MDI|Drug: Spiriva Respimat 2.5 µg
Drug: combined oral contraceptive pills
Drug: Tirofiban|Drug: Alteplase
Drug: Triptorelin SR
Drug: intravitreal injection of bevacizumab|Radiation: intravitreal injection of bevacizumab+ targeted laser
Drug: Tocilizumab Injection|Drug: Azathioprine
Drug: Epirubicin|Drug: Fluorouracil|Drug: Docetaxel|Drug: Cyclophosphamide
Drug: Tolcapone 200 MG
Drug: Dupilumab|Drug: Matching placebo
Drug: Metronidazole|Procedure: Scaling Root Planing|Behavioral: Oral Hygiene Instructions
Drug: pegylated liposomal doxorubicin|Drug: pirarubicin
Drug: Botulinum toxin injections for chronic compartment syndrome|Procedure: surgical fasciotomy for chronic compartment syndrome
Drug: Treatment of MTX and TwHF placebo|Drug: Treatment of TwHF and MTX placebo
Drug: Ipatasertib|Drug: Paclitaxel|Drug: Placebo
Drug: 100mg Berberine hydrochloride|Drug: 300mg Berberine hydrochloride|Drug: Placebo Oral Tablet
Drug: Dexmedetomidine|Drug: bupivacaine
Drug: Brivaracetam (BRV) iv|Drug: Brivaracetam (BRV) oral
Drug: Nifedipine 10 mg|Drug: Labetalol
Drug: hyperpolarized 129Xe gas MRI|Drug: Bevespi Aerosphere
Drug: Treatment of MTX|Drug: Treatment of MTX and TwHF
Drug: Tacrolimus|Drug: Envarsus XR
Drug: Hydrogen|Drug: Minocycline|Other: Placebo Hydrogen|Other: Placebo Minocycline
Drug: Empirical therapy group|Drug: Guided therapy group
Drug: Naloxegol 25 MG|Other: Placebo pill
Drug: Rituximab|Drug: Glatiramer Acetate
Drug: Valsartan|Drug: Placebo Oral Tablet
Drug: Oral paclitaxel|Drug: Paclitaxel injection
Drug: TEV-48125|Drug: Placebos
Drug: TEV-48125|Drug: Placebo
Drug: Pembrolizumab|Drug: Nivolumab|Drug: Indoximod|Drug: Placebo
Drug: Seladelpar 2 mg Capsule|Drug: Seladelpar 5 mg Capsule|Drug: Seladelpar 10 mg Capsule
Drug: BHV-4157|Drug: Placebo
Drug: Cabazitaxel|Drug: Abiraterone|Drug: Enzalutamide
Drug: Pegfilgrastim|Drug: Plinabulin|Other: D5W Placebo|Other: Saline Placebo|Drug: Docetaxel, doxorubicin, and cyclophosphamide (TAC)
Drug: Deferiprone|Drug: Placebo Oral Tablet
Drug: CyclASol topical ocular, eye drops|Drug: Vehicle topical ocular, eye drops
Drug: Hydroxyprogesterone 250 Mg|Drug: hydroxyprogesterone 500mg
Drug: Sodium Oxybate
Drug: 18F-Flutemetamol PET/MRI
Drug: Secretin, Pig|Drug: Placebo - Concentrate
Drug: Zoledronic Acid|Drug: Methylprednisolone|Drug: Placebos
Drug: BCD-100|Drug: Docetaxel
Drug: Letrozole|Drug: Everolimus
Drug: 0.2-0.7 mcg/kg/h dexmedetomedine infusion.|Drug: 10-70 mcg/kg/h propofol infusion.
Drug: DEX 0.2 µg/kg/h.
Drug: Berberine hydrochloride|Drug: Placebo
Drug: rescue regimen|Drug: high dose methotrxate
Drug: Naltrexone Injectable Suspension|Other: Treatment as usual
Drug: Trimetazidine|Drug: Placebo oral capsule
Drug: Rivaroxaban 10 mg qd|Drug: Rivaroxaban 15 mg qd|Drug: DAPT
Drug: Astragalus Membranaceus|Drug: Placebo
Drug: Azithromycin Oral Liquid Product|Drug: Nitazoxanide Oral Suspension|Dietary Supplement: Nicotinamide|Drug: Placebos
Drug: Rimegepant
Drug: HRIG
Drug: Sildenafil 20 MG|Drug: Placebo Oral Tablet
Drug: Bupivacaine HCl collagen-matrix implant|Drug: Bupivacaine HCl with epinephrine infiltration
Drug: Pethidine hydrochloride|Drug: Ropivacaine HCl Inj 7.5 MG/ML|Drug: Fentanyl
Drug: Decitabine plus Modified BUCY|Drug: Modified BUCY
Drug: Propranolol Hydrochloride|Drug: Placebo Oral Tablet
Drug: Mirtazapine 30 mg oral tablets|Drug: Placebo oral tablets
Drug: SHP607
Drug: HIPEC-gemcitabine
Drug: Neostigmine|Drug: ketamine
Drug: MT-5547|Drug: MT-5547-matching placebo
Drug: Moxifloxacin|Drug: Placebo
Drug: Megestrol Acetate|Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS)
Drug: LH-8|Drug: Placebos
Drug: intrathecal morphine|Drug: Morphine PCA|Drug: Ropivacaine infiltration
Drug: Fluocinolone Acetonide (FA) implant
Drug: Placebo oral capsule|Drug: Pregabalin Oral Capsule [Lyrica] 75mg|Drug: Pregabalin Oral Capsule [Lyrica] 150 mg
Drug: MIN-102|Drug: Placebos
Drug: Group 1 Natamycin 5% Suspension + voriconazole 1% eye drops; Group 2 Natamycin 5% Suspension + Vehicle eye drops
Drug: Busulfan (BU)|Drug: Cyclophosphamide (CY)|Drug: Etoposide (VP-16)
Drug: Xylitol|Drug: Saline
Drug: Truvada
Drug: Tumescent Anesthesia and antibiotic delivery (TAAD) plus IVAD|Device: SubQKath
Drug: AXS-05|Drug: Bupropion|Drug: Placebo
Drug: Ketamine|Other: Normal Saline|Drug: Midazolam injection
Drug: Vancomycin Hydrochloride|Drug: Saline Solution
Drug: Ginkgo Diterpene Lactone Meglumine Injection|Drug: Acetylsalicylic acid
Drug: Esomeprazole 40 mg Oral Tablet|Drug: Placebo Oral Tablet
Drug: 20% subcutaneous immunoglobulin
Drug: Empagliflozin 25mg|Drug: Placebo
Drug: D-chiro-inositol|Drug: Myoinositol
Drug: ALLOD-2 Capsules|Drug: Placebo Capsules
Drug: Multiprofen|Other: Placebo
Drug: botulinum toxin A|Drug: saline
Drug: PBI-4050
Drug: L Carnitine|Behavioral: Supervised exercise|Drug: Placebos|Behavioral: Exercise at home
Drug: Group A amantadine sulfate|Other: Group B ringer lactate
Drug: Alectinib|Drug: Atezolizumab|Drug: Pemetrexed|Drug: Cisplatin|Drug: Carboplatin|Drug: Gemcitabine
Drug: diclofenac|Drug: ketorolac
Drug: topiramate|Behavioral: prolonged exposure|Drug: placebo
Drug: MT-5199|Drug: Placebo
Drug: Diclofenac Potassium 50mg Tab|Drug: Placebo
Drug: NiuBangZi pill or NiuBangZi pill placebo
Drug: Fangji Huangqi pill or Fangji Huangqi pill placebo
Drug: Medical Marijuana|Drug: Placebo
Drug: Maraviroc 300 mg|Behavioral: Rehabilitation therapy|Drug: Placebo 300 mg
Drug: Ixazomib|Drug: Pomalidomide|Drug: Dexamethasone
Drug: Lorcaserin|Drug: Placebo
Drug: group (A)|Drug: group (B)|Drug: group (c)
Drug: Jinshuibao Capsule
Drug: selective brain cooling by cold saline perfusion|Device: mechanical thrombectomy
Drug: Diclofenac potassium|Other: Placebo
Drug: Ranolazine plus Metoprolol Combination|Drug: FlecainidE pluS Metoprolol Combination
Drug: Dexmedetomidine|Drug: Clonidine|Drug: Levobupivacaine
Drug: rAAV2-ND4
Drug: Lactobacillus crispatus CTV-05|Drug: Placebo
Drug: Propranolol Pill
Drug: Olaparib|Drug: Paclitaxel and Carboplatin
Drug: Propofol|Drug: Fentanyl
Drug: Gonadotropin-Releasing Hormone Analogue|Drug: Gonadotropin releasing hormone antagonist
Drug: Olanzapine|Other: Placebo
Drug: Glucocorticoids|Drug: Vitamin D
Drug: Sogyeonghwalhyeol-tang granule|Other: Sogyeonghwalhyeol-tang granule with manipulation procedure|Other: Placebo with manipulation procedure
Drug: Hyaluronic Acid|Drug: Triamcinolone Acetonide
Drug: CNP520 50mg|Drug: CNP520 15mg|Other: Placebo to CNP520
Drug: Dexmedetomidine|Drug: Normal saline|Device: Bispectral index|Device: Train of four ratio
Drug: Varlitinib|Drug: mFOLFOX6|Drug: Placebo
Drug: Maraviroc|Drug: Metformin
Drug: Topical epinephrine|Drug: Placebos
Drug: OTM Dexmedetomidine 1µg/ kg.|Drug: OTM Dexmedetomidine 0.75µg/ kg.|Drug: OTM Dexmedetomidine 0.5µg/ kg.
Drug: Prednisone|Drug: Vincristine|Drug: Daunorubicin|Drug: Pegaspargase|Drug: Erwinase®|Drug: Rituximab|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Mercaptopurine|Drug: Dasatinib|Drug: Methotrexate|Drug: Blinatumomab|Drug: Ruxolitinib|Drug: Bortezomib|Drug: Dexamethasone|Drug: Doxorubicin|Drug: Etoposide|Drug: Clofarabine|Drug: Vorinostat|Drug: Idarubicin
Drug: Low dose DFD07 once daily|Drug: High dose DFD07 once daily|Drug: High dose DFD07 twice daily|Drug: Placebo twice daily
Drug: Traditional Treatment (Group T)|Drug: Ketamine Infusion (Group K)
Drug: Candiplus|Drug: Clotrimazole
Drug: Buprenorphine|Drug: Naltrexone|Drug: Vivitrol
Drug: SENS-111 100mg|Drug: SENS-111 200mg|Drug: Placebo Oral Tablet
Drug: Ketamine|Procedure: Control
Drug: Nebulized Lignocaine|Drug: Lignocaine spray|Drug: Combined spray and nebulization
Drug: Norepinephrine|Drug: Dopamine
Drug: Amphora gel|Drug: Placebo
Drug: Darbepoetin Alfa
Drug: High dose Aspirin & Vitamin D|Drug: High dose Aspirin, Vitamin D placebo|Drug: Low dose Aspirin , Vitamin D|Drug: Low dose Aspirin, Vitamin D placebo|Drug: Aspirin Placebo, Vitamin D|Drug: Aspirin placebo, Vitamin D placebo
Drug: Botulinum Toxin Type A|Drug: Normal saline
Drug: Plinabulin|Drug: Pegfilgrastim|Other: Saline Placebo|Other: D5W Placebo
Drug: Elamipretide
Drug: 2mg Dexamethasone|Drug: 4mg Dexamethasone|Drug: Ropivacaine (TAP blocks)|Drug: Morphine|Drug: Bupivacaine Hydrochloride|Drug: Normal saline 1ml|Drug: Normal saline 0.5ml
Drug: Paromomycin Sulfate|Drug: Pentamidine Isethionate|Other: Placebo
Drug: CM082 combined with everolimus|Drug: CM082|Drug: Everolimus
Drug: NaBen®|Other: Placebo
Drug: Varlitinib|Drug: Capecitabine|Drug: Placebo (for Varlitinib)
Drug: Azacitidine|Drug: Cytarabine|Drug: Decitabine|Other: Laboratory Biomarker Analysis|Drug: Midostaurin|Biological: Nivolumab
Drug: Ginkgo biloba dispersible tablets|Drug: Donepezil|Drug: Ginkgo biloba dispersible tablets and Donepezil
Drug: Irinotecan liposome injection|Drug: Topotecan
Drug: Vasopressin, Arginine|Drug: Placebos
Drug: SCYX 7158
Drug: Curcumin|Drug: microcrystalline cellulose
Drug: lapatinib/herceptin
Drug: Calcium Hydroxide, Iodoform, paste|Drug: 3-mixtatin
Drug: Placebo|Drug: Visbiome|Drug: VSL#3
Drug: Erlotinib Hydrochloride
Drug: Bicalutamide|Drug: Docetaxel|Radiation: External Beam Radiation Therapy|Drug: Flutamide|Drug: Goserelin Acetate|Other: Laboratory Biomarker Analysis|Drug: Leuprolide Acetate|Drug: Nilutamide
Drug: RhIL-2
Drug: 0.5% Ropivacaine|Drug: Normal saline
Drug: Pirfenidone|Drug: Placebo oral capsule|Drug: Steroids
Drug: Ketamine, bupivacine,dexmedetomidine
Drug: Clopidogrel|Drug: ticagrelor
Drug: Metformin|Drug: Ursodeoxycholic Acid
Drug: Ibuprofen 400 mg|Drug: Acetaminophen 650 mg|Drug: OxyCODONE 5 Mg Oral Tablet
Drug: N-acetyl cysteine|Drug: Placebo oral capsule
Drug: Vortioxetine|Other: THINC-it Tool
Drug: Liothyronine|Drug: Levothyroxin|Drug: Placebos
Drug: Ondansetron|Drug: Placebos
Drug: bRESCAP|Drug: placebo
Drug: Phenylephrine|Drug: Ephedrine
Drug: NB medication (Naltrexone Bupropion combination)|Other: Placebo
Drug: Ergocalciferol|Other: Placebo
Drug: NB medication (Naltrexone Bupropion combination)|Behavioral: Behavioral Weight Loss (BWL) counseling|Other: Placebo
Drug: Omit Citrotide 0.25 dose on the day of triggering of ovulation
Drug: Allogeneic Mesenchymal Stromal Cell|Other: Placebo
Drug: Netupitant / Palonosetron|Other: Placebo|Behavioral: Symptom Questionnaires|Behavioral: Patient Diary
Drug: Testosterone cypionate|Other: Standard nutrition and physical therapy at ICU
Drug: Somatropin|Drug: 0.09% Saline Solution
Drug: Liposomal bupivacaine|Drug: Bupivacaine|Drug: Epinephrine|Drug: Normal saline
Drug: Dorzolamide-timolol|Other: Artificial tears
Drug: 600 mg Clindamycin orally|Drug: Oral Placebo
Drug: Amoxicillin/Clavulanate Potassium 875 mg-125 mg oral tablet|Drug: Oral placebo
Drug: Cetuximab plus FOLFIRI/FOLFOX|Drug: FOLFIRI/FOLFOX/CapeOX
Drug: Amoxicillin
Drug: Sunitinib|Drug: Lomustine
Drug: Caffeine
Drug: L-carnitine|Other: usual intake
Drug: Neostigmine|Drug: Dexamethasone
Drug: Haloperidol|Drug: Chlorpromazine|Behavioral: Symptom Questionnaire
Drug: Placebo Oral Capsule|Drug: Bardoxolone Methyl
Drug: ANAKINRA 100 mg/daily subcutaneously|Drug: Placebo
Drug: BHV-0223|Drug: Placebo
Drug: Setmelanotide
Drug: Sodium Butyrate|Drug: Placebo Oral Capsule
Drug: Empagliflozin|Drug: Metformin
Drug: Fecal Microbiota Therapy (FMT)|Drug: Placebo
Drug: Cumin seed extract|Drug: clotrimazole
Drug: X4P-001|Drug: Placebo
Drug: Oxytocin|Drug: Placebos
Drug: Dexmedetomidine 0.35µg/kg /h|Drug: Dexmedetomidine 0.5µg/kg /h
Drug: Melatonin|Other: Placebo
Drug: Butylphthalide Soft Capsules|Drug: Placebo Butylphthalide Soft Capsules
Drug: Peginterferon Alfa-2A
Drug: Ca Ionophore A23187|Other: Placebo
Drug: Testosterone|Drug: Placebos
Drug: PRO 140 SC injections
Drug: Intrathecal hyperbaric bupivacaine 0.25mg/kg 0.5%|Drug: caudal plain bupivacaine 2.5mg/kg 0.25%
Drug: Sofosbuvir Oral Product|Drug: Ribavirin
Drug: Berberine|Drug: Placebos|Drug: Antipsychotic Agents
Drug: 18F-DCFPyL Injection
Drug: Rosuvastatin|Drug: Atorvastatin
Drug: Cetuximab|Drug: mFOLFOX6|Drug: FOLFIRI
Drug: DLBS1033|Drug: Placebo|Drug: Standard therapy
Drug: Bupivacaine 0.25% 20ml on each side Sonar guided TAB|Drug: Morphine 10mg|Drug: Morphine 15mg
Drug: Vasopressin|Drug: Normal Saline
Drug: ALK Diluent|Drug: ALK Alutard SQ 5-grasses or ALK Alutard Birch
Drug: IMRT combine with cisplatin concurrent chemotherapy|Drug: IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
Drug: Ketalar|Drug: NaCl 9%
Drug: Morphine Sulfate|Drug: Triamcinolone|Drug: placebo
Drug: Docetaxel|Drug: FGFR Inhibitor AZD4547|Other: Laboratory Biomarker Analysis
Drug: Propranolol|Drug: Placebo
Drug: Anagrelide|Drug: Ruxolitinib (JAKAVI®)|Drug: IFNa/ PegIFNa
Drug: sofosbuvir
Drug: BHV-4157|Drug: Placebo Comparator
Drug: Pentoxifylline 400Mg Tablet
Drug: Active Treatment Group 7% Hypertonic Saline|Drug: Control Group 0.9% Isotonic Saline
Drug: aganirsen
Drug: Clostridium Botulinum Toxin Type A
Drug: Letrozole|Drug: Placebo
Drug: CI-581a
Drug: Acetazolamide|Drug: Dexamethasone
Drug: Neem leaf extract|Drug: Chlorhexidine gluconate
Drug: Placebo|Drug: Letrozole
Drug: Betamethasone|Drug: Placebo
Drug: Dexamethasone|Procedure: Any surgical intervention aim at treating chronic subdural hematoma
Drug: Salsalate|Drug: PLACEBO
Drug: Magnesium Sulfate|Drug: Bupivacaine
Drug: Lysine Acetilsalicilate|Drug: Aspirin
Drug: Erlotinib Hydrochloride|Other: Laboratory Biomarker Analysis|Biological: Rilotumumab
Drug: Docetaxel|Drug: Cisplatinum|Radiation: IMRT
Drug: Midodrine Hydrochloride
Drug: Gemcitabine|Drug: 5-FU|Drug: Capecitabine|Drug: Oxaliplatine|Drug: Irinotecan|Procedure: Pancreatic surgery
Drug: Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)|Behavioral: Aerobic Exercise Training|Other: Usual Care|Behavioral: Stretching Exercise|Drug: Atorvastatin
Drug: RO7034067
Drug: Oral azithromycin|Drug: Placebo
Drug: Blinatumomab|Drug: Investigator's Choice Chemotherapy
Drug: Ecopipam 50mg|Drug: Ecopipam 100mg
Drug: Placebo|Drug: RO7034067
Drug: Diazepam|Drug: Acetazolamide
Drug: ART plus Chidamide|Drug: ART plus Placebo
Drug: Valproic Acid
Drug: Setmelanotide|Drug: Placebo
Drug: Fecal Microbiota suspension|Drug: Normal saline
Drug: ticagrelor|Drug: clopidogrel
Drug: Intranasal Oxytocin|Drug: Placebo
Drug: Juanbi pill|Drug: Juanbi pill placebo|Drug: Methotrexate
Drug: Deferiprone|Drug: Acetylcysteine|Drug: Sitagliptin and Metformin
Drug: Postoperative chemotherapy|Drug: Neoadjuvant chemotherapy
Drug: Cholecalciferol|Other: Placebo
Drug: testosterone|Other: Progressive muscle training
Drug: EMS Fluticasone 1|Drug: EMS Fluticasone 2|Drug: EMS Fluticasone 3|Other: EMS Placebo Fluticasone
Drug: vindesine|Drug: cyclophosphamide|Drug: Epirubicin|Drug: prednisone tablets|Drug: Cinobufacini Tablets|Drug: Rituximab
Drug: SHINCORT|Drug: XYLOCAINE|Device: sham electroacupuncture|Device: electroacupuncture
Drug: Cholecalciferol|Other: Milk (Nestle)
Drug: Ascorbic Acid|Drug: Zinc acetate
Drug: Gemcitabine|Drug: Cisplatin|Radiation: Chemoradiation|Procedure: PETCECT|Procedure: Laparoscopy
Drug: Tranexamic acid|Drug: Saline 0.9%
Drug: NTRA-9620|Drug: Placebo
Drug: PRO 140
Drug: CDZ173
Drug: 2-mg Intravitreous Aflibercept Injection|Procedure: Prompt Vitrectomy Plus Panretinal Photocoagulation
Drug: Triptorelin (GnRHa) + Chemotherapy
Drug: Trichosanthes root|Drug: Placebo
Drug: Dexmedetomidine intervention|Drug: Placebo
Drug: varenicline
Drug: Capsaicin patch
Drug: TAP block w Liposomal bupivacaine|Procedure: TAP block w normal saline
Drug: Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine|Drug: 6-mercaptopurine,Methotrexate|Drug: Dexamethasone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Doxorubicin, 6-mercaptopurine|Drug: Dexamethasone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Methotrexate|Drug: Dexamethasone, Vindesine, Methotrexate, Ifosfamide, Daunorubicin, Pegylated-asparaginase|Drug: Dexamethasone, Cytarabine, Etoposide, Pegylated-asparaginase|Drug: Methotrexate, 6-mercaptopurine
Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b|Drug: Placebo
Drug: Esmolol
Drug: Atezolizumab|Biological: Bevacizumab|Other: Laboratory Biomarker Analysis|Drug: Pegylated Liposomal Doxorubicin Hydrochloride|Other: Quality-of-Life Assessment
Drug: Human derived Transfer factor|Drug: Aqua pro injectione 4ml ampules for subcutaneous injection
Drug: R-IDARAM plus intrathecal chemotherapy
Drug: Apixaban|Drug: Rivaroxaban
Drug: Harvoni
Drug: Methionine|Drug: DOTANOC
Drug: Capsaicin|Drug: Magnesia calcinada
Drug: Cetrorelix
Drug: SOX Sequential S-1|Drug: SOX|Drug: TEGAFOX Sequential S-1.
Drug: Intralipid 20%|Drug: Modified Ringers Lactate
Drug: Cisplatin-gemcitabine|Device: Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)
Drug: Adderall-XR|Drug: Matched placebo
Drug: Testosterone|Drug: Normal Saline
Drug: Nabilone|Drug: Placebo
Drug: Placebo|Drug: Lidocaine|Drug: Tamoxifen
Drug: Citrulline|Drug: Placebo
Drug: Varenicline|Drug: Cytisine|Drug: Nicotine Replacement Therapy|Drug: Varenicline Placebo|Drug: Cytisine Placebo|Drug: Nicotine Replacement Therapy Placebo
Drug: TGR-1202 + Ublituximab|Drug: TGR-1202|Drug: TGR-1202 + Ublituximab + Bendamustine
Drug: Sarizotan|Drug: Placebo
Drug: 13C-Methacetin
Drug: Docetaxel|Other: Laboratory Biomarker Analysis|Drug: Palbociclib
Drug: Ketamine|Drug: Milnacipran|Drug: Placebo
Drug: JinFuKang|Drug: XingZaoRuanJian|Drug: pemetrexed,docetaxel,gemcitabine,paclitaxel or vinorelbine combined with carboplatin?cis-platinum or nedaplatin
Drug: XELOX or FOLFOX chemotherapy
Drug: Cadisurf|Drug: Survanta
Drug: Eltrombopag|Drug: Placebo (for Eltrombopag)
Drug: Ophthalmic Tetracaine|Other: Normal Saline
Drug: Lucentis® (Raibizumab) double-dose|Drug: Lucentis® (Raibizumab) regular-dose
Drug: Oxaliplatin(OXA), 5-fluorouracil (5-FU)|Procedure: Hepatic arterial catheter implantation
Drug: Docetaxel|Biological: Durvalumab|Other: Laboratory Biomarker Analysis
Drug: Rituximab (RTX)|Drug: MOR208|Drug: Bendamustine (BEN)
Drug: Dexamethasone|Other: 0.9% NaCl Placebo|Drug: LIA Combination Mixture
Drug: Perioperative systemic therapy|Procedure: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)
Drug: Acetazolamide|Drug: Placebo
Drug: gilteritinib|Drug: azacitidine
Drug: ONO-4538|Drug: Oxaliplatin|Drug: Tegafur- Gimeracil-Oteracil potassium|Drug: Capecitabine|Drug: Placebo
Drug: Decitabine|Drug: Busulfan (BU)|Drug: Cyclophosphamide (CY)|Drug: Granulocyte Colony-Stimulating Factor(G-CSF)
Drug: Carboplatin|Drug: Paclitaxel|Drug: Cisplatin|Drug: Capecitabine|Radiation: Radiotherapy
Drug: Isoniazid|Drug: Rifapentine
Drug: Sitafloxacin|Drug: Ertapenem
Drug: BCD-033 (interferon beta 1a)|Drug: Rebif (interferon beta 1a)|Drug: Placebo
Drug: Dexmedetomidine|Drug: saline
Drug: Intravenous ketamine0.5mg/kg|Drug: Nebulized Ketamine 0.5mg/kg|Drug: Nebulized Ketamine 1mg/kg
Drug: Cabotegravir tablets|Drug: TDF/FTC tablets|Drug: TDF/FTC placebo tablets|Drug: CAB placebo tablets|Drug: CAB LA|Drug: Placebo for CAB LA
Drug: icosapent ethyl (IPE)|Other: gel cap placebo
Drug: ADI-PEG 20 plus Pem Cis|Other: Placebo plus Pem Cis
Drug: Ringer lactate
Drug: rhTPO|Drug: Placebo
Drug: Fludarabine|Drug: Thiotepa|Drug: Melphalan|Drug: ATG|Drug: Cyclosporine A|Drug: Mycophenolate mofetil|Biological: bone marrow or peripheral blood stem cells
Drug: Cyclosporin A|Drug: Dydrogesterone
Drug: Capecitabine|Drug: Oxaliplatin|Drug: 5-fluorouracil|Drug: Folinic Acid
Drug: Apatinib|Procedure: TACE
Drug: molgramostim|Drug: placebo
Drug: Pregabalin|Drug: Placebo
Drug: atropine+ propofol|Drug: atropine + atracurium + sufentanil
Drug: Palbociclib + Letrozole or Fulvestrant
Drug: L-Carnosine|Drug: Placebo|Behavioral: Cognitive Training
Drug: Aspirin|Drug: Placebo|Drug: Pantoprazole
Drug: Leuprolide Acetate|Drug: Goserelin Acetate|Drug: Triptorelin|Drug: Enzalutamide|Radiation: Stereotactic Body Radiation Therapy
Drug: ALK Alutard birch or 5-grasses|Drug: ALK diluent
Drug: Disulfiram|Dietary Supplement: Copper|Drug: Alkylating Agents
Drug: gallium Ga 68-PSMA|Procedure: Magnetic Resonance Imaging|Procedure: Positron Emission Tomography
Drug: LCZ696|Drug: Enalapril|Drug: Placebo of LCZ696|Drug: Placebo of Enalapril
Drug: Adderall XR
Drug: Idarubicin(IDA)|Drug: Busulfan (BU)|Drug: Cyclophosphamide (CY)
Drug: Busulfan (BU)|Drug: Cyclophosphamide (CY)|Radiation: Total Body Irradiation (TBI)
Drug: VX-210|Drug: Placebo
Drug: Docetaxel|Drug: Oxaliplatin|Drug: Calciumfolinat|Drug: 5-Fluorouracil|Biological: Ramucirumab
Drug: Ketamine IV Infusion|Procedure: ECT
Drug: tobramycin inhalation solution|Drug: Saline 0.9% inhalation solution
Drug: Rifaximin|Procedure: Fecal microbiota transplantation
Drug: Entecavir|Drug: Lamivudine
Drug: Donafenib|Drug: Sorafenib
Drug: docetaxel|Drug: doxorubicin or epirubicin|Drug: cyclophosphamide|Drug: gemcitabine|Drug: cisplatin
Drug: Ketamine|Drug: 0.9% NaCl
Drug: Inhaled Treprostinil
Drug: Inhaled Treprostinil|Drug: Placebo
Drug: ALXN1101
Drug: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548|Procedure: Magnetic Resonance Imaging|Procedure: Positron Emission Tomography
Drug: Fenoldopam|Drug: 0.9%NS
Drug: extended release naltrexone
Drug: Chromoendoscopy using Acetic Acid 2.5%|Other: Standard random esophageal biopsies
Drug: arimoclomol|Drug: Placebo
Drug: [68Ga]-DOTANOC PET/CT
Drug: Valganciclovir
Drug: PR Oxycodone|Drug: Levodopa|Drug: Oxycodone Placebo|Drug: Levodopa placebo
Drug: Dienogest|Drug: Levonorgestrel
Drug: Fentanyl Sublingual Spray|Procedure: Shuttle Walk Test|Behavioral: Questionnaires|Behavioral: Mental Ability Tests|Behavioral: Phone Call
Drug: Lidocaine|Drug: Saline
Drug: GEMCIS|Drug: mFolfirinox
Drug: Bedaquiline|Drug: Pretomanid|Drug: Moxifloxacin|Drug: Linezolid|Drug: Clofazimine|Drug: Locally accepted standard of care which is consistent with the WHO recommendations for the treatment of M/XDR-TB.
Drug: Anlotinib|Drug: Placebo
Drug: FLOT alone|Biological: FLOT + Herceptin/Pertuzumab
Drug: Enalapril Maleate Tablets(as the program-based antihypertension)|Drug: Enalapril Maleate and Folic Acid tablets(as the program-based antihypertension)|Drug: Placebo
Drug: sodium fusidate
Drug: Atabecestat, 5 mg|Drug: Atabecestat, 25 mg|Drug: Placebo
Drug: docetaxel + trastuzumab sc + pertuzumab|Drug: trastuzumab emtansin
Drug: Doxazosin|Drug: Nifedipine
Drug: Doxycycline|Other: Standard care for STEMI
Drug: Ledipasvir/Sofosbuvir|Drug: Sofosbuvir and Daclatasvir|Drug: Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir|Drug: Entecavir|Drug: Tenofovir disoproxil
Drug: Amitriptyline|Other: Placebo
Drug: Gabapentin|Drug: Buprenorphine|Drug: Clonidine|Drug: Naltrexone (oral)|Drug: Naltrexone (depot)|Drug: Placebo
Drug: VTS-270|Drug: Sham Procedure Control
Drug: Routine Treatment of CD|Biological: MSC treatment 01|Biological: MSC treatment 02|Other: NS
Drug: Escitalopram 10mg|Drug: LABCAT TCJUSS|Drug: LABCAT TCJUSS Placebo|Drug: Escitalopram Placebo
Drug: Floxuridine (FUDR),Dexamethasone (DXM), Heparin in combination with Oxaliplatin and Capecitabine (CapeOX) or in combination with Oxaliplatin and Leucovorin and 5-FU (mFOLFOX6)|Drug: Oxaliplatin and Capecitabine (CapeOX) or Oxaliplatin and Leucovorin and 5-FU (mFOLFOX6)
Drug: Liposomal Doxorubicin+Gemcitabine|Drug: FOLFOX4
Drug: volanesorsen|Drug: Placebo
Drug: Nifedipine
Drug: eplerenone|Drug: amiloride|Drug: Placebo|Drug: Cinacalcet
Drug: metoprolol|Drug: Nifedipine
Drug: Ticagrelor and Acetylsalicylic acid|Drug: Clopidogrel and Acetylsalicylic acid
Drug: N-Acetylcysteine followed by Placebo|Drug: Placebo followed by N-Acetylcysteine
Drug: Cediranib Maleate|Other: Laboratory Biomarker Analysis|Drug: Olaparib|Drug: Paclitaxel|Drug: Pegylated Liposomal Doxorubicin Hydrochloride|Other: Questionnaire Administration|Drug: Topotecan Hydrochloride
Drug: novolog insulin|Drug: levemir insulin|Drug: placebo
Drug: SB dexmedetomidine bupivacaine block|Drug: intravenous dexmedetomidine
Drug: Oxaliplatin HAI|Drug: Oxaliplatin IV|Drug: mFOLFOX6|Drug: LV5FU2
Drug: VM-1500|Drug: Efavirenz|Drug: Antiretroviral therapy (ART)
Drug: Sodium chloride|Drug: Fentanyl
Drug: Semi-individualised Chinese Medicine treatment|Drug: Routine medical care (active comparator)
Drug: Dexmedetomidine|Drug: Magnesium Sulphate|Drug: Bupivacaine|Drug: Dexmedetomidine + Magnesium Sulphate + Bupivacaine
Drug: PRO 140|Drug: Placebo|Drug: Optimized Background Regimen
Drug: Rapamycin|Drug: Placebo
Drug: Gemtuzumab ozogamicin (GO)
Drug: Betamethasone - ACTIVE|Other: Normal Saline - PLACEBO
Drug: Nitazoxanide|Drug: Lactulose
Drug: Fenofibrate|Other: No intervention
Drug: Linezolid|Drug: Bedaquiline|Drug: Levofloxacin|Drug: Pyrazinamide|Drug: Isoniazid|Drug: Ethionamide|Drug: Terizidone|Drug: Moxifloxacin|Drug: Kanamycin
Drug: Fenofibrate|Drug: Placebo|Drug: Propranolol
Drug: Ketamine|Other: Placebo Comparator
Drug: Pentoxifylline Plus Chemotherapy|Drug: Placebo Plus Chemotherapy
Drug: Melatonin (N-acetyl-5-methoxytryptamine)|Drug: Placebo
Drug: Rizatriptan|Drug: Placebo
Drug: Itraconazole|Drug: Glucocorticoids
Drug: Afatinib Dimaleate|Biological: Cetuximab|Other: Laboratory Biomarker Analysis
Drug: Ibrutinib|Drug: Gemcitabine|Drug: Nab-paclitaxel
Drug: Engerix B|Drug: Fendrix
Drug: ALK Alutard Birch and/or 5-grasses|Drug: ALK Diluent
Drug: Methylprednisolone + ASTED|Drug: Methylprednisolone +Placebo
Drug: I131|Drug: I123
Drug: Nicotinamide
Drug: Idarubicin|Drug: Daunorubicin|Drug: HD Cytarabine|Drug: Cyclosporine|Drug: Methotrexate|Drug: Mycophenolic acid (MPA)|Drug: vosaroxin|Drug: ID cytarabine
Drug: Fluorouracil|Drug: Oxaliplatin|Drug: Leucovorin|Biological: DC-CIK
Drug: Regular Human Insulin|Drug: Placebo
Drug: Idursulfase-IT
Drug: lorcaserin|Drug: Varenicline|Drug: Placebo
Drug: Oxytocin Spray|Drug: Placebo Spray
Drug: Prednisone,Vincristine, Cyclophosphamide|Drug: Cyclophosphamide, Vincristine, Cytarabine, Doxorubincin, Prednisone|Drug: Ifosphamide, Etoposide, Methotrexate, Vincristine, Prednisone|Drug: Cyclophosphamide, Vindelsine, Cytarabine, Doxorubincin, Prednisone|Drug: Ifosphamide, Etoposide, Methotrexate, Vindelsine, Prednisone|Drug: Rituximab
Drug: ASTED|Dietary Supplement: Selenium|Other: Placebo
Drug: Octreotide
Drug: DTG +DRV/r|Drug: SOC
Drug: Nifurtimox|Drug: Benznidazole|Drug: Placebo
Drug: Nevirapine|Drug: Kaletra|Drug: Lamivudine|Drug: Zidovudine
Drug: Gabapentin|Other: Placebo|Other: Questionnaire Administration
Drug: Valacyclovir|Drug: Placebo
Drug: QPI-1007 Injection - 1.5 mg|Drug: QPI-1007 Injection - 3.0 mg|Other: Sham Injection Procedure
Drug: lipoprostaglandin E1
Drug: Cabergoline
Drug: lanreotide|Drug: Placebo
Drug: Itraconazole|Drug: Placebo
Drug: F/TAF|Drug: 3rd ARV agent
Drug: prednisone
Drug: Nimotuzumab|Drug: Paclitaxel|Drug: Cisplatin|Radiation: Radiation|Procedure: Surgery
Drug: Propranolol
Drug: 16 weeks of VEC + CDDP|Drug: VEC + HD-MTX|Drug: Chemotherapy + Valproate|Radiation: Conformal radiotherapy|Drug: VEC|Drug: Chemotherapy|Radiation: conformal radiotherapy +/- boost
Drug: DTG
Drug: Lamotrigine|Drug: Placebo
Drug: Cholinesterase inhibitor|Drug: Sham discontinuation
Drug: Dolutegravir 50mg od|Drug: Standard of Care
Drug: CD25 monoclonal antibody|Drug: calcineurin inhibitors|Biological: MSCs
Drug: Carboplatin|Drug: Fractionated Cisplatin|Drug: Gemcitabine
Drug: dexmedetomidine|Drug: placebo
Drug: bevacizumab|Device: PASCAL Endpoint Management (EpM) laser treatment
Drug: Berberine hydrochloride|Drug: placebo
Drug: Paclitaxel|Drug: Cisplatin|Drug: Gonadotropin-releasing hormone agonist|Drug: Letrozole
Drug: Cisplatin|Radiation: Postoperative radiotherapy
Drug: Prednisone|Drug: Vinblastine|Drug: mercaptopurine|Drug: INDOMETHACIN|Drug: Methotrexate|Drug: Cytosine Arabinoside|Drug: 2-chlorodeoxyadenosine|Procedure: hematopoietic stem cell transplantation (RIC-HSCT)|Biological: Intravenous immunoglobulin
Drug: Isoquercetin
Drug: Progesterone|Drug: Placebo (for Progesterone)
Drug: fexinidazole
Drug: Intranasal Ketamine|Drug: Intranasal Saline Placebo
Drug: IV N-acetylcysteine (NAC)|Drug: Water
Drug: Doxorubicin Hydrochloride|Drug: Ifosfamide|Other: Laboratory Biomarker Analysis|Drug: Pazopanib Hydrochloride|Other: Pharmacological Study|Radiation: Radiation Therapy|Procedure: Therapeutic Conventional Surgery
Drug: nalbuphine HCl ER 90 mg BID|Drug: nalbuphine HCl ER 120 mg BID|Drug: nalbuphine HCl ER 180 mg BID
Drug: Gemcitabine|Drug: Oxaliplatin|Drug: 5-Fluorouracil|Drug: Irinotecan|Drug: Natriumfolinate
Drug: Repamipide|Drug: Placebo
Drug: Decitabine (DTC Arm)|Drug: Paclitaxel and Carboplatin (TC Arm)
Drug: Maraviroc|Drug: Placebo
Drug: Byetta 5Mcg Pen Injection
Drug: Docetaxel|Biological: Durvalumab|Drug: Erlotinib Hydrochloride|Drug: FGFR Inhibitor AZD4547|Biological: Ipilimumab|Other: Laboratory Biomarker Analysis|Biological: Nivolumab|Drug: Palbociclib|Other: Pharmacological Study|Biological: Rilotumumab|Drug: Talazoparib|Drug: Taselisib|Biological: Tremelimumab
Drug: Tapentadol prolonged release|Drug: Morphine prolonged release
Drug: Tenofovir + Emtricitabine or Lamivudine + Zidovudine|Drug: Tenofovir + Emtricitabine or Lamivudine + Lopinavir/ritonavir|Drug: Tenofovir + Emtricitabine or Lamivudine + Raltegravir
Drug: DLBS1033|Drug: Placebo
Drug: Ca plus vit D
Drug: Sugar Pill|Drug: Chinese Red Yeast Rice (CRYR)|Drug: CRYR + TRF|Device: Tocotrienol-enriched Fraction of Palm Oil (TRF)
Drug: Cisplatin|Other: Clinical Observation|Drug: Fluorouracil|Drug: Gemcitabine Hydrochloride|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Other: Quality-of-Life Assessment
Drug: dupilumab SAR231893 (REGN668)
Drug: toremifene or tamoxifen
Drug: Cladribine s.c. injection, HCL treatment
Drug: Prednisone|Drug: Allopurinol
Drug: Bupropion XL|Drug: placebo
Drug: Dexamethasone|Procedure: Burr Hole Craniostomy
Drug: Ketamine / Propofol Admixture|Drug: Etomidate
Drug: L-Threo DOPS|Drug: placebo
Drug: Tryptophan|Drug: Placebo
Drug: Carboplatin|Other: Laboratory Biomarker Analysis|Drug: Metformin Hydrochloride|Drug: Paclitaxel|Other: Placebo|Other: Quality-of-Life Assessment|Other: Questionnaire Administration
Drug: Metformin glycinate|Drug: Metformin Hydrochloride
Drug: Intravenous paracetamol|Drug: Intravenous ibuprofen
Drug: Tranexamic Acid (Cyklokapron)
Drug: Ticagrelor, Prasugrel, Clopidogrel
Drug: Spironolactone|Drug: Placebo|Drug: Standard care
Drug: GZ402666
Drug: Prucalopride|Drug: Placebo
Drug: Mitomycin-C|Drug: Fluorometholone 1% topical ocular steroid
Drug: Anlotinib|Drug: Placebo Capsule
Drug: Xeris glucagon|Drug: Lilly glucagon
Drug: ATV|Drug: DRV|Drug: Cobicistat|Drug: BR
Drug: OCYTOCINA - SPRAY NASAL
Drug: placebo (saline)|Drug: GZ402665
Drug: Paracetamol|Drug: Placebo
Drug: Misoprostol|Drug: Placebo
Drug: Oxaliplatin; Capecitabine|Other: Oxaliplatin; Capecitabine; concurrent radiotherapy
Drug: Tacrolimus and Sirolimus|Drug: Tacrolimus
Drug: Corticosteroid injection (Bupivacaine and Depo Medrol)|Biological: Platelet rich plasma injection
Drug: Anakinra 100 mg|Drug: Placebo
Drug: VP16|Radiation: TBI|Drug: Thiotepa|Drug: Treosulfan|Drug: Fludarabine|Drug: Busulfan
Drug: DLBS1442 100|Drug: Mefenamic acid|Drug: DLBS1442 200
Drug: Lithium|Drug: Placebo
Drug: Epirubicin + cisplatin + 5-fluorouracil|Radiation: Preoperative chemoradiotherapy|Procedure: Gastric resection
Drug: high dose indomethacin|Other: standard dose
Drug: acamprosate|Drug: Placebo
Drug: NaBen®|Drug: Placebo
Drug: docetaxel, epirubicin and cyclophosphamide|Drug: docetaxel, epirubicin and cyclophosphamide plus endostar
Drug: Sorafenib|Procedure: TACE
Drug: Ethanol|Procedure: Ablation
Drug: injectable naltrexone|Drug: placebo comparator
Drug: Rituximab|Drug: Cyclophosphamide
Drug: Raltegravir|Drug: Lopinavir/Ritonavir
Drug: hydrocortison hemisuccinate|Drug: placebo followed by hydrocortisone hemisuccinate
Drug: Acamprosate|Drug: Placebo
Drug: cisplatin|Drug: docetaxel|Biological: cetuximab|Other: laboratory biomarker analysis|Procedure: quality-of-life assessment|Radiation: intensity-modulated radiation therapy
Drug: Anakinra|Drug: Pentoxifylline|Drug: Zinc Sulfate|Drug: Methylprednisolone
Drug: Human apotransferrin
Drug: Postoperative Chemotherapy
Drug: L-carnitine|Drug: 5% Dextrose
Drug: ORACEA®|Drug: Placebo
Drug: Docetaxel|Biological: HyperAcute®-Lung Immunotherapy|Drug: Gemcitabine|Drug: Pemetrexed
Drug: Insulin (Humulin® R U-100)|Drug: Placebo
Drug: Gantenerumab|Drug: Solanezumab|Drug: Matching Placebo (Gantenerumab)|Drug: Matching Placebo (Solanezumab)|Drug: JNJ-54861911|Drug: Matching Placebo (JNJ-54861911)
Drug: PREOB® Implantation|Procedure: Bone Autograft
Drug: Transplants from 8/8-matched Unrelated donors|Drug: Transplants from family-mismatched/haploidentical donors
Drug: Axitinib|Drug: Sandostatin LAR|Drug: Placebo
Drug: Levosimendan|Drug: Conventional therapy
Drug: Fluconazole|Drug: Flucytosine|Procedure: lumbar punctures
Drug: Zolpidem extended-release|Behavioral: MET/CBT
Drug: FACBC|Radiation: Radiation therapy
Drug: Metformin|Drug: Sugar pill
Drug: Xeloda
Drug: Hyperbaric Oxygen
Drug: Clarithromycin Extended Release|Drug: Streptomycin intramuscular injection
Drug: FG-4592
Drug: SOMATROPINE* : Norditropine® simplexx®|Biological: Placebo
Drug: Bupivacaine
Drug: misoprostol
Drug: Cladribine and pegylated interpheron alpha-2a
Drug: Dronabinol|Drug: Clonidine|Drug: Placebo
Drug: Phenylbutyrate|Drug: Placebo powder
Drug: Tegafur, Gimeracil and Oteracil Potassium Capsules;Oxaliplatin|Drug: Oxaliplatin; Capecitabine
Drug: FOLFOX (chemotherapy)|Other: 5 FUCMT (chemoradiation)|Procedure: surgery|Procedure: magnetic resonance imaging or endorectal ultrasound
Drug: Additive classical homeopathy|Drug: Homeopathic Placebo globules
Drug: Paclitaxel(intravenous) + Carboplatin(intravenous)|Drug: Paclitaxel(intravenous) + Carboplatin(intraperitoneal)
Drug: Mifamurtide arm|Other: 3 drugs arm
Drug: masitinib|Drug: placebo
Drug: Erlotinib|Drug: Gemcitabine/cisplatin
Drug: (Epirubicin Cisplatin 5-Fluorouracil / Xeloda) OR 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel|Other: Carboplatin paclitaxel plus concurrent radiotherapy
Drug: Lidocaine|Drug: Placebo (D5W)
Drug: Sebelipase alfa (SBC-102)
Drug: Acetaminophen/APAP
Drug: Meglumine antimoniate
Drug: Talactoferrin alfa|Drug: Placebo
Drug: Clotrimazole + Gentamicin + Beclomethasone|Drug: Clotrimazole + Gentamicin
Drug: Phylloquinone|Drug: Menatetrenone (MK4)|Drug: placebo
Drug: Amsacrine|Drug: Clofarabine|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Daunorubicin hydrochloride|Drug: Dexamethasone|Drug: Doxorubicin hydrochloride|Drug: Etoposide phosphate|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Methylprednisolone|Drug: Pegaspargase|Drug: Thioguanine|Drug: Vincristine sulfate|Radiation: Whole-brain radiation therapy
Drug: 5-Fluorouracil|Drug: Leucovorin|Drug: Oxaliplatin|Drug: Docetaxel|Drug: Epirubicin|Drug: Cisplatin|Drug: 5-fluorouracil
Drug: fluorouracil|Drug: fluorouracil, oxaliplatin
Drug: Lenalidomide|Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Rituximab|Drug: Etoposide
Drug: Capecitabine and Oxaliplatin
Drug: Epigallocatechin-Gallate|Drug: Placebo
Drug: Topiramate with brief behavioral enhancement therapy|Drug: Placebo with brief behavioral enhancement therapy
Drug: Rituximab|Drug: Cyclosporine
Drug: Alemtuzumab|Drug: Basiliximab|Drug: Sirolimus|Drug: Tacrolimus
Drug: Sirolimus + calcineurin inhibitor + prednisone|Drug: Sirolimus + prednisone
Drug: Imiquimod
Drug: Carboplatin and Paclitaxel|Drug: Doxorubicin, cyclophosphamide|Drug: Doxorubicin, cyclophosphamide, carboplatin, thiotepa, cyclophosphamide
Drug: Oxcarbazepine
Drug: COPAD|Drug: COP, COPD M3, CYM|Drug: COP, COPADM8, CYVE
Drug: New Medication: Enalapril, Isradipine, Propranolol
Drug: Zoledronic acid|Drug: Placebo
Drug: carboplatin,|Drug: cisplatin|Drug: gemcitabine hydrochloride|Drug: paclitaxel|Radiation: intensity-modulated radiation therapy
Drug: Silibinin
Drug: Omegaven®
Drug: quinidine|Drug: no therapy
Drug: arbutin, tretinoin, triamcinolone|Drug: Triluma
Drug: Carbidopa|Drug: Placebo
Drug: Salsalate|Drug: Placebo
Drug: inhaled nitric oxide|Drug: oxygen
Drug: Bupropion|Drug: Varenicline|Drug: Placebo|Behavioral: Smoking Cessation Counseling
Drug: GnRH|Drug: NAL-GLU GnRH antagonist|Drug: Estrogen patch
Drug: Cyclophosphamide|Drug: Fludarabine|Procedure: Total Body Irradiation|Procedure: Bone Marrow Transplantation|Drug: Mycophenolate Mofetil|Drug: Sirolimus
Drug: Plasma-derived AT-III concentrate
Drug: Celecoxib|Drug: Docetaxel|Drug: Prednisolone|Drug: ADT|Drug: Zoledronic Acid|Drug: Abiraterone|Radiation: Radiotherapy to the prostate|Drug: Enzalutamide|Drug: Metformin|Drug: Transdermal Oestradiol
Drug: naltrexone implant|Drug: Oral naltrexone|Drug: placebo oral and placebo implant
Drug: Busulfan, Fludarabine, ATG, TLI|Drug: Busulfan, Cyclophosphamide, ATG, GCSF|Drug: Campath, Fludarabine, Cyclophosphamide|Radiation: Total Body Irradiation|Procedure: Stem cell infusion
Drug: 500 mg of depot hydroxy-progesterone
Drug: Hemolink (hemoglobin raffimer IV solution)
Drug: glyceryl trierucate|Drug: glyceryl trioleate